WO2017047547A1 - Curable composition and cured product of same - Google Patents

Curable composition and cured product of same Download PDF

Info

Publication number
WO2017047547A1
WO2017047547A1 PCT/JP2016/076818 JP2016076818W WO2017047547A1 WO 2017047547 A1 WO2017047547 A1 WO 2017047547A1 JP 2016076818 W JP2016076818 W JP 2016076818W WO 2017047547 A1 WO2017047547 A1 WO 2017047547A1
Authority
WO
WIPO (PCT)
Prior art keywords
meth
acrylate
group
monofunctional
ring
Prior art date
Application number
PCT/JP2016/076818
Other languages
French (fr)
Japanese (ja)
Inventor
孝治 小西
慎一郎 塚田
信輔 宮内
Original Assignee
大阪ガスケミカル株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大阪ガスケミカル株式会社 filed Critical 大阪ガスケミカル株式会社
Priority to JP2017539891A priority Critical patent/JP7138437B2/en
Publication of WO2017047547A1 publication Critical patent/WO2017047547A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/26Esters containing oxygen in addition to the carboxy oxygen
    • C08F220/30Esters containing oxygen in addition to the carboxy oxygen containing aromatic rings in the alcohol moiety
    • C08F220/301Esters containing oxygen in addition to the carboxy oxygen containing aromatic rings in the alcohol moiety and one oxygen in the alcohol moiety
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/38Esters containing sulfur
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F290/00Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
    • C08F290/02Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated end groups
    • C08F290/06Polymers provided for in subclass C08G

Definitions

  • the present invention relates to a novel curable composition capable of forming a cured product having a high refractive index and the cured product thereof.
  • polyfunctional (meth) acrylates having a plurality of (two or more) (meth) acryloyl groups in the molecule are used in various fields.
  • the polyfunctional (meth) acrylate having a fluorene skeleton has excellent optical properties (for example, high refractive index, high transparency, etc.) derived from the fluorene skeleton (for example, 9,9-bisarylfluorene skeleton, etc.). ) And the like, it is used as an optical material.
  • polyfunctional (meth) acrylate having a fluorene skeleton typically, 9,9-bis [(meth) acryloyloxy (poly) alkoxyaryl] fluorene and the like are known.
  • polyfunctional (meth) acrylates especially polyfunctional (meth) acrylates having a fluorene skeleton
  • polyfunctional (meth) acrylates having a fluorene skeleton often have a relatively high viscosity, and are usually monofunctional (metafunctional) for improving handling properties.
  • a reactive diluent such as acrylate.
  • Patent Document 1 discloses 9,9-bis [(meth) acryloyloxypolyalkoxyphenyl] fluorene in which the average value of the number of oxyalkylene groups added is adjusted to a specific range. , Curable compositions containing the fluorene compound, and cured products thereof. It is described that the compound having a fluorene skeleton and the curable composition containing the compound are excellent in handling properties and curability, and the cured product can achieve both a high refractive index and scratch resistance.
  • aryloxyalkyl (meth) acrylates that are aromatic (meth) acrylates [for example, C 6-10 aryloxy C 1-10 alkyl (meth) acrylates such as phenoxyethyl (meth) acrylate] have a high refractive index. It is also described that it is a monofunctional (meth) acrylate that can balance both excellent handling properties and excellent handling properties and can efficiently maintain scratch resistance.
  • curable compositions comprising a wide variety of mono- or polyfunctional acrylates such as phenoxyethyl acrylate
  • curable compositions and cured products thereof have high handling properties and exhibit high refractive index and scratch resistance in the cured products, further improvements have been required in the field of optical materials.
  • an object of the present invention is to provide a novel curable composition capable of forming a cured product having a high refractive index even if it contains a reactive diluent, a cured product thereof, and a method for producing the cured product. is there.
  • Another object of the present invention is to provide a novel curable composition capable of forming a cured product having high handling properties (low viscosity) and having a high refractive index, and a cured product thereof.
  • Still another object of the present invention is to provide a curable composition capable of forming a cured product having excellent scratch resistance (flexibility), and a cured product thereof.
  • Another object of the present invention is to provide a method and a viscosity reducing agent capable of effectively lowering the viscosity even with a high-viscosity polyfunctional (meth) acrylate.
  • the present inventors combined a polyfunctional (meth) acrylate with a monofunctional (meth) acrylate having a condensed polycyclic aryl group as a reactive diluent. Even if it contains a reactive diluent, it can form a cured product having a high refractive index, and even if the monofunctional (meth) acrylate is solid at room temperature, it has a high-viscosity polyfunctional (meth) acrylate.
  • the present invention has been completed by finding that the viscosity can be lowered and the handleability can be improved.
  • the curable composition of the present invention contains a polyfunctional (meth) acrylate and a novel first monofunctional (meth) acrylate represented by the following formula (1).
  • R 1 is a hydrogen atom or a methyl group
  • R 2 is a linear or branched alkylene group
  • R 3 is an alkyl group
  • Ar 1 is a condensed polycyclic arene ring
  • a is an integer of 1 to 4
  • b represents 0 or an integer of 1 or more.
  • the first monofunctional (meth) acrylate represented by the formula (1) may be a condensed polycyclic C 10-14 aryloxy C 2-4 alkyl (meth) acrylate.
  • Multifunctional (meth) acrylate is represented by the following formula (2)
  • R 4a and R 4b and R 5a and R 5b are the same or different non-reactive substituents
  • R 6a and R 6b are direct
  • R 7a and R 7b are hydrogen atoms or methyl groups
  • k1 and k2 are 0 or an integer of 1 or more
  • m1 and m2 are 0 or an integer of 1 or more
  • n1 and n2 are 0 or 1
  • At least one high-viscosity multifunctional selected from the group consisting of fluorene skeleton-containing (meth) acrylates, alicyclic or aromatic epoxy (meth) acrylates, urethane (meth) acrylates and polyester (meth) acrylates (Meth) acrylate may be included.
  • the rings Z 1 and Z 2 and the rings Z 3 and Z 4 may each be a benzene ring or a naphthalene ring
  • k1 and k2 may be 0, and R 5a and R 5b are It may be a C 1-6 alkyl group or a C 6-10 aryl group
  • m1 and m2 may be 0 or an integer of 1 to 2
  • R 6a and R 6b are linear C 2-6 alkylene It may be a group
  • n1 and n2 may be an integer of 1 to 10
  • p1 and p2 may be 1.
  • the polyfunctional (meth) acrylate may contain at least fluorene (meth) acrylate represented by the formula (2) and urethane (meth) acrylate.
  • the polyfunctional (meth) acrylate may contain di (meth) acrylate of an alkylene oxide adduct of biphenols or bisphenols in addition to the high-viscosity polyfunctional (meth) acrylate.
  • the aromatic epoxy (meth) acrylate may be an aromatic epoxy (meth) acrylate represented by the following formula (3).
  • R 8 represents a hydrogen atom, an alkyl group or an aryl group, respectively, and two R 8 may be bonded to each other to form a hydrocarbon ring which may have an alkyl group, R 9a and R 9b is an alkyl group or an aryl group, R 10a and R 10b are linear or branched alkylene groups, R 11a and R 11b are hydrogen atoms or methyl groups, q1 and q2 are integers of 0 to 4, r1 and r2 is 0 or an integer of 1 or more, and t is 0 or 1.
  • the urethane (meth) acrylate may be a polyester type urethane (meth) acrylate, a polyether type urethane (meth) acrylate, a polycarbonate type urethane (meth) acrylate, or the like.
  • the viscosity (25 ° C.) of the polyfunctional (meth) acrylate may be high viscosity, for example, 3000 mPa ⁇ s or more.
  • the curable composition further includes at least one second unit selected from the group consisting of alkylthio (meth) acrylates, arylthio (meth) acrylates, aralkylthio (meth) acrylates, and arylthioalkyl (meth) acrylates.
  • Functional (meth) acrylate sulfur atom-containing monofunctional (meth) acrylate
  • the curable composition may further contain a third monofunctional (meth) acrylate represented by the following formula (4).
  • R 12 is a hydrogen atom or a methyl group
  • R 13 is an alkylene group
  • R 14 is an alkyl group
  • Ar 2 is a benzene ring or a ring-arene ring
  • c is an integer of 1 to 4
  • d is 0 or 1 or more. Indicates an integer.
  • the curable composition may further contain a polymerization initiator.
  • the present invention includes a cured product obtained by curing the curable composition, and further includes a method of producing the cured product by applying active energy to the curable composition and curing the composition.
  • the present invention also includes a viscosity reducing agent for reducing the viscosity of the polyfunctional (meth) acrylate, the viscosity reducing agent including the first monofunctional (meth) acrylate.
  • the viscosity reducing agent may further contain the second monofunctional (meth) acrylate.
  • the present invention also includes a method of reducing the viscosity of the polyfunctional (meth) acrylate by adding the first monofunctional (meth) acrylate to the polyfunctional (meth) acrylate.
  • the present invention also includes the first monofunctional (meth) acrylate, which is a novel compound.
  • (poly) alkoxy means both an alkoxy group and a polyalkoxy group.
  • the curable composition of the present invention contains a polyfunctional (meth) acrylate and a monofunctional (meth) acrylate having a condensed polycyclic aryl group (first monofunctional (meth) acrylate), Even when a reactive diluent (monofunctional (meth) acrylate or the like) is contained, a cured product having a high refractive index can be formed. Therefore, the amount of expensive multifunctional (meth) acrylate used can be effectively reduced. Further, the first monofunctional (meth) acrylate can function as a viscosity reducing agent, improves the handling property (low viscosity) of the curable composition, and forms a cured product having a high refractive index. You can also Furthermore, the cured product can achieve both a high refractive index and scratch resistance (flexibility).
  • FIG. 1 is a graph showing the refractive index before curing of the compositions of Comparative Examples 1 to 5 and Examples 1 to 5 with respect to the blending ratio of the diluent.
  • FIG. 2 is a graph showing the viscosity with respect to the blending ratio of the compositions of Comparative Examples 1 to 5 and Examples 2 to 5.
  • FIG. 3 is a graph showing the viscosity (calculated value) of a composition that achieves a target refractive index in a BPEFA / reactive diluent blending system.
  • the curable composition of the present invention contains a polyfunctional (meth) acrylate and a first monofunctional (meth) acrylate having a condensed polycyclic aryl group as a reactive diluent.
  • This first monofunctional (meth) acrylate is a novel compound.
  • the first monofunctional (meth) acrylate having a condensed polycyclic aryl group is a compound represented by the following formula (1).
  • R 1 is a hydrogen atom or a methyl group
  • R 2 is a linear or branched alkylene group
  • R 3 is an alkyl group
  • Ar 1 is a condensed polycyclic arene ring
  • a is an integer of 1 to 4
  • b represents 0 or an integer of 1 or more.
  • the group R 1 is a hydrogen atom or a methyl group.
  • the group R 2 is a linear or branched alkylene group.
  • linear alkylene group examples include linear C 2-6 alkylene groups such as ethylene group, trimethylene group, tetramethylene group (preferably Can be exemplified by a linear C 2-4 alkylene group, more preferably a linear C 2-3 alkylene group, particularly an ethylene group.
  • branched alkylene group examples include a propylene group and 1,2-butanediyl.
  • a branched C 3-6 alkylene group such as a 1,3-butanediyl group (preferably a branched C 3-4 alkylene group, particularly a propylene group).
  • a linear or branched C 2-6 alkylene group (eg, a linear or branched C 2-4 alkylene group) is preferable, and a linear or branched group is more preferable. It may be a chain C 2-3 alkylene group (particularly an ethylene group or a propylene group).
  • the repeating number a of the group (R 2 O) can be selected from an integer of about 1 to 4, for example, an integer of about 1 to 3, preferably 1 or 2, and more preferably 1. If the repetition number a is too large, the refractive index of the cured product may be reduced. When a is 2 or more, the two or more groups R 2 may be the same or different.
  • the ring Ar 1 is a condensed polycyclic arene ring, such as a condensed bicyclic arene ring (for example, a condensed bicyclic C 10-16 arene ring such as a naphthalene ring), a condensed tricyclic ring, etc.
  • a condensed bi to tetracyclic arene rings such as a formula arene ring (for example, anthracene ring, phenanthrene ring, etc.).
  • Preferable ring Ar 1 includes a condensed polycyclic C 10-16 arene ring (preferably a condensed polycyclic C 10-14 arene ring) such as a naphthalene ring and an anthracene ring, and a naphthalene ring is particularly preferable.
  • the group R 3 may be an alkyl group, for example, methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group, s-butyl group, t- Linear or branched C 1-12 alkyl group such as butyl group, pentyl group, neopentyl group, hexyl group, heptyl group, octyl group, 2-ethylhexyl group, nonyl group, decyl group, preferably linear or A branched C 1-9 alkyl group, more preferably a linear or branched C 1-6 alkyl group (for example, a linear or branched C 1-4 alkyl group) and the like can be mentioned.
  • alkyl group for example, methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group
  • the substitution number b of the group R 3 may be 0 or an integer of 1 or more, for example, an integer of about 0 to 4, preferably an integer of about 0 to 2, more preferably 0 or 1, particularly 0. Good.
  • the types of the two or more groups R 3 may be the same or different.
  • aryloxyalkyl (meth) acrylate for example, 2- (2-naphthoxy) ethyl (meth) acrylate, 2- (1-naphthoxy) ethyl (meth) acrylate, 2- (2-naphthoxy) propyl (meth) acrylate, etc.
  • the first monofunctional (meth) acrylate represented by the formula (1) can be used individually or in combination of 2 or more types.
  • Such a first monofunctional (meth) acrylate represented by the formula (1) has a condensed polycyclic aryl group, or a cured product even if mixed in a large amount in the curable composition. Can maintain or improve the refractive index, and has a high viscosity reducing effect. Therefore, for example, both high refractive index and low viscosity characteristics can be achieved, and the blending ratio (or usage amount) of expensive polyfunctional (meth) acrylate can be effectively reduced.
  • the reactive diluent is a liquid compound exhibiting high fluidity at the operating temperature (for example, at room temperature of about 25 ° C.). Surprisingly, it is represented by the formula (1).
  • the first monofunctional (meth) acrylate to be produced is in the form of powder or viscous material, and is a compound that exhibits almost no fluidity, but has high viscosity and multifunctionality (meta). )
  • the viscosity of the acrylate can be significantly reduced. Therefore, the first monofunctional (meth) acrylate can also function as a viscosity reducing agent for reducing the viscosity of the polyfunctional (meth) acrylate.
  • a method of mixing a polyfunctional (meth) acrylate with a viscosity reducing agent containing at least the first monofunctional (meth) acrylate is particularly preferable.
  • the resulting curable composition can be effectively reduced in viscosity, and the refractive index can be maintained or improved.
  • the blending ratio of the first monofunctional (meth) acrylate and the polyfunctional (meth) acrylate may be the same as the ratio in the curable composition described later.
  • the compound represented by the formula (1) is a known method (for example, a method according to the method described in JP 2012-222040 A (paragraph [0014])), for example, a hydroxy-fused polycyclic arene.
  • a (meth) acrylic acid component for example, (meth) acrylic acid or an ester-forming derivative thereof (for example, acid halide, acid anhydride, lower alkyl ester, etc.)).
  • a (meth) acrylic acid component for example, (meth) acrylic acid or an ester-forming derivative thereof (for example, acid halide, acid anhydride, lower alkyl ester, etc.)
  • Examples of the hydroxy-fused polycyclic arene include compounds corresponding to the compound represented by the formula (1) (for example, 1-naphthol, 2-naphthol, etc.).
  • Examples of the alkylene oxide or alkylene carbonate include alkylene oxide or alkylene carbonate (for example, ethylene oxide) corresponding to the alkylene group exemplified in the above R 2 section.
  • Typical examples of the alkylene oxide or alkylene carbonate adduct of the hydroxy-fused polycyclic arene include 2- (2-naphthyloxy) ethanol (NEO), 2- (1-naphthyloxy) propanol, 2- (2- Examples thereof include hydroxy (mono to tetra) C 2-4 alkoxy-C 10-14 condensed polycyclic arenes such as (2-naphthyloxy) ethoxy) ethanol.
  • 90/10 to 3/97 preferably 80/20 to 5/95 (eg 70/30 to 10/90), more preferably 65/35 to 13/87 (eg 60/40 to 17/83), particularly 55/45 to 20/80 (for example, 50/50 to 22/78).
  • the proportion of the first monofunctional (meth) acrylate represented by the formula (1) is too small, there is a possibility that the refractive index and / or the viscosity cannot be sufficiently reduced.
  • the ratio of the total amount of the polyfunctional (meth) acrylate and the first monofunctional (meth) acrylate represented by the formula (1) with respect to the entire polymerizable component in the curable composition is, for example, 30 to 100% by weight (50 to 100% by weight), preferably 60 to 100% by weight (for example, 70 to 100% by weight), more preferably about 80 to 100% by weight (for example, 90 to 100% by weight).
  • it may be substantially 100% by weight (only the polyfunctional (meth) acrylate and the first monofunctional (meth) acrylate represented by the formula (1)).
  • the polyfunctional (meth) acrylate is not particularly limited as long as it has a plurality of (two or more) (meth) acryloyl groups.
  • the number of (meth) acryloyl groups per molecule may be, for example, about 2 to 10, preferably 2 to 6, and more preferably about 2 to 4 (eg 2).
  • there are too many (meth) acryloyl groups there exists a possibility that the scratch resistance of hardened
  • Typical polyfunctional (meth) acrylates include, for example, polyfunctional (meth) acrylates having a 9,9-bisarylfluorene skeleton; aliphatic epoxy (meth) acrylates [for example, 1,6-hexanediol Di (meth) acrylate such as di (meth) acrylate of alkylene glycol diglycidyl ether such as di (meth) acrylate of glycidyl ether, poly (alkylene glycol diglycidyl ether such as di (meth) acrylate of polypropylene glycol diglycidyl ether] Alicyclic epoxy (meth) acrylate; aromatic epoxy (meth) acrylate; urethane (meth) acrylate; polyester (meth) acrylate; alkylene glycol di (meth) acrylate [for example, ethylene glycol Poly C, such as polyalkylene glycol di (meth) acrylates [for example, diethylene glycol di (meth
  • the polyfunctional (meth) acrylate may be viscous or solid at room temperature (for example, 25 ° C.).
  • the viscosity (25 ° C.) of the polyfunctional (meth) acrylate may be, for example, 1000 mPa ⁇ s or more, preferably 3000 mPa ⁇ s or more, more preferably 5000 mPa ⁇ s or more.
  • the upper limit of the viscosity is not particularly limited, and for example, it may exceed the measurement limit value (for example, 352 Pa ⁇ s) of the viscometer described in Examples described later.
  • a polyfunctional (meth) acrylate having a 9,9-bisarylfluorene skeleton for example, a fluorene skeleton-containing (meth) acrylate represented by the formula (2)
  • a fat It is preferable to include at least one selected from the group consisting of cyclic epoxy (meth) acrylates, aromatic epoxy (meth) acrylates, urethane (meth) acrylates, and polyester (meth) acrylates.
  • a polyfunctional (meth) acrylate having a 9,9-bisarylfluorene skeleton for example, a fluorene skeleton-containing (meth) represented by the formula (2)
  • Acrylates aromatic epoxy (meth) acrylates
  • urethane (meth) acrylates are often used.
  • Polyfunctional (meth) acrylates having a 9,9-bisarylfluorene skeleton have various properties such as optical properties (eg, high refractive index, low birefringence, transparency), mechanical properties, and heat resistance. Since it is excellent, it is suitable for improving the properties of the obtained cured product.
  • optical properties eg, high refractive index, low birefringence, transparency
  • mechanical properties e.g., heat resistance
  • heat resistance e.g., heat resistance to improve the properties of the obtained cured product.
  • “having a 9,9-bisarylfluorene skeleton” means that the molecular structure includes at least a 9,9-bisarylfluorene skeleton, and forms a fluorene ring of the skeleton.
  • a typical polyfunctional (meth) acrylate having a 9,9-bisarylfluorene skeleton is a compound represented by the following formula (2) (sometimes referred to as a fluorene skeleton-containing (meth) acrylate). Good.
  • rings Z 1 and Z 2 and rings Z 3 and Z 4 arene rings, R 4a and R 4b and R 5a and R 5b are the same or different non-reactive substituents, and R 6a and R 6b are direct
  • a linear or branched alkylene group R 7a and R 7b are hydrogen atoms or methyl groups, k1 and k2 are 0 or an integer of 1 or more, m1 and m2 are 0 or an integer of 1 or more, and n1 and n2 are 0 or 1 (The above integers, p1 and p2 represent integers of 1 or more.)
  • examples of the arene ring represented by the rings Z 1 and Z 2 include a monocyclic arene ring such as a benzene ring, a polycyclic arene ring, and the like.
  • a polycyclic arene ring fused polycyclic aromatic hydrocarbon ring
  • a ring assembly arene ring ring assembly aromatic hydrocarbon
  • Examples of the condensed polycyclic arene ring include the condensed polycyclic arene ring exemplified in the description of the ring Ar 1 in the formula (1), and the preferred embodiment is the same as the ring Ar 1 .
  • ring-assembled arene ring examples include a bearene ring (for example, a bi-C 6-12 arene ring such as a biphenyl ring, a binaphthyl ring, and a phenylnaphthalene ring (such as a 1-phenylnaphthalene ring and a 2-phenylnaphthalene ring)), a tellarene ring (for example, a tel C 6-12 arene ring such as a terphenylene ring) can be exemplified.
  • Preferred ring-assembled arene rings include bi-C 6-10 arene rings, and biphenyl rings are particularly preferred.
  • the two rings Z 1 and Z 2 bonded to the 9-position of fluorene may be the same or different and are usually the same.
  • a benzene ring, a naphthalene ring, a biphenyl ring and the like are preferable, and a benzene ring is particularly preferable.
  • substitution positions of the rings Z 1 and Z 2 bonded to the 9-position of fluorene are not particularly limited.
  • the groups corresponding to the rings Z 1 and Z 2 bonded to the 9-position of fluorene may be 2-biphenylyl group, 3-biphenylyl group, 4-biphenylyl group, etc. There may be.
  • examples of the arene ring represented by the rings Z 3 and Z 4 include a monocyclic arene ring such as a benzene ring, a condensed polycyclic arene ring (a condensed polycyclic aromatic hydrocarbon ring). ) And the like.
  • examples of the condensed polycyclic arene ring include the condensed polycyclic arene ring exemplified in the description of the ring Ar 1 in the formula (1), and the preferred embodiment is the same as the ring Ar 1 .
  • preferred rings Z 3 and Z 4 include a benzene ring and a naphthalene ring.
  • Rings Z 3 and Z 4 form a condensed ring skeleton together with a 5-membered ring interposed between them, for example, one of the rings Z 3 and Z 4 , a benzofluorene skeleton in which one is a benzene ring and the other is a naphthalene ring, A dibenzofluorene skeleton in which is a naphthalene ring may be formed.
  • Ring Z 3 and Z 4 is a fused polycyclic arene ring
  • the ring Z 3 and Z 4 bonding position of the 5-membered ring interposed therebetween (or, in the ring Z 3 and Z 4, wherein
  • the position of two adjacent carbon atoms shared with a 5-membered ring) is not particularly limited as long as it can be bonded (or shared), and for example, 1,2-position, 2,3-position of the naphthalene ring, or The carbon atom at any position in the 3,4-position may be shared with the 5-membered ring.
  • the condensed ring skeleton structure in the above formula (2) may be any of the structures represented by the following formulas (a) to (i).
  • Particularly preferred ring Z 3 and Z 4 is a benzene ring, a condensed ring structure 5 membered ring interposed ring Z 3 and Z 4 as well as between them form both the ring Z 3 and Z 4 is a benzene ring
  • a fluorene skeleton is particularly preferred.
  • the non-reactive substituents (or non-radically polymerizable substituents) R 4a and R 4b may be hydrocarbon groups [eg, alkyl groups (eg, methyl, ethyl, propyl, isopropyl, A linear or branched C 1-6 alkyl group such as a group, a butyl group or a t-butyl group), an aryl group (eg, a C 6-10 aryl group such as a phenyl group)], a cyano group, A halogen atom (for example, a fluorine atom, a chlorine atom, a bromine atom, etc.) etc. are mentioned.
  • alkyl groups eg, methyl, ethyl, propyl, isopropyl, A linear or branched C 1-6 alkyl group such as a group, a butyl group or a t-butyl group
  • an aryl group eg, a C 6
  • an alkyl group for example, a linear or branched C 1-4 alkyl group (particularly a C 1-3 alkyl group such as a methyl group)), a cyano group, a halogen atom are preferable, and an alkyl group is particularly preferable.
  • substitution numbers k1 and k2 of the groups R 4a and R 4b are 0 or an integer of 1 or more and can be selected according to the rings Z 3 and Z 4 .
  • the number of substitutions k1 and k2 can usually be selected from an integer of about 0 to 6, for example, an integer of about 0 to 4 (eg, 0 to 3), preferably an integer of about 0 to 2, and more preferably 0 or 1 , Especially 0.
  • the substitution numbers k1 and k2 in the rings Z 3 and Z 4 may be the same or different from each other, and the types of the groups R 4a and R 4b may be the same or different from each other.
  • the types of the two or more groups R 4a and R 4b in the respective rings Z 3 and Z 4 may be the same or different from each other. Further, the substitution position of the groups R 4a and R 4b is not particularly limited. For example, when the rings Z 3 and Z 4 and the 5-membered ring interposed therebetween form a fluorene ring, the 2-position of the fluorene ring Or 7-position (2-position, 3-position, 7-position, etc.).
  • a halogen atom for example, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom
  • a hydrocarbon group
  • an alkyl group a linear or branched C 1-10 alkyl group such as methyl group, ethyl group, propyl group, isopropyl group, n-butyl group, s-butyl group, t-butyl group, preferably Linear or branched C 1-6 alkyl group, more preferably linear or branched C 1-4 alkyl group, etc .
  • cycloalkyl group eg, C 5-10 such as cyclopentyl group, cyclohexyl group, etc.
  • Cycloalkyl group etc. aryl group [eg, phenyl group, alkylphenyl
  • C 6-10 aryl -C 1-4 alkyl group such as a phenethyl group
  • an alkoxy group e.g., Linear or branched C 1-10 alkoxy group such as methoxy group, ethoxy group, propoxy group, n-butoxy group, isobutoxy group, t-butoxy group, etc., cycloalkyloxy group (for example, cyclohexyloxy group, etc.) C 5-10 cycloalkyloxy group, etc.), aryloxy group (eg, C 6-10 aryloxy group such as phenoxy group), aralkyloxy group (eg, C 6-10 aryl-C such as benzyloxy group) 1-4 alkyloxy group), alkylthio group (eg, methylthio group, ethylthio group, pro C 1-10 alkylthio such as a pyrthio group, n-butylthio group, t-butyl
  • R 5a and R 5b typically, a halogen atom, a hydrocarbon group (alkyl group, cycloalkyl group, aryl group, aralkyl group), alkoxy group, acyl group, nitro group, cyano group, substituted An amino group etc. are mentioned.
  • R 5a and R 5b include an alkyl group (such as a linear or branched C 1-6 alkyl group such as a methyl group), an aryl group (such as a C 6-14 aryl group such as a phenyl group), an alkoxy group A group (a linear or branched C 1-4 alkoxy group such as a methoxy group), in particular, an alkyl group (particularly a linear or branched C 1-4 alkyl group such as a methyl group), an aryl group (C 6-10 aryl group such as phenyl group).
  • an alkyl group such as a linear or branched C 1-6 alkyl group such as a methyl group
  • an aryl group such as a C 6-14 aryl group such as a phenyl group
  • an alkoxy group A group a linear or branched C 1-4 alkoxy group such as a methoxy group
  • an alkyl group particularly a linear or branched C 1-4
  • the groups R 5a and R 5b are aryl groups
  • the groups R 5a and R 5b may form the ring assembly arene ring together with the rings Z 1 and Z 2 .
  • the types of the groups R 5a and R 5b may be the same or different.
  • the number of substitutions m1 and m2 is 2 or more
  • the types of two or more groups R 2a and R 2b substituted on the same ring Z 1 and Z 2 may be the same or different.
  • the substitution numbers m1 and m2 of the groups R 5a and R 5b may be 0 or an integer of 1 or more, and can be appropriately selected depending on the types of the rings Z 1 and Z 2 .
  • it may be an integer of about 0 to 8, preferably an integer of about 0 to 4 (eg, 0 to 3), more preferably an integer of about 0 to 2 (eg, 0 or 1), particularly 0.
  • the substitution numbers m1 and m2 may be the same or different from each other.
  • the rings Z 1 and Z 2 may be benzene rings, naphthalene rings or biphenyl rings, and the groups R 5a and R 5b may be methyl groups.
  • the alkylene groups R 6a and R 6b include a linear or branched alkylene group.
  • Representative alkylene groups R 6a and R 6b include, for example, a linear or branched alkylene group exemplified in the description relating to the group R 2 in the above formula (1), and a preferable embodiment also includes the group R 2 . It is the same.
  • the types of alkylene groups R 6a and R 6b may be the same or different and are usually the same. is there.
  • the repeating numbers n1 and n2 are 2 or more
  • the types of alkylene groups R 6a and R 6b in the same (meth) acryloyl group-containing group may be different, but are preferably the same.
  • the number of repetitions n1 and n2 of the oxyalkylene group can be selected from 0 or an integer of 1 or more (for example, an integer of about 0 to 20), for example, an integer of about 1 to 15, preferably May be an integer of about 1 to 10 (eg 2 to 8), more preferably an integer of about 3 to 7 (eg 4 to 6).
  • n 1 and n 2 may be the same or different.
  • the number of repeating oxyalkylene groups refers to oxyalkylene in one molecule of a compound. It is used to mean both the number of groups (integer) and the average value (or arithmetic average value, arithmetic average value) of the number of oxyalkylene groups in the molecular assembly of the compound [that is, average added mole number]. Therefore, the repeating numbers n1 and n2 may be an average value (arithmetic average or arithmetic average) in the molecular assembly of the compound represented by the formula (2), and the range is equivalent to the integer range. It may be a degree.
  • the total number of repeating numbers n1 and n2 means the total number (total number of additions) of oxyalkylene groups in one molecule of the fluorene skeleton-containing (meth) acrylate represented by the formula (2), and is simply referred to as n1 + n2. There is a case.
  • n1 + n2 means the total number of all n1 and n2 which exists by the number of p1 and p2, when p1 and / or p2 are two or more.
  • n1 + n2 can be selected from an integer range of about 0 to 30, for example, an integer of about 1 to 25 (eg, 2 to 20), preferably an integer of about 3 to 18 (eg, 4 to 16), Preferably, it may be an integer of about 5 to 14 (eg, 6 to 12), particularly an integer of about 7 to 11 (eg, 8 to 10).
  • n1 + n2 may be an integer as described above, but may be an average added mole number in the molecular assembly of the fluorene skeleton-containing (meth) acrylate represented by the formula (2), and the range thereof is For example, it may be equivalent to the integer range.
  • n1 + n2 When the value of n1 + n2 is too small, the viscosity of the curable composition tends to increase, and the handling property may be lowered. Moreover, there exists a possibility that the scratch resistance of hardened
  • the refractive index can be maintained or improved, so even if the value of n1 + n2 is relatively small. , Can effectively improve handling properties (decrease viscosity).
  • N1 + n2 can be measured by a conventional method. For example, it has a 9,9-bisarylfluorene skeleton used as a raw material in the preparation of the fluorene skeleton-containing (meth) acrylate represented by the formula (2).
  • the ratio of the amount of the hydroxy compound and the amount of alkylene oxide or alkylene carbonate consumed in the reaction can be measured by a method of calculating as an arithmetic average or arithmetic average value (for example, the method described in Patent Document 1). .
  • the groups R 7a and R 7b are a hydrogen atom or a methyl group.
  • group R 7a and R 7b may be the same or different, usually the same.
  • the substitution number p1 and p2 of the (meth) acryloyl group-containing group is an integer of 1 or more, for example, an integer of 1 to 4, preferably an integer of 1 to 3, more preferably 1 or 2 (especially 1) may be sufficient. If p1 and p2 are too large, the scratch resistance may decrease.
  • substituents which p1 and p2, in each ring Z 1 and Z 2 may be the same or different.
  • (Meth) acryloyl group-containing groups can be substituted in a suitable position on the ring Z 1 and Z 2, for example, when ring Z 1 and Z 2 is a benzene ring, the suitable position 2 to position 6
  • p1 and p2 are 1, it is often substituted at any position of 2-position, 3-position, 4-position (particularly 3-position or 4-position) of the phenyl group .
  • p1 and p2 are 2, when substituted at 2-position and 4-position, 3-position and 4-position, 3-position and 5-position (especially 3-position and 5-position), etc. There are many.
  • the substitution position is not particularly limited.
  • the rings Z 1 and Z 2 are naphthalene rings, they are often substituted at any of the 5- to 8-positions of the naphthyl group.
  • p1 and p2 are 1, The 1-position or 2-position of the naphthalene ring is substituted with respect to the 9-position (substitution is carried out in relation to 1-naphthyl or 2-naphthyl), and the 1,5-position, 2,6 with respect to this substitution position
  • the (meth) acryloyl group-containing group is substituted in a relationship such as a -position (particularly a relationship in the 2,6-position).
  • p1 and p2 are 2 or more, a substitution position is not specifically limited.
  • the substitution position of the (meth) acryloyl group-containing group is not particularly limited.
  • the ring and / or the arene ring adjacent to the arene ring may be substituted.
  • the 3-position or 4-position of the biphenyl rings Z 1 and Z 2 may be bonded to the 9-position of fluorene.
  • (meth) substitution position of acryloyl group-containing groups 2-position of the biphenyl ring, 4-position, 5-position , 6-position, 2′-position, 3′-position, 4′-position, usually 6-position, 3′-position, 4′-position, preferably 6-position, 4 It may be substituted at any position of the '-position (particularly the 6-position).
  • the substitution position of the (meth) acryloyl group-containing group is the 2-position, 3-position, 2′-position of the biphenyl ring.
  • Position, 3′-position, 4′-position usually 2-position, 3′-position, 4′-position, preferably any position of 2-position, 4′-position (Especially 2-position) may be substituted.
  • a substitution position is not specifically limited.
  • the fluorene skeleton-containing (meth) acrylate represented by the formula (2) typically, in the formula (2), the ring Z 3 and Z 4 are benzene rings, that is, the following formula (2a)
  • rings Z 1 and Z 2 , R 4a and R 4b , R 5a and R 5b , R 6a and R 6b , R 7a and R 7b , k1 and k2, m1 and m2, n1 and n2, and p1 and p2 is the same as the formula (2) including preferred embodiments.
  • the compound represented by these is mentioned.
  • 9,9-bis [(meth) acryloyloxyphenyl] fluorenes in the above formula (2a), the ring Z 1 and Z 2 are benzene rings, n1 and n2 are 0, p1 and p2 are 1,
  • 9,9-bis [(meth) acryloyloxyphenyl] fluorene eg, 9,9-bis [4- (meth) acryloyloxyphenyl] fluorene, 9,9-bis [3- (meth) acryloyloxyphenyl) 9,9-bis [(meth) acryloyloxy-mono or dialkylphenyl] fluorene (eg, 9,9-bis [4- (meth) acryloyloxy-3-methylphenyl] fluorene, 9,9) -Bis [4- (meth) acryloyloxy-3-tert-butylphenyl] fluorene, 9,9-bis [4- (meth) Acryl
  • rings Z 1 and Z 2 are benzene rings, and n1 and n2 are 1 to 10 (preferably 1 6), compounds wherein p1 and p2 are 1, for example, 9,9-bis [(meth) acryloyloxy (poly) alkoxyphenyl] fluorene (for example, 9,9-bis [4- (2- (meth)) Acryloyloxyethoxy) phenyl] fluorene, 9,9-bis [4- (2- (meth) acryloyloxypropoxy) phenyl] fluorene, 9,9-bis [4- (2- (2- (meth) acryloyloxyethoxy) ) ethoxy) phenyl] 9,9-bis fluorene [(meth) acryloyloxy (mono- to deca) C 2-4 alkoxyphen
  • 9,9-bis [(meth) acryloyloxynaphthyl] fluorenes in the above formula (2a), the ring Z 1 and Z 2 are naphthalene rings, n1 and n2 are 0, p1 and p2 are 1,
  • 9,9-bis [(meth) acryloyloxynaphthyl] fluorene eg, 9,9-bis [6- (meth) acryloyloxy-2-naphthyl] fluorene, 9,9-bis [5- (meth)) Acryloyloxy-1-naphthyl] fluorene and the like.
  • rings Z 1 and Z 2 are naphthalene rings, and n1 and n2 are 1 to 10 (preferably 1 6), compounds wherein p1 and p2 are 1, for example, 9,9-bis [(meth) acryloyloxy (poly) alkoxynaphthyl] fluorene (for example, 9,9-bis [6- (2- (meth)) [Acryloyloxyethoxy) -2-naphthyl] fluorene, 9,9-bis [5- (2- (meth) acryloyloxypropoxy) -1-naphthyl] fluorene, 9,9-bis [6- (2- (2- (meth) acryloyloxy) ethoxy) -2-naphthyl] fluorene such as 9,9-
  • fluorene skeleton-containing (meth) acrylates can be used alone or in combination of two or more.
  • the rings Z 1 and Z 2 are benzene rings, n1 and n2 are 1 to 10 (preferably 1 to 6), and p1 and p2 are 1.
  • 9,9-bis [(meth) acryloyloxy (poly) alkoxyphenyl] fluorenes among which 9,9-bis [(meth) acryloyloxy (poly) alkoxyphenyl] fluorene (
  • 9,9-bis [4- (2- (meth) acryloyloxyethoxy) phenyl] fluorene 9,9-bis [4- (2- (2- (2- (meth) acryloyloxypropoxy) propoxy) phenyl) fluorene 9,9-bis such [(meth) acryloyloxy (mono- to deca) C 2-4 alkoxyphenyl] fluorene ); 9,9-bis [(meth) acryloyloxy (poly) alkoxy-mono or dialkylphenyl] fluorene (eg, 9,9-bis [4- (2- (meth) acryloyloxyethoxy) -3-methylphenyl
  • fluorene skeleton-containing (meth) acrylates may be commercially available or may be prepared by a conventional method (for example, the method described in Patent Document 1).
  • the alicyclic epoxy (meth) acrylate may be a polyfunctional epoxy (meth) acrylate having at least one alicyclic hydrocarbon ring (aliphatic ring), and examples of the aliphatic ring include C Examples thereof include 5-8 cycloalkane rings (eg, cyclopentane ring, cyclohexane ring), C 7-10 bi- or tricycloalkane rings (eg, norbornane ring, adamantane ring, etc.).
  • alicyclic hydrocarbon ring aliphatic ring
  • examples of the aliphatic ring include C Examples thereof include 5-8 cycloalkane rings (eg, cyclopentane ring, cyclohexane ring), C 7-10 bi- or tricycloalkane rings (eg, norbornane ring, adamantane ring, etc.).
  • alicyclic epoxy (meth) acrylate for example, di (meth) acrylate of an epoxy compound having a C 5-10 aliphatic ring such as di (meth) acrylate of 1,4-cyclohexanedimethanol diglycidyl ether. ) Acrylate and the like.
  • di (meth) acrylate of an epoxy compound having a C 5-10 aliphatic ring such as di (meth) acrylate of 1,4-cyclohexanedimethanol diglycidyl ether. ) Acrylate and the like.
  • These alicyclic epoxy (meth) acrylates can be used alone or in combination of two or more.
  • the aromatic epoxy (meth) acrylate may be any polyfunctional epoxy (meth) acrylate having at least an aromatic ring, and examples of the aromatic ring include C 10-14 such as a benzene ring and a naphthalene ring. Examples thereof include a condensed polycyclic arene ring. Since the aromatic epoxy (meth) acrylate has the aromatic ring, it is suitable for obtaining a cured product having a high refractive index.
  • Representative aromatic epoxy (meth) acrylates include, for example, di (meth) acrylates of diglycidyl ethers of biphenols or bisphenols (or their alkylene oxide adducts), poly (meth) acrylates of novolac type epoxy resins. Etc. These aromatic epoxy (meth) acrylates can be used alone or in combination of two or more.
  • Preferred aromatic epoxy (meth) acrylates include di (meth) acrylates of diglycidyl ethers (epoxy compounds) of biphenols or bisphenols (or their alkylene oxide adducts).
  • the biphenols include p, p′-biphenol, m, m′-biphenol, o, o′-biphenol, and the like.
  • the bisphenols include general-purpose bisphenols such as bisphenol A, bisphenol F, bisphenol B, bisphenol AP, bisphenol AF, and bisphenol S.
  • the alkylene oxide include C 2-4 alkylene oxide such as ethylene oxide and propylene oxide, preferably C 2-3 alkylene oxide.
  • the alkylene oxide adduct may be an alkylene carbonate adduct corresponding to the exemplified alkylene oxide.
  • di (meth) acrylates of diglycidyl ethers of typical biphenols or bisphenols (or their alkylene oxide adducts) include aromatic epoxy (meth) acrylates represented by the following formula (3).
  • R 8 represents a hydrogen atom, an alkyl group or an aryl group, respectively, and two R 8 may be bonded to each other to form a hydrocarbon ring which may have an alkyl group, R 9a and R 9b is an alkyl group or an aryl group, R 10a and R 10b are linear or branched alkylene groups, R 11a and R 11b are hydrogen atoms or methyl groups, q1 and q2 are integers of 0 to 4, r1 and r2 is 0 or an integer of 1 or more, and t is 0 or 1.
  • the alkyl group represented by R 8 is, for example, a linear or branched C 1-6 alkyl group such as a methyl group, an ethyl group, an isopropyl group, or a t-butyl group, preferably a linear group.
  • the aryl group for R 8 may be, for example, a C 6-10 aryl group (particularly a phenyl group) such as a phenyl group or a naphthyl group.
  • the type of R 8 may be the same or different.
  • the hydrocarbon ring that may be formed by bonding two R 8 to each other may be a C 5-8 cycloalkane ring such as a cyclopentane ring or a cyclohexane ring.
  • alkyl group which may be substituted on the hydrocarbon ring examples include the alkyl groups exemplified in the section of the alkyl group of R 8 above, and the same may be included including preferred embodiments.
  • the number and position of substitution of the alkyl group substituted on the hydrocarbon ring may be, for example, an integer of 0 to 3, preferably an integer of 0 to 2, more preferably 0 or 1, particularly 0.
  • the substitution position may be substituted, for example, at any position from the 3-position to the 5-position.
  • R 9a and R 9b include the alkyl groups and aryl groups exemplified in R 8 , and may be the same including preferred embodiments.
  • the number of substitutions q1 and q2 of R 9a and R 9b is an integer of 0 to 4, for example, an integer of 0 to 3, preferably an integer of 0 to 2, more preferably 0 or 1, particularly 0. Good.
  • the types of R 9a and R 9b may be the same or different. When q1 and q2 are 2 or more, the types of two or more R 9a and R 9b bonded to the same benzene ring are the same or different. May be.
  • the substitution position of R 9a and R 9b is not particularly limited, and may be substituted at any position (2-position, 3-position, etc.) of the benzene ring.
  • Examples of the linear or branched alkylene group represented by R 10a and R 10b include the straight chain exemplified in the section of R 2 of the formula (1) (and R 6a and R 6b of the formula (2)). Or a branched alkylene group, and the same applies to preferred embodiments. Note that the types of R 10a and R 10b may be the same or different from each other. In addition, when the number of repetitions r1 and r2 of the oxyalkylene group (OR 10a and OR 10b ) is 2 or more, the types of the two or more R 10a and R 10b may be different but are preferably the same. .
  • the total number of r1 and r2 and r1 and r2 [the total number of oxyalkylene groups (total number of additions), sometimes simply referred to as r1 + r2. ] Is the same as the values (integer or average value) exemplified in the terms of n1 and n2 and n1 + n2 in the formula (2), including preferred embodiments. If the value of r1 + r2 is too small, the viscosity of the curable composition tends to increase, and the handling properties may be reduced.
  • the refractive index can be maintained or improved even if a large amount of the first monofunctional (meth) acrylate represented by the above formula (1) is mixed, so even if the value of r1 + r2 is relatively small. , Can effectively improve handling properties (decrease viscosity). If the value of r1 + r2 is too large, the aromatic ring content (for example, the number of moles contained) is also reduced, so that excellent properties such as a high refractive index may be reduced. Note that r1 + r2 may be measured with reference to the method exemplified in the section of n1 + n2 in the formula (2).
  • R 11a and R 11b may be the same or different from each other, and are usually the same.
  • T is 0 or 1, and is preferably 1.
  • the aromatic epoxy (meth) acrylate represented by the formula (3) can be used alone or in combination of two or more.
  • Compounds in which 8 is a hydrogen atom or an alkyl group are preferable.
  • Urethane (meth) acrylate has a main chain skeleton (a skeleton of a urethane oligomer or urethane polymer portion) formed of units derived from a reaction product of a polyol component and a polyisocyanate component.
  • the polyol component may be a low molecular weight polyol component (for example, alkylene glycol such as ethylene glycol), but is preferably a high molecular weight polyol component from the viewpoint of improving scratch resistance in a cured product.
  • the high molecular weight polyol component may be a polymer or an oligomer having a relatively small number of repeating units.
  • the weight average molecular weight (Mw) of the polymer polyol component can be measured by gel permeation chromatography (GPC) or the like, and can be selected from a range of, for example, about 300 or more (for example, 400 to 50000) in terms of standard polystyrene. It may be about 500 to 10000 (for example, 600 to 5000), preferably about 700 to 3000 (for example, 800 to 2000). If the molecular weight (weight average molecular weight) of the polyol component is too low, the scratch resistance of the cured product may be reduced, and if it is too high, the viscosity becomes high and the handling property may be reduced. In the present invention, by combining with the first monofunctional (meth) acrylate, even a relatively high-viscosity polyfunctional (meth) acrylate can be effectively reduced in viscosity.
  • GPC gel permeation chromatography
  • Examples of the high molecular weight polyol component include polyether polyol, polyester polyol, and polycarbonate polyol.
  • Examples of the polyether polyol (particularly, polyether diol) include polyalkylene oxide [or polyalkylene glycols such as ethylene oxide, propylene oxide, 1,2-butylene oxide, 1,4-butylene oxide (tetrahydrofuran), etc.
  • C 2-6 alkylene oxide homo- or copolymers eg, polyoxy C 2-6 alkylene glycols such as polyethylene glycol, polypropylene glycol, polytetramethylene ether glycol, polyethylene oxide-polypropylene oxide block copolymers, etc., especially polytetra Methylene ether glycol), etc.
  • These polyether polyols can be used alone or in combination of two or more.
  • Polyester polyols include diol components and dicarboxylic acid components [dicarboxylic acids or derivatives thereof (for example, lower alkyl esters (such as C 1-2 alkyl esters such as methyl esters), acid halides, acid anhydrides, etc.) ] Or a lactone (C 3-10 lactone such as ⁇ -caprolactone, ⁇ -valerolactone) or a copolymer (poly- ⁇ -). Caprolactone, etc.), a copolymer of the diol component, dicarboxylic acid component, hydroxyalkanecarboxylic acid and / or lactone, etc.
  • dicarboxylic acid components dicarboxylic acids or derivatives thereof (for example, lower alkyl esters (such as C 1-2 alkyl esters such as methyl esters), acid halides, acid anhydrides, etc.)
  • a lactone C 3-10 lactone such as ⁇ -caprolactone, ⁇ -valerolactone
  • dicarboxylic acid component examples include aromatic dicarboxylic acids (for example, terephthalic acid, isophthalic acid, 2,6-naphthalenedicarboxylic acid) Alicyclic dicarboxylic acids (e.g., cyclohexane dicarboxylic acid), aliphatic dicarboxylic acids (e.g., adipic acid, straight-chain C 4-12 dicarboxylic acid such as sebacic acid), and derivatives of these dicarboxylic acids.
  • aromatic dicarboxylic acids for example, terephthalic acid, isophthalic acid, 2,6-naphthalenedicarboxylic acid
  • Alicyclic dicarboxylic acids e.g., cyclohexane dicarboxylic acid
  • aliphatic dicarboxylic acids e.g., adipic acid, straight-chain C 4-12 dicarboxylic acid such as sebacic acid
  • diol component examples include alkanediols (for example, C 2 such as ethylene glycol, propylene glycol, trimethylene glycol, 1,3-butanediol, 1,4-butanediol, 1,6-hexanediol, neopentyl glycol). such as -10 alkanediol), polyoxyalkylene glycols (e.g., poly alkanediol) polyether diols, such as such as diethylene glycol, alicyclic diols (e.g., 1,4-cyclohexanediol, cyclohexanedimethanol, etc.), etc.
  • alkanediols for example, C 2 such as ethylene glycol, propylene glycol, trimethylene glycol, 1,3-butanediol, 1,4-butanediol, 1,6-hexanediol, neopentyl glycol.
  • polyester polyols include polyester diols having terminal hydroxyl groups such as polyethylene adipate and polydiethylene glycol adipate. , Polypropylene adipate, polytetramethylene adipate, polyhexamethylene adipate, copolymers thereof, etc. These polyester polyols can be used alone or in combination of two or more.
  • polycarbonate polyol examples include a polyol (such as the low molecular weight polyol, polyether polyol, and polyester polyol exemplified above) and a dialkyl carbonate (such as dimethyl carbonate) or alkylene carbonate (such as ethylene carbonate). And polycarbonate diol (for example, polyhexamethylene carbonate diol) obtained by the reaction with).
  • a polyol such as the low molecular weight polyol, polyether polyol, and polyester polyol exemplified above
  • dialkyl carbonate such as dimethyl carbonate
  • alkylene carbonate such as ethylene carbonate
  • polycarbonate diol for example, polyhexamethylene carbonate diol obtained by the reaction with
  • the polyisocyanate component is not particularly limited, and examples thereof include aliphatic polyisocyanates (for example, hexamethylene diisocyanate (HDI), 1,3,6-hexamethylene triisocyanate); alicyclic polyisocyanates [for example, isophorone diisocyanate (for example, IPDI), hydrogenated xylylene diisocyanate (hydrogenated XDI), hydrogenated diphenylmethane-4,4′-diisocyanate (hydrogenated MDI), etc.]; araliphatic polyisocyanates [eg, xylylene diisocyanate (XDI), tetramethylxylylene Range isocyanate (TMXDI) and the like]; aromatic polyisocyanate (eg, tolylene diisocyanate (TDI), diphenylmethane diisocyanate (MDI), 1,5-naphthalene diisocyanate (NDI), Lysine diisocyan
  • the polyisocyanate component is a modified product [or derivative such as a multimer (dimer, trimer (triisocyanurate ring, etc.)), carbodiimide body, biuret body, allophanate body, uretdione body, polyamine modified body. Etc.]. These polyisocyanate components can be used alone or in combination of two or more.
  • Typical urethane (meth) acrylates include polyester-type urethane (meth) acrylate, polyether-type urethane (meth) acrylate, and polycarbonate-type urethane (meth) acrylate having a polyol component. These urethane (meth) acrylates can be used alone or in combination of two or more. These urethane (meth) acrylates can effectively improve the scratch resistance of the cured product, and among them, it is preferable to include polyester type urethane (meth) acrylate and / or polyether type urethane (meth) acrylate.
  • the polyester (meth) acrylate can be prepared by a reaction of the same polyester polyol as described above and (meth) acrylic acid, including preferred embodiments.
  • the polyester polyol has an aliphatic monomer component (for example, an aliphatic diol component (such as C 2-12 alkylene glycol such as butylene glycol) and an aliphatic dicarboxylic acid component [adipic acid, C 4-20 alkanecarboxylic acid such as dodecanedioic acid or derivatives thereof (acid halide, acid anhydride, lower alkyl ester, etc.), aliphatic lactone component ( ⁇ -caprolactone, etc.), aliphatic hydroxycarboxylic acid component (3- Etc.) may be formed from units derived from such as hydroxybutyric acid, 5-hydroxyvaleric acid and the like.
  • These polyester polyols can be used alone or in combination of two or more.
  • the content of the high-viscosity polyfunctional (meth) acrylate can be selected from the range of, for example, 10% by weight or more, for example, 30% by weight or more, preferably 50% by weight, based on the entire multifunctional (meth) acrylate. More preferably, it may be 60% by weight or more (for example, 80% by weight or more), in particular, substantially 100% by weight. If the proportion of the high-viscosity polyfunctional (meth) acrylate is too small, the viscosity may not be effectively reduced.
  • these high-viscosity polyfunctional (meth) acrylates may be used alone or in combination of two or more depending on the application, etc., and each characteristic (for example, refractive index, scratch resistance, heat resistance) Property, mechanical properties, etc.) may be adjusted.
  • each characteristic for example, refractive index, scratch resistance, heat resistance
  • a cured product having a high refractive index tends to have a large rigidity and lack flexibility, but in the present invention, both a high refractive index and scratch resistance (flexibility) can be achieved at a high level.
  • a polyfunctional (meth) acrylate is a polyfunctional (meth) acrylate having a 9,9-bisarylfluorene skeleton excellent in optical properties such as a high refractive index (for example, represented by the above formula (2)). Fluorene skeleton-containing (meth) acrylate and the like) and urethane (meth) acrylate excellent in scratch resistance of the cured product.
  • a polyfunctional (meth) acrylate can form a cured product having a high refractive index and excellent scratch resistance in a balanced manner.
  • the ratio of the polyfunctional (meth) acrylate having a 9,9-bisarylfluorene skeleton (for example, the fluorene skeleton-containing (meth) acrylate represented by the formula (2)) and the urethane (meth) acrylate is, for example,
  • the former / the latter (weight ratio) can be selected from a range of about 50/50 to 99/1, for example, 53/47 to 90/10, preferably 55/45 to 80/20, and more preferably 58/42 to It may be about 70/30 (for example, 60/40 to 65/35). If the amount of the polyfunctional (meth) acrylate having a 9,9-bisarylfluorene skeleton is too small, the refractive index of the cured product may be lowered.
  • the multifunctional (meth) acrylate may further contain di (meth) acrylate of an alkylene oxide adduct of biphenols or bisphenols in addition to the high-viscosity multifunctional (meth) acrylate.
  • di (meth) acrylate of an alkylene oxide adduct of biphenols or bisphenols in addition to the high-viscosity multifunctional (meth) acrylate.
  • Such a polyfunctional (meth) acrylate is easy to improve the low viscosity in the curable composition and the high refractive index and scratch resistance in the cured product in a balanced manner.
  • examples of the biphenols, bisphenols, and alkylene oxides include diglycidyl of the biphenols or bisphenols (or their alkylene oxide adducts).
  • Biphenols, bisphenols, and alkylene oxides exemplified in the section of ether di (meth) acrylate are exemplified, and the same applies to preferred embodiments.
  • the total number of oxyalkylene groups (total addition number) (integer or average addition mole number) derived from addition of alkylene oxide (or alkylene carbonate) can be selected from a range of about 1 to 30, for example, 2 to 25 Preferably, it may be about 3 to 20, more preferably about 5 to 15 (for example, 8 to 12). If the total number of oxyalkylene groups is too low, scratch resistance may not be improved.
  • di (meth) acrylate of an alkylene oxide adduct of biphenols or bisphenols examples include, for example, di (meth) acrylate of an alkylene oxide adduct of biphenol [for example, to 1 mol of p, p′-biphenol.
  • adduct di (meth) in which about 2 to 25 mol of C 2-4 alkylene oxide is added to 1 mol biphenols such as di (meth) acrylate in adduct with about 10 mol of ethylene oxide added.
  • di (meth) acrylates of alkylene oxide adducts of bisphenols for example, di (meth) acrylates of adducts in which about 10 mol of ethylene oxide is added to 1 mol of bisphenol A, 1 mol of bisphenol For F, propylene oxide is 0 one mole of C 2-4 di (meth) acrylate adducts of alkylene oxide are added about 2 to 25 mol relative to bisphenol such as di (meth) acrylate of moles added was adduct], and the like It is done.
  • di (meth) acrylates of alkylene oxide adducts of biphenols or bisphenols may be used alone or in combination of two or more.
  • biphenols or di (meth) acrylates of alkylene oxide adducts of bisphenols di (meth) acrylates of alkylene oxide adducts of bisphenols are preferred, and C 2-3 alkylene per mole of bisphenols
  • An adduct di (meth) acrylate added with about 3 to 20 moles of oxide for example, an adduct di (meth) acrylate with about 10 moles of ethylene oxide added to 1 mole of bisphenol A
  • Commercially available products may be used as the di (meth) acrylates of these biphenols or alkylene oxide adducts of bisphenols.
  • weight ratio about 50/50 to 99/1
  • the curable composition of the present invention further includes other monofunctional polymerizable components.
  • (Or monomer) may be included.
  • the curable composition contains other monofunctional polymerizable components to adjust or improve properties such as handling properties (low viscosity), refractive index, and scratch resistance (flexibility) according to the application.
  • Any compound may be used, for example, a monofunctional vinyl monomer [eg, ⁇ -olefin monomer (eg, ethylene, propylene, etc.); styrene monomer (eg, styrene, ⁇ -methylstyrene, vinyl toluene, etc.); vinyl Examples thereof include ester monomers (for example, vinyl acetate); N-vinylpyrrolidone, etc.], monofunctional (meth) acrylic monomers, and the like. These monofunctional polymerizable components can be used alone or in combination of two or more. Of these monofunctional polymerizable components, monofunctional (meth) acrylic monomers are preferred.
  • a monofunctional vinyl monomer eg, ⁇ -olefin monomer (eg, ethylene, propylene, etc.); styrene monomer (eg, styrene, ⁇ -methylstyrene, vinyl toluene, etc.); vinyl Examples thereof include ester monomers (for
  • Examples of the monofunctional (meth) acrylic monomer include (meth) acrylic acid, (meth) acrylamide, N-substituted (meth) acrylamide (for example, N-methylol (meth) acrylamide, N, N-dimethyl (meth) ) Acrylamide), (meth) acrylonitrile, etc., but monofunctional (meth) acrylates are often used.
  • monofunctional (meth) acrylates include aliphatic monofunctional (meth) acrylates [for example, C 1-20 alkyl such as methyl (meth) acrylate, butyl (meth) acrylate, 2-ethylhexyl (meth) acrylate, etc.
  • (meth) acrylate, etc.] alicyclic monofunctional (meth) acrylates [e.g., cyclohexyl (meth) C 5-10 cycloalkyl (meth) acrylates such as acrylate, dicyclopentenyl (meth) acrylate, isobornyl (meth) Bridged cyclic (meth) acrylates such as acrylates, etc.]; aromatic monofunctional (meth) acrylates (however, the monofunctional (meth) acrylates represented by the above formula (1) are not included); sulfur atoms And monofunctional (meth) acrylates containing These monofunctional (meth) acrylates can be used alone or in combination of two or more.
  • alicyclic monofunctional (meth) acrylates e.g., cyclohexyl (meth) C 5-10 cycloalkyl (meth) acrylates such as acrylate, dicyclopentenyl (meth) acrylate, isobornyl (
  • the curable composition contains a sulfur atom because it can improve the handleability of the curable composition and the high refractive index and scratch resistance of the cured product in a well-balanced manner. It is preferable to include a monofunctional (meth) acrylate (sometimes simply referred to as a second monofunctional (meth) acrylate), and the second monofunctional (meth) acrylate has an aromatic ring. You may have. Moreover, from the point which can improve the refractive index of hardened
  • a preferred monofunctional (meth) acrylate may be a monofunctional (meth) acrylate having an aromatic ring and having a sulfur atom.
  • Examples of the second monofunctional (meth) acrylate containing a sulfur atom include alkylthio (meth) acrylate (for example, C 1-6 alkylthio (meth) acrylate such as methylthio (meth) acrylate), arylthio (meta) ) Acrylates (eg C 6-10 arylthio (meth) acrylates such as phenylthio (meth) acrylate), aralkylthio (meth) acrylates (eg C 6-10 aryl C 1-6 alkylthio such as benzylthio (meth) acrylate) (Meth) acrylates), arylthioalkyl (meth) acrylates (eg, C 6-10 arylthio C 2-6 alkyl (meth) acrylates such as phenylthioethyl (meth) acrylate), and the like.
  • alkylthio (meth) acrylate for example, C 1-6 al
  • These 2nd monofunctional (meth) acrylate containing a sulfur atom can also be used individually or in combination of 2 or more types.
  • arylthio can be particularly improved from the viewpoint of improving the handleability of the curable composition and the refractive index and scratch resistance of the cured product.
  • a commercial item etc. may be used for the 2nd monofunctional (meth) acrylate containing such a sulfur atom.
  • the ratio of the first monofunctional (meth) acrylate is too small, the handling property and the refractive index of the cured product may be reduced.
  • aromatic monofunctional (meth) acrylate examples include aryl (meth) acrylate (for example, phenyl (meth) acrylate), aralkyl (meth) acrylate ( For example, benzyl (meth) acrylate, etc.), mono (meth) acrylate of bisphenols (or alkylene oxide adducts thereof) (for example, mono (meth) acrylate of ethylene oxide adducts of bisphenol A), fluorene skeleton ( (Meth) acrylate (for example, 9- (meth) acryloyloxymethylfluorene), the following formula (4)
  • R 12 is a hydrogen atom or a methyl group
  • R 13 is an alkylene group
  • R 14 is an alkyl group
  • Ar 2 is a benzene ring or a ring-arene ring
  • c is an integer of 1 to 4
  • d is 0 or 1 or more.
  • monofunctional (meth) acrylates represented by These third monofunctional (meth) acrylates can be used alone or in combination of two or more.
  • the third represented by the above formula (4) is able to improve the refractive index of the cured product while improving the handleability of the curable composition.
  • the monofunctional (meth) acrylate is preferably included.
  • the group R 12 is a hydrogen atom or a methyl group.
  • the base R 13 is a linear or branched alkylene group, for example, the group R 2 can be exemplified include (as well as radicals R 6a and R 6b) alkylene group exemplified in the preferred embodiment also the radical R 2 (And groups R 6a and R 6b ).
  • the repeating number c of the group (R 13 O) can be selected from an integer of about 1 to 4, for example, an integer of about 1 to 3, preferably 1 or 2, and more preferably 1. If the number of repetitions c is too large, the refractive index of the cured product may be reduced. In addition, when c is 2 or more, two or more groups R 13 may be the same or different.
  • the ring Ar 2 is a benzene ring or a ring assembly arene ring, and examples of the ring assembly arene ring include the ring assembly arene rings exemplified in the rings Z 1 and Z 2.
  • the embodiment is also the same as the ring assembly arene ring of the rings Z 1 and Z 2 .
  • a benzene ring or a biphenyl ring is preferable.
  • the group R 14 is an alkyl group, and examples thereof include the alkyl group exemplified in the group R 3 in the formula (1), and the preferred embodiment is the same as the group R 3 .
  • the substitution number d of the group R 14 may be 0 or an integer of 1 or more, for example, an integer of about 0 to 4, preferably an integer of about 0 to 2, more preferably 0 or 1, particularly 0. .
  • d is 2 or more, the types of the two or more groups R 14 may be the same or different.
  • the substitution position of the group R 14 is not particularly limited.
  • the ring Ar 2 is a benzene ring, and the bonding position of the group [—O— (R 13 O) c —CO—CR 12 ⁇ CH 2 ] is 1
  • the 1-phenyl group may be substituted at any position from 2 to 6-position, for example, any position from 3 to 5-position (for example, 4-position) May be substituted.
  • the ring Ar 2 is a biphenyl ring and the group [—O— (R 13 O) c —CO—CR 12 ⁇ CH 2 ] is bonded to the 2-position, 3 to 6 of the 2-biphenylyl group It may be substituted at any position of the -position and the 2 'to 6'-position.
  • Compound, ie, alkylphenoxyalkyl (meth) acrylate [eg, C 1-12 alkylphenoxy C 2-4 alkyl (meth) acrylate such as 2- (nonylphenoxy) ethyl (meth) acrylate, etc.];
  • third monofunctional (meth) acrylates represented by the formula (4) can be used alone or in combination of two or more.
  • the compound represented by Formula (4) may use a commercial item, for example, an alkylene oxide or alkylene carbonate adduct of phenol or a hydroxy ring assembly polycyclic arene, such as sulfuric acid, may be used. It can be prepared by a method of reacting with (meth) acrylic acid in the presence of an esterification catalyst, a polymerization inhibitor such as hydroquinone and, if necessary, a solvent.
  • the ratio of the first monofunctional (meth) acrylate represented by the formula (1) and the third monofunctional (meth) acrylate represented by the formula (4) is the former / the latter (weight).
  • Ratio) 100/0 to 20/80 (for example, 80/20 to 20/80) or so, for example, 70/30 to 25/75, preferably 65/35 to 30/70 (for example, 60/40 to 35/65), more preferably about 55/45 to 40/60 (for example, 50/50 to 43/57). If the ratio of the first monofunctional (meth) acrylate represented by the formula (1) is too small, the handling property and the refractive index of the cured product may be lowered.
  • the other monofunctional polymerizable component for example, the second monofunctional (meth) acrylate 3rd monofunctional (meth) acrylate (especially 2nd monofunctional (meth) acrylate) etc.
  • the other monofunctional polymerizable components may be the same as described above, including preferred embodiments (representative compounds, ratios with the first monofunctional (meth) acrylate, etc.) and the like.
  • the curable composition may contain a polymerization initiator in addition to the polymerizable component (or monomer component).
  • the polymerization initiator may be a thermal polymerization initiator (thermal radical generator) or a photopolymerization initiator (photo radical generator).
  • thermal polymerization initiator examples include organic peroxides [eg, dialkyl peroxides (eg, di-tert-butyl peroxide), diacyl peroxides (eg, lauroyl peroxide, benzoyl peroxide, etc.), Peracids (or peracid esters) (for example, tert-butyl hydroperoxide, cumene hydroperoxide, tert-butyl peracetate, etc.), ketone peroxides, peroxycarbonates, peroxyketals, etc.], azo Examples include compounds [for example, azonitrile compounds such as 2,2′-azobis (isobutyronitrile), azoamide compounds, azoamidine compounds, etc.]. These thermal polymerization initiators can be used alone or in combination of two or more.
  • organic peroxides eg, dialkyl peroxides (eg, di-tert-butyl peroxide), diacyl peroxides (eg, lauroy
  • photopolymerization initiator examples include benzoins (for example, benzoin alkyl ethers such as benzoin and benzoin ethyl ether) and acetophenones (for example, acetophenone, 2-hydroxy-2-methyl-1-phenylpropane-1- ), Aminoacetophenones ⁇ eg 2-methyl-1- [4- (methylthio) phenyl] -2-morpholinoaminopropanone-1 ⁇ , anthraquinones (eg anthraquinone, 2-methylanthraquinone etc.), Thioxanthones (eg, 2,4-dimethylthioxanthone, 2,4-diethylthioxanthone, 2-chlorothioxanthone, etc.), ketals (eg, acetophenone dimethyl ketal, benzyldimethyl ketal, etc.), benzophenones (eg, Benzophenone), such as x
  • the ratio of the polymerization initiator is 0.1 to 15 parts by weight, preferably 0.5 to 10 parts by weight (for example, 1 to 1 part by weight based on 100 parts by weight of the total amount of the polymerizable components). 8 parts by weight), more preferably about 2 to 5 parts by weight.
  • the photopolymerization initiator may be combined with a photosensitizer.
  • the photosensitizer include tertiary amines ⁇ eg, trialkylamine, trialkanolamine (eg, triethanolamine), ethyl N, N-dimethylaminobenzoate [eg, p- (dimethylamino). ) Ethyl benzoate, etc.], N, N-dimethylaminobenzoic acid amyl [eg, p- (dimethylamino) benzoic acid amyl etc.], etc., dialkylaminobenzoic acid alkyl esters, 4,4-bis (diethylamino) benzophenone, etc.
  • photosensitizers such as bis (dialkylamino) benzophenone, dialkylaminobenzophenone such as 4- (dimethylamino) benzophenone ⁇ and the like. These photosensitizers may be used alone or in combination of two or more.
  • the ratio of the photosensitizer may be 1 to 200 parts by weight, preferably 5 to 150 parts by weight, and more preferably about 10 to 100 parts by weight with respect to 100 parts by weight of the polymerization initiator.
  • the curable composition may contain the solvent as needed.
  • the solvent is not particularly limited.
  • hydrocarbons for example, aliphatic hydrocarbons such as hexane and heptane, alicyclic hydrocarbons such as cyclohexane, aromatic hydrocarbons such as toluene and xylene, etc.
  • Halogenated hydrocarbons eg, methylene chloride, chloroform, 1,2-dichloroethane, etc.
  • ethers eg, dialkyl ethers such as diethyl ether, cyclic ethers such as tetrahydrofuran, dioxane, etc.
  • ketones eg, , Dialkyl ketones such as acetone and methyl ethyl ketone, cyclic ketones such as cyclohexanone, etc .
  • esters eg, acetate esters such as methyl acetate, ethyl acetate, butyl
  • the curable composition can be prepared by using conventional additives such as colorants, stabilizers (thermal stabilizers, antioxidants, ultraviolet absorbers, etc.), fillers, antistatic agents, flame retardants, surfactants, plasticizers.
  • additives such as colorants, stabilizers (thermal stabilizers, antioxidants, ultraviolet absorbers, etc.), fillers, antistatic agents, flame retardants, surfactants, plasticizers.
  • An agent, a curing agent, a polymerization inhibitor and the like may be included. These additives can be used alone or in combination of two or more.
  • the curable composition of this invention hardens
  • active energy thermal energy and / or light energy (for example, ultraviolet rays, X-rays, etc.) are useful.
  • the heating temperature may be, for example, 50 to 200 ° C., preferably 60 to 150 ° C., more preferably about 70 to 120 ° C.
  • the amount of light irradiation energy can be appropriately selected according to the application, for example, 50 to 10000 mJ / cm 2 , preferably 70 to 8000 mJ / cm 2. More preferably, it may be about 100 to 5000 mJ / cm 2 (for example, 500 to 3000 mJ / cm 2 ).
  • the shape of the cured product is not particularly limited, and may be a cured product having a three-dimensional structure (for example, a lens), a cured product having a two-dimensional structure (or a cured film) (for example, a film or a sheet), a primary
  • the cured product may have a base structure (for example, linear, rod-like, tubular, etc.).
  • the method for producing a cured product is not particularly limited.
  • the curable composition is molded according to the shape of the cured product or in a predetermined mold. After being cast (injected), it may be produced by curing (heating and / or light irradiation).
  • the curable composition is used as a base material or a substrate [for example, metal (for example, aluminum), ceramics (for example, titanium oxide, glass, quartz, etc.), etc.
  • Inorganic materials organic materials such as plastics (for example, cyclic olefin-based resins, polycarbonate-based resins, etc., porous materials such as wood, etc.) to form a film-like coating film (or thin film), You may manufacture by giving a hardening process.
  • plastics for example, cyclic olefin-based resins, polycarbonate-based resins, etc., porous materials such as wood, etc.
  • the curable composition of the present invention contains a polyfunctional (meth) acrylate and the first monofunctional (meth) acrylate represented by the formula (1), it has a relatively low viscosity, It has excellent handling properties and can form a cured product having a high refractive index.
  • the viscosity (temperature 25 ° C.) of the curable composition may be, for example, about 1 to 500,000 mPa ⁇ s (for example, 50 to 100,000 mPa ⁇ s), depending on the type of polyfunctional (meth) acrylate, etc.
  • it can be selected from a range of about 1 to 50000 mPa ⁇ s (for example, 5 to 25000 mPa ⁇ s), for example, 10 to 20000 mPa ⁇ s (for example, 20 to 10000 mPa ⁇ s), preferably 30 to 6000 mPa ⁇ s (for example, 50 to 2000 mPa ⁇ s), more preferably about 70 to 1000 mPa ⁇ s (for example, 90 to 300 mPa ⁇ s).
  • a viscosity can be effectively reduced by combining with 1st monofunctional (meth) acrylate.
  • the viscosity (temperature 60 ° C.) of the curable composition can be selected from a range of about 100 Pa ⁇ s or less (eg, 0.1 to 50 Pa ⁇ s), for example, 30 Pa ⁇ s or less (eg, 1 to 1). 27 Pa ⁇ s), preferably about 25 Pa ⁇ s or less (eg, 10 to 23 Pa ⁇ s).
  • the viscosity can be measured by the method described in Examples described later.
  • the refractive index (refractive index before curing) (temperature 25 ° C., wavelength 589 nm) of the curable composition before curing can be selected from the range of about 1.5 to 1.7, for example, 1.52 to 1. It may be 65 (for example, 1.53 to 1.62), preferably 1.54 to 1.61, and more preferably about 1.55 to 1.60.
  • the curable composition usually has a tendency to improve the refractive index by curing, and a curable composition prepared by heating and mixing 3 parts by weight of a photopolymerization initiator with respect to 100 parts by weight of the polymerizable component is prepared.
  • the refractive index (temperature 25 ° C., wavelength 589 nm) of a cured product cured by UV irradiation (500 mJ / cm 2 ) (for example, a cured product cured by the method described in the Examples section below) is, for example, 1. It can be selected from a range of about 5 to 1.7, and may be, for example, about 1.52 to 1.66, preferably 1.54 to 1.63, and more preferably about 1.56 to 1.6.
  • a refractive index can be measured by the method as described in the Example mentioned later.
  • viscosity Using a TV-22 type viscometer (cone plate type, “TVE-22L” manufactured by Toki Sangyo Co., Ltd.), the viscosity at 25 ° C. was measured using an optional rotor (01: 1 ° 34 ′ ⁇ R24, 07: 3 ° ⁇ R7.7) was selected, and the measurement was performed at a rotational speed of 0.5 to 20 rpm.
  • the viscosity at 60 ° C. was measured using an E-type melt viscometer (“CAP2000 +” manufactured by BROOK FIELD).
  • the obtained solution was washed with 20% by weight saline solution, neutralized with 10% by weight sodium hydroxide aqueous solution and 20% by weight saline solution, and it was confirmed that the aqueous layer had a pH of 10 or more. Thereafter, 500 ppm of 4-methoxyphenol was added to the organic layer to homogenize the solution. This solution was washed twice with 20% by weight saline and three times with distilled water. After confirming that the aqueous layer had a pH of 7, the organic layer was concentrated and filtered through Celite. After filtration, the filtrate was concentrated and dried to obtain NEOA as a powdery white solid.
  • NEOA had a refractive index (25 ° C., 589 nm) of 1.59 and a melting point of 62 ° C. The melting point was measured with a differential scanning calorimeter (DSC) (“EXSTAR DSC 6220” manufactured by SII Nanotechnology Inc.).
  • DSC differential scanning calorimeter
  • the comparative example maintains a relatively high refractive index and has a viscosity of the same level even though it contains a large amount of diluent, as compared with the Comparative Examples. Can be reduced.
  • POA is a transparent liquid like a general reactive diluent
  • NEOA is a powdery white solid that does not exhibit fluidity at all, and has a viscosity. Only when mixed with BPEFA, which was a solid, became liquid and showed low viscosity, which was a very surprising result.
  • FIG. 2 are equations showing approximate lines based on the measured values of Comparative Examples 1 to 5 and Examples 1 to 5, where x is the mixing ratio of each reactive diluent and y is the refractive index or viscosity.
  • x is the mixing ratio of each reactive diluent
  • y is the refractive index or viscosity.
  • the approximate line was calculated using “Microsoft Excel (Microsoft Office Standard 2010)” manufactured by Microsoft Corporation, linear approximation was used for the refractive index, and power approximation was used for the viscosity.
  • the viscosity of the curable composition that achieves each target refractive index is lower than that in the BPEFA / POA blending system, and in particular, the target refractive index is large. It turns out that the difference in viscosity becomes very large. Moreover, in the BPEFA / NEOA blending system, it can be seen that the proportion of the reactive diluent is large in the blending ratio for achieving the target refractive index, and the use proportion of BPEFA can be reduced.
  • each prepared curable composition (polymerizable component), and the mixture was heated and melted and mixed.
  • Each obtained curable composition was applied on a TAC (cellulose acetate) film to a film thickness of 200 ⁇ m using an applicator, and UV irradiation (500 mJ / cm 2 ) was performed once to prepare a cured product. .
  • Each of the obtained cured products was a film having a film thickness of 100 ⁇ m, and the refractive index (after curing) was measured using this cured product.
  • a mold is placed on the glass to which the release agent is attached by spraying, and each curable composition mixed with the photopolymerization initiator is poured into this mold, and the mold is sandwiched between the glass subjected to the same treatment, UV irradiation (500 mJ / cm 2 ) was repeated four times to produce a cured product having a size of 50 mm ⁇ 15 mm ⁇ 2 mm. Scratch resistance was measured using the obtained cured product.
  • Table 3 shows the blending ratio and evaluation results.
  • the number in () of Table 3 means the weight part of each structural component in a curable composition (hereinafter, Table 4 is also the same).
  • Comparative Example 6 has a high refractive index, but has a high viscosity, so that the handling property is not sufficient, and the handling property and the high refractive index cannot be achieved at the same time. On the other hand, Example 6 has excellent handling properties and high refractive index while maintaining scratch resistance.
  • each of the properties is different because it contains a soft bifunctional (meth) acrylate or maintains a relatively good handling property and achieves both a high refractive index and scratch resistance. Excellent balance.
  • the UV-3200B mixed in Example 7 shows relatively good handling properties even though the viscosity at 60 ° C. is as high as 40,000 to 60,000 mPa ⁇ s.
  • Examples 9 to 12 other monofunctional acrylates (second monofunctional (meth) acrylate containing a sulfur atom or third monofunctional (meth) represented by the above formula (3)) are used. (Acrylate) in combination achieves both excellent handling properties and a high refractive index. In particular, in Example 10, not only the handling property and the high refractive index are compatible at a high level, but also the scratch resistance is improved.
  • cured products of the respective curable compositions prepared by the same method as in Comparative Example 6 and Examples 6 to 12 (a cured film having a film thickness of 100 ⁇ m and a cured product having a size of 50 mm ⁇ 15 mm ⁇ 2 mm) Were used, and the refractive index (after curing) and scratch resistance were measured using these cured products.
  • Table 4 shows the blending ratio and the evaluation results.
  • the curable composition of the present invention is excellent in properties such as low viscosity, high refractive index, and scratch resistance, it can be used in various applications.
  • ink materials for example, light emitting materials (for example, organic EL light emitting materials), organic semiconductors, graphitized precursors, gas separation membranes (for example, CO 2 gas separation membranes), coating agents (for example, LEDs (light emitting diodes))
  • Optical overcoat agent or hard coat agent such as a coating agent for an optical element
  • lens eg, pickup lens (eg, pickup lens for DVD (digital versatile disk)), micro lens (eg, for liquid crystal projector) Micro lenses, etc.), spectacle lenses, etc.]
  • polarizing films eg, polarizing films for liquid crystal displays
  • antireflection films or antireflection films, eg, antireflection films for display devices
  • touch panel films flexible substrates Film
  • display film for example, PDP ( Laser display), LCD (liquid crystal display), VFD (vacuum fluorescent display
  • the curable composition of the present invention can be suitably used for optical material applications.
  • the shape of such an optical material include a film shape (or sheet shape), a plate shape, a lens shape, and a tubular shape. It is done.
  • first monofunctional (meth) acrylate of the present invention can also be used as a viscosity reducing agent for reducing the viscosity of the polyfunctional (meth) acrylate.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Provided are: a curable composition which is capable of forming a cured product that has high refractive index; and a cured product of this curable composition. This curable composition contains a polyfunctional (meth)acrylate and a monofunctional (meth)acrylate represented by formula (1). (In the formula, R1 represents a hydrogen atom or a methyl group; R2 represents an alkylene group; R3 represents an alkyl group; Ar1 represents a condensed polycyclic arene ring; a represents an integer of 1-4; and b represents 0 or an integer of 1 or more.)

Description

硬化性組成物及びその硬化物Curable composition and cured product thereof
 本発明は、高屈折率の硬化物を形成可能な新規な硬化性組成物及びその硬化物に関する。 The present invention relates to a novel curable composition capable of forming a cured product having a high refractive index and the cured product thereof.
 重合反応により、3次元網目構造を有する硬化物を形成するので、分子内に複数(2以上)の(メタ)アクリロイル基を有する多官能性(メタ)アクリレートが様々な分野で利用されている。なかでも、フルオレン骨格を有する多官能性(メタ)アクリレートは、フルオレン骨格(例えば、9,9-ビスアリールフルオレン骨格など)に由来する優れた光学的特性(例えば、高屈折率、高透明性など)などを有しているため、光学材料として利用されている。フルオレン骨格を有する多官能性(メタ)アクリレートとして、代表的には、9,9-ビス[(メタ)アクリロイルオキシ(ポリ)アルコキシアリール]フルオレンなどが知られている。しかし、多官能性(メタ)アクリレート(特に、フルオレン骨格を有する多官能性(メタ)アクリレート)は、比較的高粘度である場合が多く、ハンドリング性改善のために、通常、単官能性(メタ)アクリレートなどの反応性希釈剤と混合して使用される。 Since a cured product having a three-dimensional network structure is formed by a polymerization reaction, polyfunctional (meth) acrylates having a plurality of (two or more) (meth) acryloyl groups in the molecule are used in various fields. Among them, the polyfunctional (meth) acrylate having a fluorene skeleton has excellent optical properties (for example, high refractive index, high transparency, etc.) derived from the fluorene skeleton (for example, 9,9-bisarylfluorene skeleton, etc.). ) And the like, it is used as an optical material. As a polyfunctional (meth) acrylate having a fluorene skeleton, typically, 9,9-bis [(meth) acryloyloxy (poly) alkoxyaryl] fluorene and the like are known. However, polyfunctional (meth) acrylates (especially polyfunctional (meth) acrylates having a fluorene skeleton) often have a relatively high viscosity, and are usually monofunctional (metafunctional) for improving handling properties. ) Used in combination with a reactive diluent such as acrylate.
 例えば、国際公開第2013/022065号(特許文献1)には、オキシアルキレン基の付加数の平均値を特定の範囲に調整した9,9-ビス[(メタ)アクリロイルオキシポリアルコキシフェニル]フルオレンと、そのフルオレン化合物を含む硬化性組成物及びそれらの硬化物とが開示されている。このフルオレン骨格を有する化合物及びそれを含む硬化性組成物は、ハンドリング性及び硬化性に優れ、硬化物においては、高い屈折率と、耐スクラッチ性とを両立できることが記載されている。特に、芳香族(メタ)アクリレートであるアリールオキシアルキル(メタ)アクリレート[例えば、フェノキシエチル(メタ)アクリレートなどのC6-10アリールオキシC1-10アルキル(メタ)アクリレートなど]は、高屈折率と優れたハンドリング性とをバランスよく両立でき、耐スクラッチ性を効率よく維持できる単官能性(メタ)アクリレートであることも記載されている。この文献の実施例では、9,9-ビス[4-((メタ)アクリロイルオキシポリエトキシ)フェニル]フルオレン(1分子に付加するエトキシ基の平均個数10.9)と、芳香族アクリレート(例えば、フェノキシエチルアクリレートなど)などの多種多様な単官能性又は多官能性アクリレートとを含む硬化性組成物を調製している。これらの硬化性組成物及びその硬化物は、高いハンドリング性を有し、硬化物において高い屈折率及び耐スクラッチ性を示すものの、光学材料の分野においては、さらなる改善が求められていた。 For example, International Publication No. 2013/022065 (Patent Document 1) discloses 9,9-bis [(meth) acryloyloxypolyalkoxyphenyl] fluorene in which the average value of the number of oxyalkylene groups added is adjusted to a specific range. , Curable compositions containing the fluorene compound, and cured products thereof. It is described that the compound having a fluorene skeleton and the curable composition containing the compound are excellent in handling properties and curability, and the cured product can achieve both a high refractive index and scratch resistance. In particular, aryloxyalkyl (meth) acrylates that are aromatic (meth) acrylates [for example, C 6-10 aryloxy C 1-10 alkyl (meth) acrylates such as phenoxyethyl (meth) acrylate] have a high refractive index. It is also described that it is a monofunctional (meth) acrylate that can balance both excellent handling properties and excellent handling properties and can efficiently maintain scratch resistance. In the examples of this document, 9,9-bis [4-((meth) acryloyloxypolyethoxy) phenyl] fluorene (average number of ethoxy groups 10.9 added to one molecule) and an aromatic acrylate (for example, Curable compositions comprising a wide variety of mono- or polyfunctional acrylates such as phenoxyethyl acrylate) have been prepared. Although these curable compositions and cured products thereof have high handling properties and exhibit high refractive index and scratch resistance in the cured products, further improvements have been required in the field of optical materials.
国際公開第2013/022065号(請求の範囲、段落[0013][0107][0111][0112]、実施例)International Publication No. 2013/022065 (Claims, paragraphs [0013] [0107] [0111] [0112], Examples)
 従って、本発明の目的は、反応性希釈剤を含有しても、高い屈折率の硬化物を形成可能な新規硬化性組成物、その硬化物、及び前記硬化物の製造方法を提供することにある。 Accordingly, an object of the present invention is to provide a novel curable composition capable of forming a cured product having a high refractive index even if it contains a reactive diluent, a cured product thereof, and a method for producing the cured product. is there.
 本発明の他の目的は、高いハンドリング性(低粘性)を有し、かつ高屈折率を有する硬化物を形成可能な新規硬化性組成物及びその硬化物を提供することにある。 Another object of the present invention is to provide a novel curable composition capable of forming a cured product having high handling properties (low viscosity) and having a high refractive index, and a cured product thereof.
 本発明のさらに他の目的は、優れた耐スクラッチ性(柔軟性)をも有する硬化物を形成可能な硬化性組成物及びその硬化物を提供することにある。 Still another object of the present invention is to provide a curable composition capable of forming a cured product having excellent scratch resistance (flexibility), and a cured product thereof.
 本発明の別の目的は、高粘度の多官能性(メタ)アクリレートであっても、有効に低粘度化できる方法及び低粘度化剤を提供することにある。 Another object of the present invention is to provide a method and a viscosity reducing agent capable of effectively lowering the viscosity even with a high-viscosity polyfunctional (meth) acrylate.
 本発明者らは、前記課題を達成するため鋭意検討した結果、多官能性(メタ)アクリレートと、反応性希釈剤としての縮合多環式アリール基を有する単官能性(メタ)アクリレートとを組み合わせると、反応性希釈剤を含有しても、高い屈折率を有する硬化物を形成できること、前記単官能性(メタ)アクリレートが室温で固体であっても、高粘度の多官能性(メタ)アクリレートを低粘度化できハンドリング性を改善できることを見いだし、本発明を完成した。 As a result of intensive studies to achieve the above-mentioned problems, the present inventors combined a polyfunctional (meth) acrylate with a monofunctional (meth) acrylate having a condensed polycyclic aryl group as a reactive diluent. Even if it contains a reactive diluent, it can form a cured product having a high refractive index, and even if the monofunctional (meth) acrylate is solid at room temperature, it has a high-viscosity polyfunctional (meth) acrylate. The present invention has been completed by finding that the viscosity can be lowered and the handleability can be improved.
 すなわち、本発明の硬化性組成物は、多官能性(メタ)アクリレートと、下記式(1)で表される新規な第1の単官能性(メタ)アクリレートとを含む。 That is, the curable composition of the present invention contains a polyfunctional (meth) acrylate and a novel first monofunctional (meth) acrylate represented by the following formula (1).
Figure JPOXMLDOC01-appb-C000005
Figure JPOXMLDOC01-appb-C000005
(式中、Rは水素原子又はメチル基、Rは直鎖状又は分岐鎖状アルキレン基、Rはアルキル基、Arは縮合多環式アレーン環、aは1~4の整数、bは0又は1以上の整数を示す。)
 多官能性(メタ)アクリレートと、前記式(1)で表される第1の単官能性(メタ)アクリレートとの割合は、前者/後者(重量比)=99/1~1/99(例えば、80/20~5/95など)程度であってもよい。前記式(1)で表される第1の単官能性(メタ)アクリレートは、縮合多環式C10-14アリールオキシC2-4アルキル(メタ)アクリレートであってもよい。
(Wherein R 1 is a hydrogen atom or a methyl group, R 2 is a linear or branched alkylene group, R 3 is an alkyl group, Ar 1 is a condensed polycyclic arene ring, a is an integer of 1 to 4, b represents 0 or an integer of 1 or more.)
The ratio of the polyfunctional (meth) acrylate and the first monofunctional (meth) acrylate represented by the formula (1) is the former / the latter (weight ratio) = 99/1 to 1/99 (for example, 80/20 to 5/95, etc.). The first monofunctional (meth) acrylate represented by the formula (1) may be a condensed polycyclic C 10-14 aryloxy C 2-4 alkyl (meth) acrylate.
 多官能性(メタ)アクリレートは、下記式(2) Multifunctional (meth) acrylate is represented by the following formula (2)
Figure JPOXMLDOC01-appb-C000006
Figure JPOXMLDOC01-appb-C000006
(式中、環Z及びZ並びに環Z及びZはアレーン環、R4a及びR4b並びにR5a及びR5bはそれぞれ同一又は異なる非反応性置換基、R6a及びR6bは直鎖状又は分岐鎖状アルキレン基、R7a及びR7bは水素原子又はメチル基、k1及びk2は0又は1以上の整数、m1及びm2は0又は1以上の整数、n1及びn2は0又は1以上の整数、p1及びp2は1以上の整数を示す。)
で表されるフルオレン骨格含有(メタ)アクリレート、脂環族又は芳香族エポキシ(メタ)アクリレート、ウレタン(メタ)アクリレート及びポリエステル(メタ)アクリレートからなる群より選択された少なくとも1種の高粘度多官能性(メタ)アクリレートを含んでいてもよい。
(Wherein rings Z 1 and Z 2 and rings Z 3 and Z 4 are arene rings, R 4a and R 4b and R 5a and R 5b are the same or different non-reactive substituents, and R 6a and R 6b are direct A linear or branched alkylene group, R 7a and R 7b are hydrogen atoms or methyl groups, k1 and k2 are 0 or an integer of 1 or more, m1 and m2 are 0 or an integer of 1 or more, and n1 and n2 are 0 or 1 (The above integers, p1 and p2 represent integers of 1 or more.)
At least one high-viscosity multifunctional selected from the group consisting of fluorene skeleton-containing (meth) acrylates, alicyclic or aromatic epoxy (meth) acrylates, urethane (meth) acrylates and polyester (meth) acrylates (Meth) acrylate may be included.
 前記式(2)において、環Z及びZ並びに環Z及びZはそれぞれベンゼン環又はナフタレン環であってもよく、k1及びk2は0であってもよく、R5a及びR5bはC1-6アルキル基又はC6-10アリール基であってもよく、m1及びm2は0又は1~2の整数であってもよく、R6a及びR6bは直鎖状C2-6アルキレン基であってもよく、n1及びn2は1~10の整数であってもよく、p1及びp2は1であってもよい。 In the formula (2), the rings Z 1 and Z 2 and the rings Z 3 and Z 4 may each be a benzene ring or a naphthalene ring, k1 and k2 may be 0, and R 5a and R 5b are It may be a C 1-6 alkyl group or a C 6-10 aryl group, m1 and m2 may be 0 or an integer of 1 to 2, and R 6a and R 6b are linear C 2-6 alkylene It may be a group, n1 and n2 may be an integer of 1 to 10, and p1 and p2 may be 1.
 また、多官能性(メタ)アクリレートは、式(2)で表されるフルオレン(メタ)アクリレートと、ウレタン(メタ)アクリレートとを少なくとも含んでいてもよい。式(2)で表されるフルオレン骨格含有(メタ)アクリレートと、ウレタン(メタ)アクリレートとの割合は、前者/後者(重量比)=50/50~99/1程度であってもよい。 Moreover, the polyfunctional (meth) acrylate may contain at least fluorene (meth) acrylate represented by the formula (2) and urethane (meth) acrylate. The ratio of the fluorene skeleton-containing (meth) acrylate represented by the formula (2) to the urethane (meth) acrylate may be about the former / the latter (weight ratio) = 50/50 to 99/1.
 さらに、前記多官能性(メタ)アクリレートは、前記高粘度多官能性(メタ)アクリレートに加えて、ビフェノール類又はビスフェノール類のアルキレンオキサイド付加体のジ(メタ)アクリレートを含んでいてもよい。前記高粘度多官能性(メタ)アクリレートと、ビフェノール類又はビスフェノール類のアルキレンオキサイド付加体のジ(メタ)アクリレートとの割合は、前者/後者(重量比)=50/50~99/1程度であってもよい。 Furthermore, the polyfunctional (meth) acrylate may contain di (meth) acrylate of an alkylene oxide adduct of biphenols or bisphenols in addition to the high-viscosity polyfunctional (meth) acrylate. The ratio of the high-viscosity polyfunctional (meth) acrylate to the di (meth) acrylate of the alkylene oxide adduct of biphenols or bisphenols is about the former / the latter (weight ratio) = 50/50 to 99/1. There may be.
 芳香族エポキシ(メタ)アクリレートは、下記式(3)で表される芳香族エポキシ(メタ)アクリレートであってもよい。 The aromatic epoxy (meth) acrylate may be an aromatic epoxy (meth) acrylate represented by the following formula (3).
Figure JPOXMLDOC01-appb-C000007
Figure JPOXMLDOC01-appb-C000007
(式中、Rはそれぞれ水素原子、アルキル基又はアリール基を示し、2つのRは互いに結合して、アルキル基を有してもよい炭化水素環を形成してもよく、R9a及びR9bはそれぞれアルキル基又はアリール基、R10a及びR10bは直鎖状又は分岐鎖状アルキレン基、R11a及びR11bは水素原子又はメチル基、q1及びq2は0~4の整数、r1及びr2は0又は1以上の整数、tは0又は1を示す。)
 ウレタン(メタ)アクリレートは、ポリエステル型ウレタン(メタ)アクリレート、ポリエーテル型ウレタン(メタ)アクリレート、ポリカーボネート型ウレタン(メタ)アクリレートなどであってもよい。
(Wherein R 8 represents a hydrogen atom, an alkyl group or an aryl group, respectively, and two R 8 may be bonded to each other to form a hydrocarbon ring which may have an alkyl group, R 9a and R 9b is an alkyl group or an aryl group, R 10a and R 10b are linear or branched alkylene groups, R 11a and R 11b are hydrogen atoms or methyl groups, q1 and q2 are integers of 0 to 4, r1 and r2 is 0 or an integer of 1 or more, and t is 0 or 1.)
The urethane (meth) acrylate may be a polyester type urethane (meth) acrylate, a polyether type urethane (meth) acrylate, a polycarbonate type urethane (meth) acrylate, or the like.
 また、多官能性(メタ)アクリレートの粘度(25℃)は、高粘度、例えば、3000mPa・s以上であってもよい。 Further, the viscosity (25 ° C.) of the polyfunctional (meth) acrylate may be high viscosity, for example, 3000 mPa · s or more.
 前記硬化性組成物は、さらに、アルキルチオ(メタ)アクリレート、アリールチオ(メタ)アクリレート、アラルキルチオ(メタ)アクリレート及びアリールチオアルキル(メタ)アクリレートからなる群より選択される少なくとも1種の第2の単官能性(メタ)アクリレート(硫黄原子含有単官能性(メタ)アクリレート)を含んでいてもよい。前記第1の単官能性(メタ)アクリレートと、第2の単官能性(メタ)アクリレートとの割合は、前者/後者(重量比)=80/20~20/80程度であってもよい。 The curable composition further includes at least one second unit selected from the group consisting of alkylthio (meth) acrylates, arylthio (meth) acrylates, aralkylthio (meth) acrylates, and arylthioalkyl (meth) acrylates. Functional (meth) acrylate (sulfur atom-containing monofunctional (meth) acrylate) may be included. The ratio of the first monofunctional (meth) acrylate to the second monofunctional (meth) acrylate may be about the former / the latter (weight ratio) = 80/20 to 20/80.
 前記硬化性組成物は、さらに、下記式(4)で表される第3の単官能性(メタ)アクリレートを含んでいてもよい。 The curable composition may further contain a third monofunctional (meth) acrylate represented by the following formula (4).
Figure JPOXMLDOC01-appb-C000008
Figure JPOXMLDOC01-appb-C000008
(式中、R12は水素原子又はメチル基、R13はアルキレン基、R14はアルキル基、Arはベンゼン環又は環集合アレーン環、cは1~4の整数、dは0又は1以上の整数を示す。)
前記式(1)で表される第1の単官能性(メタ)アクリレートと、前記式(3)で表される第3の単官能性(メタ)アクリレートとの割合は、前者/後者(重量比)=80/20~20/80程度であってもよい。
(Wherein R 12 is a hydrogen atom or a methyl group, R 13 is an alkylene group, R 14 is an alkyl group, Ar 2 is a benzene ring or a ring-arene ring, c is an integer of 1 to 4, and d is 0 or 1 or more. Indicates an integer.)
The ratio of the first monofunctional (meth) acrylate represented by the formula (1) and the third monofunctional (meth) acrylate represented by the formula (3) is the former / the latter (weight) Ratio) = about 80/20 to 20/80.
 前記硬化性組成物は、さらに、重合開始剤を含んでいてもよい。 The curable composition may further contain a polymerization initiator.
 本発明は、前記硬化性組成物が硬化した硬化物も含み、さらに、前記硬化性組成物に、活性エネルギーを与えて硬化させ、前記硬化物を製造する方法も包含する。 The present invention includes a cured product obtained by curing the curable composition, and further includes a method of producing the cured product by applying active energy to the curable composition and curing the composition.
 また、本発明は、多官能性(メタ)アクリレートを低粘度化するための低粘度化剤であって、前記第1の単官能性(メタ)アクリレートを含む低粘度化剤も含む。前記低粘度化剤は、さらに、前記第2の単官能性(メタ)アクリレートを含んでいてもよい。 The present invention also includes a viscosity reducing agent for reducing the viscosity of the polyfunctional (meth) acrylate, the viscosity reducing agent including the first monofunctional (meth) acrylate. The viscosity reducing agent may further contain the second monofunctional (meth) acrylate.
 本発明は、多官能性(メタ)アクリレートに前記第1の単官能性(メタ)アクリレートを添加して、多官能性(メタ)アクリレートの粘度を低減する方法も含む。 The present invention also includes a method of reducing the viscosity of the polyfunctional (meth) acrylate by adding the first monofunctional (meth) acrylate to the polyfunctional (meth) acrylate.
 また、本発明は、新規な化合物である前記第1の単官能性(メタ)アクリレートも包含する。 The present invention also includes the first monofunctional (meth) acrylate, which is a novel compound.
 なお、本明細書中、「(ポリ)アルコキシ」とは、アルコキシ基及びポリアルコキシ基の双方を意味する。 In the present specification, “(poly) alkoxy” means both an alkoxy group and a polyalkoxy group.
 本発明の硬化性組成物は、多官能性(メタ)アクリレートと、縮合多環式アリール基を有する単官能性(メタ)アクリレート(第1の単官能性(メタ)アクリレート)とを含むため、反応性希釈剤(単官能性(メタ)アクリレートなど)を含有しても、高い屈折率の硬化物を形成できる。そのため、高価な多官能性(メタ)アクリレートの使用量を有効に低減できる。また、第1の単官能性(メタ)アクリレートは、低粘度化剤として機能させることができ、前記硬化性組成物のハンドリング性(低粘性)を向上し、かつ高い屈折率の硬化物を形成することもできる。さらに、前記硬化物は、高屈折率と耐スクラッチ性(柔軟性)とを両立できる。 Since the curable composition of the present invention contains a polyfunctional (meth) acrylate and a monofunctional (meth) acrylate having a condensed polycyclic aryl group (first monofunctional (meth) acrylate), Even when a reactive diluent (monofunctional (meth) acrylate or the like) is contained, a cured product having a high refractive index can be formed. Therefore, the amount of expensive multifunctional (meth) acrylate used can be effectively reduced. Further, the first monofunctional (meth) acrylate can function as a viscosity reducing agent, improves the handling property (low viscosity) of the curable composition, and forms a cured product having a high refractive index. You can also Furthermore, the cured product can achieve both a high refractive index and scratch resistance (flexibility).
図1は、比較例1~5及び実施例1~5の組成物の希釈剤配合割合に対する硬化前屈折率を示すグラフである。FIG. 1 is a graph showing the refractive index before curing of the compositions of Comparative Examples 1 to 5 and Examples 1 to 5 with respect to the blending ratio of the diluent. 図2は、比較例1~5及び実施例2~5の組成物の希釈剤配合割合に対する粘度を示すグラフである。FIG. 2 is a graph showing the viscosity with respect to the blending ratio of the compositions of Comparative Examples 1 to 5 and Examples 2 to 5. 図3は、BPEFA/反応性希釈剤配合系において、目標屈折率を達成する組成物の粘度(計算値)を示すグラフである。FIG. 3 is a graph showing the viscosity (calculated value) of a composition that achieves a target refractive index in a BPEFA / reactive diluent blending system.
 本発明の硬化性組成物は、多官能性(メタ)アクリレートと、反応性希釈剤としての縮合多環式アリール基を有する第1の単官能性(メタ)アクリレートとを含む。この第1の単官能性(メタ)アクリレートは、新規化合物である。 The curable composition of the present invention contains a polyfunctional (meth) acrylate and a first monofunctional (meth) acrylate having a condensed polycyclic aryl group as a reactive diluent. This first monofunctional (meth) acrylate is a novel compound.
 <縮合多環式アリール基を有する第1の単官能性(メタ)アクリレート>
 縮合多環式アリール基を有する第1の単官能性(メタ)アクリレートは、下記式(1)で表される化合物である。
<First monofunctional (meth) acrylate having a condensed polycyclic aryl group>
The first monofunctional (meth) acrylate having a condensed polycyclic aryl group is a compound represented by the following formula (1).
Figure JPOXMLDOC01-appb-C000009
Figure JPOXMLDOC01-appb-C000009
(式中、Rは水素原子又はメチル基、Rは直鎖状又は分岐鎖状アルキレン基、Rはアルキル基、Arは縮合多環式アレーン環、aは1~4の整数、bは0又は1以上の整数を示す。)
 前記式(1)において、基Rは水素原子又はメチル基である。また、基Rは直鎖状又は分岐鎖状アルキレン基であり、直鎖状アルキレン基としては、例えば、エチレン基、トリメチレン基、テトラメチレン基などの直鎖状C2-6アルキレン基(好ましくは直鎖状C2-4アルキレン基、さらに好ましくは直鎖状C2-3アルキレン基、特にエチレン基)が例示でき、分岐鎖状アルキレン基としては、例えば、プロピレン基、1,2-ブタンジイル基、1,3-ブタンジイル基などの分岐鎖状C3-6アルキレン基(好ましくは分岐鎖状C3-4アルキレン基、特にプロピレン基)などが挙げられる。これらの基Rのうち、好ましくは直鎖状又は分岐鎖状C2-6アルキレン基(例えば、直鎖状又は分岐鎖状C2-4アルキレン基など)、さらに好ましくは直鎖状又は分岐鎖状C2-3アルキレン基(特にエチレン基、プロピレン基)であってもよい。基(RO)の繰り返し数aは、1~4程度の整数から選択でき、例えば、1~3程度の整数、好ましくは1又は2、さらに好ましくは1であってもよい。繰り返し数aが大きすぎると、硬化物の屈折率が低下するおそれがある。なお、aが2以上である場合、2以上の基Rは、同一又は異なっていてもよい。
(Wherein R 1 is a hydrogen atom or a methyl group, R 2 is a linear or branched alkylene group, R 3 is an alkyl group, Ar 1 is a condensed polycyclic arene ring, a is an integer of 1 to 4, b represents 0 or an integer of 1 or more.)
In the formula (1), the group R 1 is a hydrogen atom or a methyl group. The group R 2 is a linear or branched alkylene group. Examples of the linear alkylene group include linear C 2-6 alkylene groups such as ethylene group, trimethylene group, tetramethylene group (preferably Can be exemplified by a linear C 2-4 alkylene group, more preferably a linear C 2-3 alkylene group, particularly an ethylene group. Examples of the branched alkylene group include a propylene group and 1,2-butanediyl. And a branched C 3-6 alkylene group such as a 1,3-butanediyl group (preferably a branched C 3-4 alkylene group, particularly a propylene group). Of these groups R 2, a linear or branched C 2-6 alkylene group (eg, a linear or branched C 2-4 alkylene group) is preferable, and a linear or branched group is more preferable. It may be a chain C 2-3 alkylene group (particularly an ethylene group or a propylene group). The repeating number a of the group (R 2 O) can be selected from an integer of about 1 to 4, for example, an integer of about 1 to 3, preferably 1 or 2, and more preferably 1. If the repetition number a is too large, the refractive index of the cured product may be reduced. When a is 2 or more, the two or more groups R 2 may be the same or different.
 前記式(1)において、環Arは縮合多環式アレーン環であり、例えば、縮合二環式アレーン環(例えば、ナフタレン環などの縮合二環式C10-16アレーン環)、縮合三環式アレーン環(例えば、アントラセン環、フェナントレン環など)などの縮合二乃至四環式アレーン環などが挙げられる。好ましい環Arとしては、ナフタレン環、アントラセン環などの縮合多環式C10-16アレーン環(好ましくは縮合多環式C10-14アレーン環)が挙げられ、特に、ナフタレン環が好ましい。前記式(1)において、環Arに対する基[-O-(RO)-CO-CR=CH]の結合位置は特に制限されず、例えば、環Arがナフタレン環である場合には、1-位、2-位のいずれの位置に結合していてもよいが、2-位に結合しているのが好ましい。 In the formula (1), the ring Ar 1 is a condensed polycyclic arene ring, such as a condensed bicyclic arene ring (for example, a condensed bicyclic C 10-16 arene ring such as a naphthalene ring), a condensed tricyclic ring, etc. Examples thereof include condensed bi to tetracyclic arene rings such as a formula arene ring (for example, anthracene ring, phenanthrene ring, etc.). Preferable ring Ar 1 includes a condensed polycyclic C 10-16 arene ring (preferably a condensed polycyclic C 10-14 arene ring) such as a naphthalene ring and an anthracene ring, and a naphthalene ring is particularly preferable. In the formula (1), the bonding position of the group [-O- (R 2 O) a -CO-CR 1 = CH 2] for the ring Ar 1 is not particularly limited, for example, the ring Ar 1 is a naphthalene ring In some cases, it may be bonded to either the 1-position or the 2-position, but is preferably bonded to the 2-position.
 前記式(1)において、基Rはアルキル基であってもよく、例えば、メチル基、エチル基、n-プロピル基、イソプロピル基、n-ブチル基、イソブチル基、s-ブチル基、t-ブチル基、ペンチル基、ネオペンチル基、ヘキシル基、ヘプチル基、オクチル基、2-エチルヘキシル基、ノニル基、デシル基などの直鎖状又は分岐鎖状C1-12アルキル基、好ましくは直鎖状又は分岐鎖状C1-9アルキル基、さらに好ましくは直鎖状又は分岐鎖状C1-6アルキル基(例えば、直鎖状又は分岐鎖状C1-4アルキル基)などが挙げられる。基Rの置換数bは0又は1以上の整数であればよく、例えば、0~4程度の整数、好ましくは0~2程度の整数、さらに好ましくは0又は1、特に0であってもよい。なお、bが2以上である場合、2以上の基Rの種類はそれぞれ同一又は異なっていてもよい。また、基Rの置換位置は特に制限されず、例えば、環Arがナフタレン環であり、基[-O-(RO)-CO-CR=CH]が2-位に結合している場合、2-ナフチル基の1-位及び3-位乃至8-位のうちのいずれの位置に置換していてもよい。 In the above formula (1), the group R 3 may be an alkyl group, for example, methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group, s-butyl group, t- Linear or branched C 1-12 alkyl group such as butyl group, pentyl group, neopentyl group, hexyl group, heptyl group, octyl group, 2-ethylhexyl group, nonyl group, decyl group, preferably linear or A branched C 1-9 alkyl group, more preferably a linear or branched C 1-6 alkyl group (for example, a linear or branched C 1-4 alkyl group) and the like can be mentioned. The substitution number b of the group R 3 may be 0 or an integer of 1 or more, for example, an integer of about 0 to 4, preferably an integer of about 0 to 2, more preferably 0 or 1, particularly 0. Good. When b is 2 or more, the types of the two or more groups R 3 may be the same or different. The substitution position of the group R 3 is not particularly limited, for example, the ring Ar 1 is a naphthalene ring, group [-O- (R 2 O) a -CO-CR 1 = CH 2] is the 2-position When they are bonded, they may be substituted at any of the 1-position and 3-position to 8-position of the 2-naphthyl group.
 前記式(1)で表される第1の単官能性(メタ)アクリレートの代表例としては、例えば、前記式(1)において、a=1及びb=0である化合物、すなわち、縮合多環式アリールオキシアルキル(メタ)アクリレート[例えば、2-(2-ナフトキシ)エチル(メタ)アクリレート、2-(1-ナフトキシ)エチル(メタ)アクリレート、2-(2-ナフトキシ)プロピル(メタ)アクリレートなどの縮合多環式C10-14アリールオキシC2-4アルキル(メタ)アクリレートなど];前記式(1)において、a≧2及びb=0である化合物、すなわち、縮合多環式アリールオキシ(モノ乃至トリ)アルコキシアルキル(メタ)アクリレート[例えば、2-(2-(2-ナフトキシ)エトキシ)エチル(メタ)アクリレート、2-(2-(2-ナフトキシ)プロポキシ)プロピル(メタ)アクリレートなどの縮合多環式C10-14アリールオキシ(モノ乃至トリ)C2-4アルコキシC2-4アルキル(メタ)アクリレートなど];前記式(1)において、a=1及びb=1である化合物、すなわち、アルキル縮合多環式アリールオキシアルキル(メタ)アクリレート[例えば、2-(4-t-ブチル-1-ナフトキシ)エチル(メタ)アクリレートなどのC1-12アルキル縮合多環式C10-16アリールオキシC2-4アルキル(メタ)アクリレートなど];前記式(1)において、a≧2及びb=1である化合物、すなわち、アルキル縮合多環式アリールオキシ(モノ乃至トリ)アルコキシアルキル(メタ)アクリレート[例えば、2-(2-(2-(4-t-ブチル-1-ナフトキシ)エトキシ)エトキシ)エチル(メタ)アクリレートなどのC1-12アルキル縮合多環式C10-14アリールオキシ(モノ乃至トリ)C2-4アルコキシC2-4アルキル(メタ)アクリレートなど)などが挙げられる。これらの前記式(1)で表される第1の単官能性(メタ)アクリレートは単独で又は二種以上組み合わせて使用できる。好ましい前記式(1)で表される第1の単官能性(メタ)アクリレートとしては、前記式(1)において、a=1及びb=0である化合物、すなわち、縮合多環式アリールオキシアルキル(メタ)アクリレート、さらに好ましくは、縮合多環式C10-14アリールオキシC2-4アルキル(メタ)アクリレート(例えば、2-(2-ナフトキシ)エチル(メタ)アクリレートなどのナフトキシC2-4アルキル(メタ)アクリレートなど)などが挙げられる。このような前記式(1)で表される第1の単官能性(メタ)アクリレートは、縮合多環式アリール基を有するためか、硬化性組成物中に多量に混合しても、硬化物における屈折率を保持又は向上でき、かつ粘度低減効果も高い。そのため、例えば、高屈折率かつ低粘度の特性を両立でき、高価な多官能性(メタ)アクリレートの配合割合(又は使用量)を有効に低減できる。また、通常、反応性希釈剤には、使用温度下(例えば、25℃程度の室温下)で高い流動性を示す液状化合物が使用されるが、意外なことに、前記式(1)で表される第1の単官能性(メタ)アクリレートは、粉体状や粘稠体状などの形態であり、ほとんど流動性を示さない化合物であるにもかかわらず、高粘度な多官能性(メタ)アクリレートを著しく低粘度化できる。そのため、第1の単官能性(メタ)アクリレートは、多官能性(メタ)アクリレートの粘度を低減するための低粘度化剤として機能させることもできる。多官能性(メタ)アクリレートの低粘度化方法においては、少なくとも第1の単官能性(メタ)アクリレートを含む低粘度化剤と、多官能性(メタ)アクリレートとを混合する方法であれば特に制限されず、得られる硬化性組成物を有効に低粘度化でき、かつ屈折率を保持又は向上することもできる。第1の単官能性(メタ)アクリレートと、多官能性(メタ)アクリレートとの配合割合は、後述する硬化性組成物における割合と同様であってもよい。 As a typical example of the first monofunctional (meth) acrylate represented by the formula (1), for example, a compound in which a = 1 and b = 0 in the formula (1), that is, a condensed polycycle Formula aryloxyalkyl (meth) acrylate [for example, 2- (2-naphthoxy) ethyl (meth) acrylate, 2- (1-naphthoxy) ethyl (meth) acrylate, 2- (2-naphthoxy) propyl (meth) acrylate, etc. A condensed polycyclic C 10-14 aryloxy C 2-4 alkyl (meth) acrylate, etc.]; a compound in which a ≧ 2 and b = 0 in the above formula (1), that is, a condensed polycyclic aryloxy ( Mono to tri) alkoxyalkyl (meth) acrylates [eg, 2- (2- (2-naphthoxy) ethoxy) ethyl (meth) acrylate, 2- ( - (2-naphthoxy) propoxy) propyl (meth) fused polycyclic C 10-14 aryloxy (mono- to tri) C 2-4 alkoxy C 2-4 alkyl (meth) acrylates such as acrylate]; Formula ( 1) a compound in which a = 1 and b = 1, ie an alkyl-fused polycyclic aryloxyalkyl (meth) acrylate [eg 2- (4-tert-butyl-1-naphthoxy) ethyl (meth) acrylate C 1-12 alkyl condensed polycyclic C 10-16 aryloxy C 2-4 alkyl (meth) acrylate and the like]; a compound in which a ≧ 2 and b = 1 in the formula (1), ie, alkyl Fused polycyclic aryloxy (mono to tri) alkoxyalkyl (meth) acrylates [eg 2- (2- (2- (4-t C 1-12 alkyl condensed polycyclic C 10-14 aryloxy (mono to tri) C 2-4 alkoxy C 2-4 alkyl (meth) -butyl-1-naphthoxy) ethoxy) ethoxy) ethyl (meth) acrylate ) Acrylate, etc.). These 1st monofunctional (meth) acrylate represented by the said Formula (1) can be used individually or in combination of 2 or more types. The first monofunctional (meth) acrylate represented by the formula (1) is preferably a compound in which a = 1 and b = 0 in the formula (1), that is, a condensed polycyclic aryloxyalkyl. (Meth) acrylates, more preferably fused polycyclic C 10-14 aryloxy C 2-4 alkyl (meth) acrylates (eg naphthoxy C 2-4 such as 2- (2-naphthoxy) ethyl (meth) acrylate) Alkyl (meth) acrylate, etc.). Such a first monofunctional (meth) acrylate represented by the formula (1) has a condensed polycyclic aryl group, or a cured product even if mixed in a large amount in the curable composition. Can maintain or improve the refractive index, and has a high viscosity reducing effect. Therefore, for example, both high refractive index and low viscosity characteristics can be achieved, and the blending ratio (or usage amount) of expensive polyfunctional (meth) acrylate can be effectively reduced. In general, the reactive diluent is a liquid compound exhibiting high fluidity at the operating temperature (for example, at room temperature of about 25 ° C.). Surprisingly, it is represented by the formula (1). The first monofunctional (meth) acrylate to be produced is in the form of powder or viscous material, and is a compound that exhibits almost no fluidity, but has high viscosity and multifunctionality (meta). ) The viscosity of the acrylate can be significantly reduced. Therefore, the first monofunctional (meth) acrylate can also function as a viscosity reducing agent for reducing the viscosity of the polyfunctional (meth) acrylate. In the method for reducing the viscosity of the polyfunctional (meth) acrylate, a method of mixing a polyfunctional (meth) acrylate with a viscosity reducing agent containing at least the first monofunctional (meth) acrylate is particularly preferable. Without being limited, the resulting curable composition can be effectively reduced in viscosity, and the refractive index can be maintained or improved. The blending ratio of the first monofunctional (meth) acrylate and the polyfunctional (meth) acrylate may be the same as the ratio in the curable composition described later.
 なお、式(1)で表される化合物は、公知の方法(例えば、特開2012-226040号公報(段落[0014])に記載の方法に準ずる方法など)、例えば、ヒドロキシ縮合多環式アレーンのアルキレンオキサイド又はアルキレンカーボネート付加体を、硫酸、p-トルエンスルホン酸一水和物などのエステル化触媒、ハイドロキノン、4-メトキシフェノールなどの重合禁止剤、及び必要に応じてトルエンなどの溶媒の存在下、(メタ)アクリル酸成分(例えば、(メタ)アクリル酸又はそのエステル形成性誘導体(例えば、酸ハライド、酸無水物、低級アルキルエステルなど)など)と反応させる方法などにより調製できる。 The compound represented by the formula (1) is a known method (for example, a method according to the method described in JP 2012-222040 A (paragraph [0014])), for example, a hydroxy-fused polycyclic arene. An alkylene oxide or an alkylene carbonate adduct, an esterification catalyst such as sulfuric acid or p-toluenesulfonic acid monohydrate, a polymerization inhibitor such as hydroquinone or 4-methoxyphenol, and a solvent such as toluene if necessary. Then, it can be prepared by a method of reacting with a (meth) acrylic acid component (for example, (meth) acrylic acid or an ester-forming derivative thereof (for example, acid halide, acid anhydride, lower alkyl ester, etc.)).
 ヒドロキシ縮合多環式アレーンとしては、例えば、前記式(1)で表される化合物に対応する化合物(例えば、1-ナフトール、2-ナフトールなど)などが例示できる。アルキレンオキサイド又はアルキレンカーボネートとしては、前記Rの項に例示したアルキレン基に対応するアルキレンオキサイド又はアルキレンカーボネート(例えば、エチレンオキサイドなど)などが挙げられる。代表的なヒドロキシ縮合多環式アレーンのアルキレンオキサイド又はアルキレンカーボネート付加体としては、例えば、2-(2-ナフチルオキシ)エタノール(NEO)、2-(1-ナフチルオキシ)プロパノール、2-(2-(2-ナフチルオキシ)エトキシ)エタノールなどのヒドロキシ(モノ乃至テトラ)C2-4アルコキシ-C10-14縮合多環式アレーンなどが例示できる。 Examples of the hydroxy-fused polycyclic arene include compounds corresponding to the compound represented by the formula (1) (for example, 1-naphthol, 2-naphthol, etc.). Examples of the alkylene oxide or alkylene carbonate include alkylene oxide or alkylene carbonate (for example, ethylene oxide) corresponding to the alkylene group exemplified in the above R 2 section. Typical examples of the alkylene oxide or alkylene carbonate adduct of the hydroxy-fused polycyclic arene include 2- (2-naphthyloxy) ethanol (NEO), 2- (1-naphthyloxy) propanol, 2- (2- Examples thereof include hydroxy (mono to tetra) C 2-4 alkoxy-C 10-14 condensed polycyclic arenes such as (2-naphthyloxy) ethoxy) ethanol.
 多官能性(メタ)アクリレートと、式(1)で表される第1の単官能性(メタ)アクリレートとの割合は、例えば、前者/後者(重量比)=99/1~1/99程度の範囲から選択でき、例えば、90/10~3/97、好ましくは80/20~5/95(例えば、70/30~10/90)、さらに好ましくは65/35~13/87(例えば、60/40~17/83)、特に55/45~20/80(例えば、50/50~22/78)程度であってもよい。式(1)で表される第1の単官能性(メタ)アクリレートの割合が少なすぎると、十分に高屈折率化及び/又は低粘度化できないおそれがある。 The ratio of the polyfunctional (meth) acrylate and the first monofunctional (meth) acrylate represented by the formula (1) is, for example, the former / the latter (weight ratio) = about 99/1 to 1/99. For example, 90/10 to 3/97, preferably 80/20 to 5/95 (eg 70/30 to 10/90), more preferably 65/35 to 13/87 (eg 60/40 to 17/83), particularly 55/45 to 20/80 (for example, 50/50 to 22/78). If the proportion of the first monofunctional (meth) acrylate represented by the formula (1) is too small, there is a possibility that the refractive index and / or the viscosity cannot be sufficiently reduced.
 また、硬化性組成物中の重合性成分全体に対して、多官能性(メタ)アクリレート及び式(1)で表される第1の単官能性(メタ)アクリレートの総量の割合は、例えば、30~100重量%(50~100重量%)、好ましくは60~100重量%(例えば、70~100重量%)、さらに好ましくは80~100重量%(例えば、90~100重量%)程度であってもよく、実質的に100重量%(多官能性(メタ)アクリレートと式(1)で表される第1の単官能性(メタ)アクリレートのみ)で形成されていてもよい。 Moreover, the ratio of the total amount of the polyfunctional (meth) acrylate and the first monofunctional (meth) acrylate represented by the formula (1) with respect to the entire polymerizable component in the curable composition is, for example, 30 to 100% by weight (50 to 100% by weight), preferably 60 to 100% by weight (for example, 70 to 100% by weight), more preferably about 80 to 100% by weight (for example, 90 to 100% by weight). Alternatively, it may be substantially 100% by weight (only the polyfunctional (meth) acrylate and the first monofunctional (meth) acrylate represented by the formula (1)).
 <多官能性(メタ)アクリレート>
 前記多官能性(メタ)アクリレートは、複数(2以上)の(メタ)アクリロイル基を有する限り、特に制限されない。1分子当たりの(メタ)アクリロイル基の数は、例えば、2~10、好ましくは2~6、さらに好ましくは2~4(例えば、2)程度であってもよい。(メタ)アクリロイル基の数が多すぎると、硬化物の耐スクラッチ性が低下するおそれがある。
<Multifunctional (meth) acrylate>
The polyfunctional (meth) acrylate is not particularly limited as long as it has a plurality of (two or more) (meth) acryloyl groups. The number of (meth) acryloyl groups per molecule may be, for example, about 2 to 10, preferably 2 to 6, and more preferably about 2 to 4 (eg 2). When there are too many (meth) acryloyl groups, there exists a possibility that the scratch resistance of hardened | cured material may fall.
 代表的な多官能性(メタ)アクリレートとしては、例えば、9,9-ビスアリールフルオレン骨格を有する多官能性(メタ)アクリレート;脂肪族エポキシ(メタ)アクリレート[例えば、1,6-ヘキサンジオールジグリシジルエーテルのジ(メタ)アクリレートなどのアルキレングリコールジグリシジルエーテルのジ(メタ)アクリレート、ポリプロピレングリコールジグリシジルエーテルのジ(メタ)アクリレートなどのポリアルキレングリコールジグリシジルエーテルなどのジ(メタ)アクリレートなど];脂環族エポキシ(メタ)アクリレート;芳香族エポキシ(メタ)アクリレート;ウレタン(メタ)アクリレート;ポリエステル(メタ)アクリレート;アルキレングリコールジ(メタ)アクリレート[例えば、エチレングリコールジ(メタ)アクリレート、ブタンジオールジ(メタ)アクリレートなどのC2-10アルキレングリコールジ(メタ)アクリレートなど];ポリアルキレングリコールジ(メタ)アクリレート[例えば、ジエチレングリコールジ(メタ)アクリレートなどのポリC2-10アルキレングリコールジ(メタ)アクリレートなど];ビフェノール類若しくはビスフェノール類(又はそれらのアルキレンオキサイド付加体)のジ(メタ)アクリレート;3~6個程度のヒドロキシル基を有する低分子量ポリオール化合物のポリ(メタ)アクリレート[例えば、トリメチロールプロパントリ(メタ)アクリレート、ペンタエリスリトールトリ(メタ)アクリレート、ペンタエリスリトールテトラ(メタ)アクリレート、ジペンタエリスリトールペンタ(メタ)アクリレート、ジペンタエリスリトールヘキサ(メタ)アクリレートなど]などが挙げられる。これらの多官能性(メタ)アクリレートは、単独で又は2種以上組み合わせて使用してもよい。 Typical polyfunctional (meth) acrylates include, for example, polyfunctional (meth) acrylates having a 9,9-bisarylfluorene skeleton; aliphatic epoxy (meth) acrylates [for example, 1,6-hexanediol Di (meth) acrylate such as di (meth) acrylate of alkylene glycol diglycidyl ether such as di (meth) acrylate of glycidyl ether, poly (alkylene glycol diglycidyl ether such as di (meth) acrylate of polypropylene glycol diglycidyl ether] Alicyclic epoxy (meth) acrylate; aromatic epoxy (meth) acrylate; urethane (meth) acrylate; polyester (meth) acrylate; alkylene glycol di (meth) acrylate [for example, ethylene glycol Poly C, such as polyalkylene glycol di (meth) acrylates [for example, diethylene glycol di (meth) acrylate; distearate (meth) acrylates, C 2-10 and alkylene glycol di (meth) acrylate], such as butanediol di (meth) acrylate 2-10 alkylene glycol di (meth) acrylate, etc.]; di (meth) acrylate of biphenols or bisphenols (or their alkylene oxide adducts); poly of low molecular weight polyol compounds having about 3 to 6 hydroxyl groups (Meth) acrylate [for example, trimethylolpropane tri (meth) acrylate, pentaerythritol tri (meth) acrylate, pentaerythritol tetra (meth) acrylate, dipentaerythritol pe And the like, and the like. These polyfunctional (meth) acrylates may be used alone or in combination of two or more.
 これらの多官能性(メタ)アクリレートのうち、比較的高粘度の(メタ)アクリレートであっても、第1の単官能性(メタ)アクリレートにより、有効に低粘度化できる。そのため、多官能性(メタ)アクリレートは、室温下(例えば、25℃)で粘稠体又は固体であってもよい。多官能性(メタ)アクリレートの粘度(25℃)は、例えば、1000mPa・s以上、好ましくは3000mPa・s以上、さらに好ましくは5000mPa・s以上であってもよい。前記粘度の上限値は特に制限されず、例えば、後述する実施例に記載の粘度計の測定限界値(例えば、352Pa・s)程度を超えていてもよい。前記多官能性(メタ)アクリレートのうち、9,9-ビスアリールフルオレン骨格を有する多官能性(メタ)アクリレート(例えば、式(2)で表されるフルオレン骨格含有(メタ)アクリレートなど)、脂環族エポキシ(メタ)アクリレート、芳香族エポキシ(メタ)アクリレート、ウレタン(メタ)アクリレート、及びポリエステル(メタ)アクリレートからなる群より選択される少なくとも1種を含むのが好ましい。これらの高粘度多官能性(メタ)アクリレートのうち、通常、9,9-ビスアリールフルオレン骨格を有する多官能性(メタ)アクリレート(例えば、式(2)で表されるフルオレン骨格含有(メタ)アクリレートなど)、芳香族エポキシ(メタ)アクリレート、ウレタン(メタ)アクリレートが使用されることが多い。 Among these polyfunctional (meth) acrylates, even a relatively high viscosity (meth) acrylate can be effectively reduced in viscosity by the first monofunctional (meth) acrylate. Therefore, the polyfunctional (meth) acrylate may be viscous or solid at room temperature (for example, 25 ° C.). The viscosity (25 ° C.) of the polyfunctional (meth) acrylate may be, for example, 1000 mPa · s or more, preferably 3000 mPa · s or more, more preferably 5000 mPa · s or more. The upper limit of the viscosity is not particularly limited, and for example, it may exceed the measurement limit value (for example, 352 Pa · s) of the viscometer described in Examples described later. Among the polyfunctional (meth) acrylates, a polyfunctional (meth) acrylate having a 9,9-bisarylfluorene skeleton (for example, a fluorene skeleton-containing (meth) acrylate represented by the formula (2)), a fat It is preferable to include at least one selected from the group consisting of cyclic epoxy (meth) acrylates, aromatic epoxy (meth) acrylates, urethane (meth) acrylates, and polyester (meth) acrylates. Of these high-viscosity polyfunctional (meth) acrylates, a polyfunctional (meth) acrylate having a 9,9-bisarylfluorene skeleton (for example, a fluorene skeleton-containing (meth) represented by the formula (2)) Acrylates), aromatic epoxy (meth) acrylates, and urethane (meth) acrylates are often used.
 9,9-ビスアリールフルオレン骨格を有する多官能性(メタ)アクリレートは、光学的特性(例えば、高屈折率、低複屈折、透明性など)、機械的特性、耐熱性などの種々の特性に優れるため、得られる硬化物の特性を向上するのに適している。なお、本明細書において、「9,9-ビスアリールフルオレン骨格を有する」とは、分子構造中に少なくとも9,9-ビスアリールフルオレン骨格を含むことを意味し、前記骨格のフルオレン環を形成する2つのベンゼン環のうち、少なくとも一方にアレーン環が縮合した骨格(例えば、ビスアリールベンゾフルオレン骨格、ビスアリールジベンゾフルオレン骨格など)を有することも含む意味に用いる。代表的な9,9-ビスアリールフルオレン骨格を有する多官能性(メタ)アクリレートは、下記式(2)で表される化合物(フルオレン骨格含有(メタ)アクリレートという場合がある。)であってもよい。 Polyfunctional (meth) acrylates having a 9,9-bisarylfluorene skeleton have various properties such as optical properties (eg, high refractive index, low birefringence, transparency), mechanical properties, and heat resistance. Since it is excellent, it is suitable for improving the properties of the obtained cured product. In this specification, “having a 9,9-bisarylfluorene skeleton” means that the molecular structure includes at least a 9,9-bisarylfluorene skeleton, and forms a fluorene ring of the skeleton. It is used in the meaning including having a skeleton (for example, a bisarylbenzofluorene skeleton, a bisaryldibenzofluorene skeleton, etc.) in which at least one of two benzene rings is condensed with an arene ring. A typical polyfunctional (meth) acrylate having a 9,9-bisarylfluorene skeleton is a compound represented by the following formula (2) (sometimes referred to as a fluorene skeleton-containing (meth) acrylate). Good.
Figure JPOXMLDOC01-appb-C000010
Figure JPOXMLDOC01-appb-C000010
(式中、環Z及びZ並びに環Z及びZはアレーン環、R4a及びR4b並びにR5a及びR5bはそれぞれ同一又は異なる非反応性置換基、R6a及びR6bは直鎖状又は分岐鎖状アルキレン基、R7a及びR7bは水素原子又はメチル基、k1及びk2は0又は1以上の整数、m1及びm2は0又は1以上の整数、n1及びn2は0又は1以上の整数、p1及びp2は1以上の整数を示す。)
 前記式(2)において、環Z及びZで表されるアレーン環として、ベンゼン環などの単環式アレーン環、多環式アレーン環などが挙げられ、多環式アレーン環には、縮合多環式アレーン環(縮合多環式芳香族炭化水素環)、環集合アレーン環(環集合芳香族炭化水素環)などが含まれる。
(Wherein rings Z 1 and Z 2 and rings Z 3 and Z 4 are arene rings, R 4a and R 4b and R 5a and R 5b are the same or different non-reactive substituents, and R 6a and R 6b are direct A linear or branched alkylene group, R 7a and R 7b are hydrogen atoms or methyl groups, k1 and k2 are 0 or an integer of 1 or more, m1 and m2 are 0 or an integer of 1 or more, and n1 and n2 are 0 or 1 (The above integers, p1 and p2 represent integers of 1 or more.)
In the formula (2), examples of the arene ring represented by the rings Z 1 and Z 2 include a monocyclic arene ring such as a benzene ring, a polycyclic arene ring, and the like. A polycyclic arene ring (fused polycyclic aromatic hydrocarbon ring), a ring assembly arene ring (ring assembly aromatic hydrocarbon ring) and the like are included.
 縮合多環式アレーン環としては、例えば、前記式(1)の環Arに関する記載で例示した縮合多環式アレーン環などが挙げられ、好ましい態様も前記環Arと同様である。 Examples of the condensed polycyclic arene ring include the condensed polycyclic arene ring exemplified in the description of the ring Ar 1 in the formula (1), and the preferred embodiment is the same as the ring Ar 1 .
 環集合アレーン環としては、ビアレーン環(例えば、ビフェニル環、ビナフチル環、フェニルナフタレン環(1-フェニルナフタレン環、2-フェニルナフタレン環など)などのビC6-12アレーン環など)、テルアレーン環(例えば、テルフェニレン環などのテルC6-12アレーン環など)などが例示できる。好ましい環集合アレーン環は、ビC6-10アレーン環などが挙げられ、特にビフェニル環が好ましい。 Examples of the ring-assembled arene ring include a bearene ring (for example, a bi-C 6-12 arene ring such as a biphenyl ring, a binaphthyl ring, and a phenylnaphthalene ring (such as a 1-phenylnaphthalene ring and a 2-phenylnaphthalene ring)), a tellarene ring ( For example, a tel C 6-12 arene ring such as a terphenylene ring) can be exemplified. Preferred ring-assembled arene rings include bi-C 6-10 arene rings, and biphenyl rings are particularly preferred.
 フルオレンの9-位に結合する2つの環Z及びZは、同一又は異なっていてもよく、通常、同一であることが多い。環Z及びZのうち、ベンゼン環、ナフタレン環、ビフェニル環などが好ましく、特にベンゼン環が好ましい。 The two rings Z 1 and Z 2 bonded to the 9-position of fluorene may be the same or different and are usually the same. Of the rings Z 1 and Z 2 , a benzene ring, a naphthalene ring, a biphenyl ring and the like are preferable, and a benzene ring is particularly preferable.
 なお、フルオレンの9-位に結合する環Z及びZの置換位置は、特に限定されない。例えば、環Z及びZがナフタレン環の場合、フルオレンの9-位に結合する環Z及びZに対応する基は、1-ナフチル基、2-ナフチル基などであってもよい。また、環Z及びZがビフェニル環の場合、フルオレンの9-位に結合する環Z及びZに対応する基は、2-ビフェニリル基、3-ビフェニリル基、4-ビフェニリル基などであってもよい。 Note that the substitution positions of the rings Z 1 and Z 2 bonded to the 9-position of fluorene are not particularly limited. For example, when the rings Z 1 and Z 2 are naphthalene rings, the group corresponding to the rings Z 1 and Z 2 bonded to the 9-position of fluorene may be a 1-naphthyl group, a 2-naphthyl group, or the like. Further, when the rings Z 1 and Z 2 are biphenyl rings, the groups corresponding to the rings Z 1 and Z 2 bonded to the 9-position of fluorene are 2-biphenylyl group, 3-biphenylyl group, 4-biphenylyl group, etc. There may be.
 前記式(2)において、環Z及びZで表されるアレーン環としては、例えば、ベンゼン環などの単環式アレーン環、縮合多環式アレーン環(縮合多環式芳香族炭化水素環)などが挙げられる。縮合多環式アレーン環としては、例えば、前記式(1)の環Arに関する記載で例示した縮合多環式アレーン環などが挙げられ、好ましい態様も前記環Arと同様である。これらのアレーン環のうち、好ましい環Z及びZとしては、ベンゼン環、ナフタレン環などが挙げられる。 In the formula (2), examples of the arene ring represented by the rings Z 3 and Z 4 include a monocyclic arene ring such as a benzene ring, a condensed polycyclic arene ring (a condensed polycyclic aromatic hydrocarbon ring). ) And the like. Examples of the condensed polycyclic arene ring include the condensed polycyclic arene ring exemplified in the description of the ring Ar 1 in the formula (1), and the preferred embodiment is the same as the ring Ar 1 . Among these arene rings, preferred rings Z 3 and Z 4 include a benzene ring and a naphthalene ring.
 環Z及びZは、その間に介在する5員環とともに縮合環骨格を形成し、例えば、環Z及びZのうち、一方がベンゼン環、他方がナフタレン環であるベンゾフルオレン骨格、双方がナフタレン環であるジベンゾフルオレン骨格などを形成してもよい。なお、環Z及びZが縮合多環式アレーン環である場合、環Z及びZと、その間に介在する5員環との結合位置(又は、環Z及びZにおいて、前記5員環と共有する2つの隣接した炭素原子の位置)は、結合(又は共有)可能である限り、特に制限されず、例えば、ナフタレン環の1,2-位、2,3-位、又は3,4-位のいずれかの位置の炭素原子を前記5員環と共有していてもよい。すなわち、環Z及びZのうち、一方がナフタレン環、他方がベンゼン環である場合、及び双方がナフタレン環である場合の前記式(2)における縮合環骨格構造(但し、R4a及びR4b、k1及びk2は省略している)は、下記式(a)~(i)で表される構造のいずれかであってもよい。 Rings Z 3 and Z 4 form a condensed ring skeleton together with a 5-membered ring interposed between them, for example, one of the rings Z 3 and Z 4 , a benzofluorene skeleton in which one is a benzene ring and the other is a naphthalene ring, A dibenzofluorene skeleton in which is a naphthalene ring may be formed. Incidentally, when Ring Z 3 and Z 4 is a fused polycyclic arene ring, the ring Z 3 and Z 4, bonding position of the 5-membered ring interposed therebetween (or, in the ring Z 3 and Z 4, wherein The position of two adjacent carbon atoms shared with a 5-membered ring) is not particularly limited as long as it can be bonded (or shared), and for example, 1,2-position, 2,3-position of the naphthalene ring, or The carbon atom at any position in the 3,4-position may be shared with the 5-membered ring. That is, when one of the rings Z 3 and Z 4 is a naphthalene ring, the other is a benzene ring, and both are naphthalene rings, the condensed ring skeleton structure in the above formula (2) (where R 4a and R 4 4b , k1 and k2 are omitted) may be any of the structures represented by the following formulas (a) to (i).
Figure JPOXMLDOC01-appb-C000011
Figure JPOXMLDOC01-appb-C000011
 特に好ましい環Z及びZはベンゼン環であり、環Z及びZ並びにその間に介在する5員環が形成する縮合環骨格としては、環Z及びZの双方がベンゼン環であるフルオレン骨格が特に好ましい。 Particularly preferred ring Z 3 and Z 4 is a benzene ring, a condensed ring structure 5 membered ring interposed ring Z 3 and Z 4 as well as between them form both the ring Z 3 and Z 4 is a benzene ring A fluorene skeleton is particularly preferred.
 前記式(2)において、非反応性置換基(又は非ラジカル重合性置換基)R4a及びR4bとしては、炭化水素基[例えば、アルキル基(例えば、メチル基、エチル基、プロピル基、イソプロピル基、ブチル基、t-ブチル基などの直鎖状又は分岐鎖状C1-6アルキル基など)、アリール基(例えば、フェニル基などのC6-10アリール基など)など]、シアノ基、ハロゲン原子(例えば、フッ素原子、塩素原子、臭素原子など)などが挙げられる。 In the formula (2), the non-reactive substituents (or non-radically polymerizable substituents) R 4a and R 4b may be hydrocarbon groups [eg, alkyl groups (eg, methyl, ethyl, propyl, isopropyl, A linear or branched C 1-6 alkyl group such as a group, a butyl group or a t-butyl group), an aryl group (eg, a C 6-10 aryl group such as a phenyl group)], a cyano group, A halogen atom (for example, a fluorine atom, a chlorine atom, a bromine atom, etc.) etc. are mentioned.
 これらの基R4a及びR4bのうち、アルキル基(例えば、直鎖状又は分岐鎖状C1-4アルキル基(特に、メチル基などのC1-3アルキル基))、シアノ基、ハロゲン原子が好ましく、特にアルキル基が好ましい。 Of these groups R 4a and R 4b , an alkyl group (for example, a linear or branched C 1-4 alkyl group (particularly a C 1-3 alkyl group such as a methyl group)), a cyano group, a halogen atom Are preferable, and an alkyl group is particularly preferable.
 基R4a及びR4bの置換数k1及びk2は、0又は1以上の整数であり、環Z及びZに応じて選択できる。置換数k1及びk2は、通常、0~6程度の整数から選択でき、例えば、0~4(例えば、0~3)程度の整数、好ましくは0~2程度の整数、さらに好ましくは0又は1、特に0である。なお、環Z及びZにおける置換数k1及びk2は、互いに同一又は異なっていてもよく、基R4a及びR4bの種類は、互いに同一又は異なっていてもよい。k1及びk2が2以上である場合、それぞれの環Z及びZ内における2以上の基R4a及びR4bの種類は、互いに同一又は異なっていてもよい。また、基R4a及びR4bの置換位置は、特に制限されず、例えば、環Z及びZと、その間に介在する5員環とがフルオレン環を形成する場合、フルオレン環の2-位乃至7-位(2-位、3-位及び7-位など)であってもよい。 The substitution numbers k1 and k2 of the groups R 4a and R 4b are 0 or an integer of 1 or more and can be selected according to the rings Z 3 and Z 4 . The number of substitutions k1 and k2 can usually be selected from an integer of about 0 to 6, for example, an integer of about 0 to 4 (eg, 0 to 3), preferably an integer of about 0 to 2, and more preferably 0 or 1 , Especially 0. In addition, the substitution numbers k1 and k2 in the rings Z 3 and Z 4 may be the same or different from each other, and the types of the groups R 4a and R 4b may be the same or different from each other. When k1 and k2 are 2 or more, the types of the two or more groups R 4a and R 4b in the respective rings Z 3 and Z 4 may be the same or different from each other. Further, the substitution position of the groups R 4a and R 4b is not particularly limited. For example, when the rings Z 3 and Z 4 and the 5-membered ring interposed therebetween form a fluorene ring, the 2-position of the fluorene ring Or 7-position (2-position, 3-position, 7-position, etc.).
 前記式(2)において、非反応性置換基(又は非ラジカル重合性置換基)R5a及びR5bとしては、ハロゲン原子(例えば、フッ素原子、塩素原子、臭素原子、ヨウ素原子)、炭化水素基{例えば、アルキル基(メチル基、エチル基、プロピル基、イソプロピル基、n-ブチル基、s-ブチル基、t-ブチル基などの直鎖状又は分岐鎖状C1-10アルキル基、好ましくは直鎖状又は分岐鎖状C1-6アルキル基、さらに好ましくは直鎖状又は分岐鎖状C1-4アルキル基など);シクロアルキル基(例えば、シクロペンチル基、シクロヘキシル基などのC5-10シクロアルキル基など);アリール基[例えば、フェニル基、アルキルフェニル基(例えば、メチルフェニル基(トリル基)、ジメチルフェニル基(キシリル基)など)、ビフェニリル基、ナフチル基などのC6-12アリール基など];アラルキル基(例えば、ベンジル基、フェネチル基などのC6-10アリール-C1-4アルキル基など)など}、アルコキシ基(例えば、メトキシ基、エトキシ基、プロポキシ基、n-ブトキシ基、イソブトキシ基、t-ブトキシ基などの直鎖状又は分岐鎖状C1-10アルコキシ基など)、シクロアルキルオキシ基(例えば、シクロヘキシルオキシ基などのC5-10シクロアルキルオキシ基など)、アリールオキシ基(例えば、フェノキシ基などのC6-10アリールオキシ基など)、アラルキルオキシ基(例えば、ベンジルオキシ基などのC6-10アリール-C1-4アルキルオキシ基など)、アルキルチオ基(例えば、メチルチオ基、エチルチオ基、プロピルチオ基、n-ブチルチオ基、t-ブチルチオ基などのC1-10アルキルチオなど)、シクロアルキルチオ基(例えば、シクロヘキシルチオ基などのC5-10シクロアルキルチオ基など)アリールチオ基(例えば、チオフェノキシ基などのC6-10アリールチオ基など)、アラルキルチオ基(例えば、ベンジルチオ基などのC6-10アリール-C1-4アルキルチオ基など)、アシル基(例えば、アセチル基などのC1-6アシル基など)、ニトロ基、シアノ基、置換アミノ基[例えば、ジアルキルアミノ基(例えば、ジメチルアミノ基などのジC1-4アルキルアミノ基など)、ジアルキルカルボニルアミノ基(例えば、ジアセチルアミノ基などのジ(C1-4アルキル-カルボニル)アミノ基など)など]などが例示できる。 In the formula (2), as the non-reactive substituent (or non-radical polymerizable substituent) R 5a and R 5b , a halogen atom (for example, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom), a hydrocarbon group {For example, an alkyl group (a linear or branched C 1-10 alkyl group such as methyl group, ethyl group, propyl group, isopropyl group, n-butyl group, s-butyl group, t-butyl group, preferably Linear or branched C 1-6 alkyl group, more preferably linear or branched C 1-4 alkyl group, etc .; cycloalkyl group (eg, C 5-10 such as cyclopentyl group, cyclohexyl group, etc.) Cycloalkyl group etc.); aryl group [eg, phenyl group, alkylphenyl group (eg, methylphenyl group (tolyl group), dimethylphenyl group (xylyl group), etc.)] Biphenylyl group, C 6-12 aryl group such as a naphthyl group]; aralkyl groups (e.g., benzyl group, etc. C 6-10 aryl -C 1-4 alkyl group such as a phenethyl group), etc.}, an alkoxy group (e.g., Linear or branched C 1-10 alkoxy group such as methoxy group, ethoxy group, propoxy group, n-butoxy group, isobutoxy group, t-butoxy group, etc., cycloalkyloxy group (for example, cyclohexyloxy group, etc.) C 5-10 cycloalkyloxy group, etc.), aryloxy group (eg, C 6-10 aryloxy group such as phenoxy group), aralkyloxy group (eg, C 6-10 aryl-C such as benzyloxy group) 1-4 alkyloxy group), alkylthio group (eg, methylthio group, ethylthio group, pro C 1-10 alkylthio such as a pyrthio group, n-butylthio group, t-butylthio group, etc.), cycloalkylthio group (eg, C 5-10 cycloalkylthio group such as cyclohexylthio group), arylthio group (eg, thiophenoxy group) C 6-10 arylthio group, etc.), aralkylthio group (eg, C 6-10 aryl-C 1-4 alkylthio group, such as benzylthio group), acyl group (eg, C 1-6 acyl, such as acetyl group) Group), nitro group, cyano group, substituted amino group [eg, dialkylamino group (eg, diC 1-4 alkylamino group such as dimethylamino group), dialkylcarbonylamino group (eg, diacetylamino group etc.) di (C 1-4 alkyl - carbonyl) amino group, etc.), etc.], etc. are for illustrative That.
 これらの基R5a及びR5bのうち、代表的には、ハロゲン原子、炭化水素基(アルキル基、シクロアルキル基、アリール基、アラルキル基)、アルコキシ基、アシル基、ニトロ基、シアノ基、置換アミノ基などが挙げられる。好ましい基R5a及びR5bとしては、アルキル基(メチル基などの直鎖状又は分岐鎖状C1-6アルキル基など)、アリール基(フェニル基などのC6-14アリール基など)、アルコキシ基(メトキシ基などの直鎖状又は分岐鎖状C1-4アルコキシ基など)、特に、アルキル基(特に、メチル基などの直鎖状又は分岐鎖状C1-4アルキル基)、アリール基(フェニル基などのC6-10アリール基など)が挙げられる。なお、基R5a及びR5bがアリール基であるとき、基R5a及びR5bは、環Z及びZとともに前記環集合アレーン環を形成してもよい。なお、基R5a及びR5bの種類は、同一又は異なっていてもよい。置換数m1及びm2が2以上である場合、同一の環Z及びZに置換する2以上の基R2a及びR2bの種類は、同一又は異なっていてもよい。 Of these groups R 5a and R 5b , typically, a halogen atom, a hydrocarbon group (alkyl group, cycloalkyl group, aryl group, aralkyl group), alkoxy group, acyl group, nitro group, cyano group, substituted An amino group etc. are mentioned. Preferred groups R 5a and R 5b include an alkyl group (such as a linear or branched C 1-6 alkyl group such as a methyl group), an aryl group (such as a C 6-14 aryl group such as a phenyl group), an alkoxy group A group (a linear or branched C 1-4 alkoxy group such as a methoxy group), in particular, an alkyl group (particularly a linear or branched C 1-4 alkyl group such as a methyl group), an aryl group (C 6-10 aryl group such as phenyl group). When the groups R 5a and R 5b are aryl groups, the groups R 5a and R 5b may form the ring assembly arene ring together with the rings Z 1 and Z 2 . Note that the types of the groups R 5a and R 5b may be the same or different. When the number of substitutions m1 and m2 is 2 or more, the types of two or more groups R 2a and R 2b substituted on the same ring Z 1 and Z 2 may be the same or different.
 基R5a及びR5bの置換数m1及びm2は、0又は1以上の整数であればよく、環Z及びZの種類に応じて適宜選択できる。例えば、0~8程度の整数であってもよく、好ましくは0~4(例えば、0~3)程度の整数、さらに好ましくは0~2程度の整数(例えば、0又は1)、特に0であってもよい。なお、置換数m1及びm2は、互いに同一又は異なっていてもよい。特に、m1及びm2が1である場合、環Z及びZがベンゼン環、ナフタレン環又はビフェニル環、基R5a及びR5bがメチル基であってもよい。また、基R5a及びR5bの置換位置は、特に制限されず、基[-(OR6an1-OC(=O)-CR7a=CH]及び基[-(OR6bn2-OC(=O)-CR7b=CH](この2つの基を、(メタ)アクリロイル基含有基という場合がある)の置換位置以外の位置に置換していればよい。 The substitution numbers m1 and m2 of the groups R 5a and R 5b may be 0 or an integer of 1 or more, and can be appropriately selected depending on the types of the rings Z 1 and Z 2 . For example, it may be an integer of about 0 to 8, preferably an integer of about 0 to 4 (eg, 0 to 3), more preferably an integer of about 0 to 2 (eg, 0 or 1), particularly 0. There may be. The substitution numbers m1 and m2 may be the same or different from each other. In particular, when m1 and m2 are 1, the rings Z 1 and Z 2 may be benzene rings, naphthalene rings or biphenyl rings, and the groups R 5a and R 5b may be methyl groups. Further, the substitution positions of the groups R 5a and R 5b are not particularly limited, and the group [— (OR 6a ) n1 —OC (═O) —CR 7a ═CH 2 ] and the group [— (OR 6b ) n2 —OC It may be substituted at a position other than the substitution position of (= O) —CR 7b ═CH 2 ] (sometimes referred to as (meth) acryloyl group-containing group).
 前記式(2)において、アルキレン基R6a及びR6bには、直鎖状又は分岐鎖状アルキレン基が含まれる。代表的なアルキレン基R6a及びR6bには、例えば、前記式(1)の基Rに関する記載において例示した直鎖状又は分岐鎖状アルキレン基などが挙げられ、好ましい態様も基Rと同様である。なお、同一の又は異なる環Z及びZに置換したそれぞれの(メタ)アクリロイル基含有基間において、アルキレン基R6a及びR6bの種類は、同一又は異なっていてもよく、通常、同一である。また、繰り返し数n1及びn2が2以上である場合、同一の(メタ)アクリロイル基含有基内のアルキレン基R6a及びR6bの種類は、異なっていてもよいが、同一であることが好ましい。 In the formula (2), the alkylene groups R 6a and R 6b include a linear or branched alkylene group. Representative alkylene groups R 6a and R 6b include, for example, a linear or branched alkylene group exemplified in the description relating to the group R 2 in the above formula (1), and a preferable embodiment also includes the group R 2 . It is the same. In addition, among the (meth) acryloyl group-containing groups substituted on the same or different rings Z 1 and Z 2 , the types of alkylene groups R 6a and R 6b may be the same or different and are usually the same. is there. Moreover, when the repeating numbers n1 and n2 are 2 or more, the types of alkylene groups R 6a and R 6b in the same (meth) acryloyl group-containing group may be different, but are preferably the same.
 オキシアルキレン基(OR6a及びOR6b)の繰り返し数n1及びn2は、0又は1以上の整数(例えば、0~20程度の整数)の範囲から選択でき、例えば、1~15程度の整数、好ましくは1~10(例えば、2~8)程度の整数、さらに好ましくは3~7(例えば、4~6)程度の整数であってもよい。また、同一の又は異なる環Z及びZに置換したそれぞれの(メタ)アクリロイル基含有基において、n1及びn2は、それぞれ同一又は異なっていてもよい。なお、本明細書中において、特に断りのない限り、「オキシアルキレン基の繰り返し数」(及び後述する「オキシアルキレン基の合計数(合計付加数)」)とは、化合物1分子中におけるオキシアルキレン基の数(整数)、及び化合物の分子集合体におけるオキシアルキレン基の個数の平均値(又は相加平均値、算術平均値)[すなわち、平均付加モル数]の双方を含む意味に用いる。そのため、繰り返し数n1及びn2は、前記式(2)で表される化合物の分子集合体における平均値(相加平均又は算術平均)であってもよく、その範囲は、前記整数の範囲と同等程度であってもよい。 The number of repetitions n1 and n2 of the oxyalkylene group (OR 6a and OR 6b ) can be selected from 0 or an integer of 1 or more (for example, an integer of about 0 to 20), for example, an integer of about 1 to 15, preferably May be an integer of about 1 to 10 (eg 2 to 8), more preferably an integer of about 3 to 7 (eg 4 to 6). In each (meth) acryloyl group-containing group substituted with the same or different rings Z 1 and Z 2 , n 1 and n 2 may be the same or different. In the present specification, unless otherwise specified, “the number of repeating oxyalkylene groups” (and “the total number of oxyalkylene groups (total number of additions)” described later) refers to oxyalkylene in one molecule of a compound. It is used to mean both the number of groups (integer) and the average value (or arithmetic average value, arithmetic average value) of the number of oxyalkylene groups in the molecular assembly of the compound [that is, average added mole number]. Therefore, the repeating numbers n1 and n2 may be an average value (arithmetic average or arithmetic average) in the molecular assembly of the compound represented by the formula (2), and the range is equivalent to the integer range. It may be a degree.
 また、繰り返し数n1及びn2の合計数は、前記式(2)で表されるフルオレン骨格含有(メタ)アクリレート1分子中のオキシアルキレン基の合計数(合計付加数)を意味し、単にn1+n2という場合がある。なお、n1+n2は、p1及び/又はp2が2以上である場合、p1及びp2の数だけ存在する全てのn1及びn2の合計数を意味する。n1+n2は、例えば、0~30程度の整数の範囲から選択でき、例えば、1~25(例えば、2~20)程度の整数、好ましくは3~18(例えば、4~16)程度の整数、さらに好ましくは5~14(例えば、6~12)程度の整数、特に7~11(例えば、8~10)程度の整数であってもよい。また、n1+n2は前記のように整数であってもよいが、前記式(2)で表されるフルオレン骨格含有(メタ)アクリレートの分子集合体における平均付加モル数であってもよく、その範囲は、例えば、前記整数の範囲と同等程度であってもよい。n1+n2の値が小さすぎると、硬化性組成物の粘度が上昇し易く、ハンドリング性が低下するおそれがある。また、硬化物の耐スクラッチ性も低下するおそれがある。しかし、本発明では、前記式(1)で表される第1の単官能性(メタ)アクリレートを多量に混合しても屈折率を保持又は向上できるため、比較的n1+n2の値が小さくても、有効にハンドリング性を向上(粘度を低下)できる。n1+n2の値が大きすぎると、硬化物の単位量(例えば、単位重量)当たりの9,9-ビスアリールフルオレン骨格含有量(例えば、含有モル数)も低下するため、前記骨格に由来する高屈折率、高耐熱性などの優れた特性が低下するおそれがある。なお、n1+n2は、慣用の方法で測定することができ、例えば、前記式(2)で表されるフルオレン骨格含有(メタ)アクリレートの調製において、原料となる9,9-ビスアリールフルオレン骨格を有するヒドロキシ化合物の量と、反応で消費されるアルキレンオキサイド又はアルキレンカーボネートの量との割合から、相加平均又は算術平均の値として算出する方法(例えば、特許文献1記載の方法など)などにより測定できる。 The total number of repeating numbers n1 and n2 means the total number (total number of additions) of oxyalkylene groups in one molecule of the fluorene skeleton-containing (meth) acrylate represented by the formula (2), and is simply referred to as n1 + n2. There is a case. In addition, n1 + n2 means the total number of all n1 and n2 which exists by the number of p1 and p2, when p1 and / or p2 are two or more. n1 + n2 can be selected from an integer range of about 0 to 30, for example, an integer of about 1 to 25 (eg, 2 to 20), preferably an integer of about 3 to 18 (eg, 4 to 16), Preferably, it may be an integer of about 5 to 14 (eg, 6 to 12), particularly an integer of about 7 to 11 (eg, 8 to 10). Further, n1 + n2 may be an integer as described above, but may be an average added mole number in the molecular assembly of the fluorene skeleton-containing (meth) acrylate represented by the formula (2), and the range thereof is For example, it may be equivalent to the integer range. When the value of n1 + n2 is too small, the viscosity of the curable composition tends to increase, and the handling property may be lowered. Moreover, there exists a possibility that the scratch resistance of hardened | cured material may also fall. However, in the present invention, even if a large amount of the first monofunctional (meth) acrylate represented by the formula (1) is mixed, the refractive index can be maintained or improved, so even if the value of n1 + n2 is relatively small. , Can effectively improve handling properties (decrease viscosity). If the value of n1 + n2 is too large, the 9,9-bisarylfluorene skeleton content (for example, the number of moles contained) per unit amount (for example, unit weight) of the cured product also decreases, so that the high refraction derived from the skeleton is high. There is a possibility that excellent characteristics such as rate and high heat resistance may deteriorate. N1 + n2 can be measured by a conventional method. For example, it has a 9,9-bisarylfluorene skeleton used as a raw material in the preparation of the fluorene skeleton-containing (meth) acrylate represented by the formula (2). From the ratio of the amount of the hydroxy compound and the amount of alkylene oxide or alkylene carbonate consumed in the reaction, it can be measured by a method of calculating as an arithmetic average or arithmetic average value (for example, the method described in Patent Document 1). .
 前記式(2)において、基R7a及びR7bは、水素原子又はメチル基である。同一の又は異なる環Z及びZに置換したそれぞれの(メタ)アクリロイル基含有基において、基R7a及びR7bはそれぞれ同一又は異なっていてもよく、通常、同一である。 In the formula (2), the groups R 7a and R 7b are a hydrogen atom or a methyl group. In the same or different rings Z 1 and Z 2 each substituted on (meth) acryloyl group-containing group, group R 7a and R 7b may be the same or different, usually the same.
 前記式(2)において、(メタ)アクリロイル基含有基の置換数p1及びp2は、1以上の整数であり、例えば、1~4の整数、好ましくは1~3の整数、さらに好ましくは1又は2(特に1)であってもよい。p1及びp2が大きすぎると、耐スクラッチ性が低下するおそれがある。なお、置換数p1及びp2は、それぞれの環Z及びZにおいて、同一又は異なっていてもよい。 In the above formula (2), the substitution number p1 and p2 of the (meth) acryloyl group-containing group is an integer of 1 or more, for example, an integer of 1 to 4, preferably an integer of 1 to 3, more preferably 1 or 2 (especially 1) may be sufficient. If p1 and p2 are too large, the scratch resistance may decrease. Incidentally, substituents which p1 and p2, in each ring Z 1 and Z 2, may be the same or different.
 (メタ)アクリロイル基含有基は、環Z及びZの適当な位置に置換でき、例えば、環Z及びZがベンゼン環である場合には、2~6-位の適当な位置に置換でき、p1及びp2が1である場合、フェニル基の2-位、3-位、4-位(特に、3-位又は4-位)のいずれかの位置に置換している場合が多い。p1及びp2が2である場合、2-位及び4-位、3-位及び4-位、3-位及び5-位(特に、3-位及び5-位)などに置換している場合が多い。p1及びp2が3以上である場合、置換位置は、特に限定されない。また、環Z及びZがナフタレン環である場合には、ナフチル基の5~8-位のいずれかに置換している場合が多く、例えば、p1及びp2が1である場合、フルオレンの9-位に対してナフタレン環の1-位又は2-位が置換し(1-ナフチル又は2-ナフチルの関係で置換し)、この置換位置に対して、1,5-位、2,6-位などの関係(特に2,6-位の関係)で(メタ)アクリロイル基含有基が置換している場合が多い。また、p1及びp2が2以上である場合、置換位置は、特に限定されない。また、環集合アレーン環Z及びZにおいて、(メタ)アクリロイル基含有基の置換位置は、特に限定されず、例えば、p1及びp2が1である場合、フルオレンの9-位に結合したアレーン環及び/又はこのアレーン環に隣接するアレーン環に置換していてもよい。例えば、ビフェニル環Z及びZの3-位又は4-位がフルオレンの9-位に結合していてもよい。ビフェニル環Z及びZの3-位がフルオレンの9-位に結合しているとき、(メタ)アクリロイル基含有基の置換位置は、ビフェニル環の2-位、4-位、5-位、6-位、2’-位、3’-位、4’-位のいずれであってもよく、通常、6-位、3’-位、4’-位、好ましくは6-位、4’-位のいずれかの位置(特に、6-位)に置換していてもよい。ビフェニル環Z及びZの4-位がフルオレンの9-位に結合しているとき、(メタ)アクリロイル基含有基の置換位置は、ビフェニル環の2-位、3-位、2’-位、3’-位、4’-位のいずれであってもよく、通常、2-位、3’-位、4’-位、好ましくは2-位、4’-位のいずれかの位置(特に、2-位)に置換していてもよい。また、p1及びp2が2以上である場合、置換位置は特に限定されない。 (Meth) acryloyl group-containing groups can be substituted in a suitable position on the ring Z 1 and Z 2, for example, when ring Z 1 and Z 2 is a benzene ring, the suitable position 2 to position 6 When p1 and p2 are 1, it is often substituted at any position of 2-position, 3-position, 4-position (particularly 3-position or 4-position) of the phenyl group . When p1 and p2 are 2, when substituted at 2-position and 4-position, 3-position and 4-position, 3-position and 5-position (especially 3-position and 5-position), etc. There are many. When p1 and p2 are 3 or more, the substitution position is not particularly limited. Further, when the rings Z 1 and Z 2 are naphthalene rings, they are often substituted at any of the 5- to 8-positions of the naphthyl group. For example, when p1 and p2 are 1, The 1-position or 2-position of the naphthalene ring is substituted with respect to the 9-position (substitution is carried out in relation to 1-naphthyl or 2-naphthyl), and the 1,5-position, 2,6 with respect to this substitution position In many cases, the (meth) acryloyl group-containing group is substituted in a relationship such as a -position (particularly a relationship in the 2,6-position). Moreover, when p1 and p2 are 2 or more, a substitution position is not specifically limited. In addition, in the ring-assembled arene rings Z 1 and Z 2 , the substitution position of the (meth) acryloyl group-containing group is not particularly limited. The ring and / or the arene ring adjacent to the arene ring may be substituted. For example, the 3-position or 4-position of the biphenyl rings Z 1 and Z 2 may be bonded to the 9-position of fluorene. When the 3-position biphenyl ring Z 1 and Z 2 is attached to the 9-position of fluorene, (meth) substitution position of acryloyl group-containing groups, 2-position of the biphenyl ring, 4-position, 5-position , 6-position, 2′-position, 3′-position, 4′-position, usually 6-position, 3′-position, 4′-position, preferably 6-position, 4 It may be substituted at any position of the '-position (particularly the 6-position). When the 4-position of the biphenyl rings Z 1 and Z 2 is bonded to the 9-position of fluorene, the substitution position of the (meth) acryloyl group-containing group is the 2-position, 3-position, 2′-position of the biphenyl ring. Position, 3′-position, 4′-position, usually 2-position, 3′-position, 4′-position, preferably any position of 2-position, 4′-position (Especially 2-position) may be substituted. Moreover, when p1 and p2 are 2 or more, a substitution position is not specifically limited.
 前記式(2)で表されるフルオレン骨格含有(メタ)アクリレートとして、代表的には、前記式(2)において、環Z及びZがベンゼン環である化合物、すなわち、下記式(2a) As the fluorene skeleton-containing (meth) acrylate represented by the formula (2), typically, in the formula (2), the ring Z 3 and Z 4 are benzene rings, that is, the following formula (2a)
Figure JPOXMLDOC01-appb-C000012
Figure JPOXMLDOC01-appb-C000012
(式中、環Z及びZ、R4a及びR4b、R5a及びR5b、R6a及びR6b、R7a及びR7b、k1及びk2、m1及びm2、n1及びn2、並びにp1及びp2は、好ましい態様も含めて前記式(2)に同じ。)
で表される化合物が挙げられる。より具体的には、前記式(2a)において、p1及びp2が1であるフルオレン類、例えば、9,9-ビス[(メタ)アクリロイルオキシフェニル]フルオレン類、9,9-ビス[(メタ)アクリロイルオキシ(ポリ)アルコキシフェニル]フルオレン類、9,9-ビス[(メタ)アクリロイルオキシナフチル]フルオレン類、9,9-ビス[(メタ)アクリロイルオキシ(ポリ)アルコキシナフチル]フルオレン類などが挙げられる。なお、これらのフルオレン類は、それぞれ対応する9,9-ビス[(メタ)アクリロイルオキシアリール]フルオレン骨格又は9,9-ビス[(メタ)アクリロイルオキシ(ポリ)アルコキシアリール]フルオレン骨格を有する限り、フルオレン骨格を構成する2つのベンゼン環、及び/又は環Z及びZに非反応性置換基を有する化合物(前記式(2a)において、k1及びk2、及び/又はm1及びm2が1以上である化合物)も含む意味に用いる。
(Wherein rings Z 1 and Z 2 , R 4a and R 4b , R 5a and R 5b , R 6a and R 6b , R 7a and R 7b , k1 and k2, m1 and m2, n1 and n2, and p1 and p2 is the same as the formula (2) including preferred embodiments.)
The compound represented by these is mentioned. More specifically, in the formula (2a), fluorenes in which p1 and p2 are 1, such as 9,9-bis [(meth) acryloyloxyphenyl] fluorenes, 9,9-bis [(meth) And acryloyloxy (poly) alkoxyphenyl] fluorenes, 9,9-bis [(meth) acryloyloxynaphthyl] fluorenes, 9,9-bis [(meth) acryloyloxy (poly) alkoxynaphthyl] fluorenes, etc. . As long as these fluorenes each have a corresponding 9,9-bis [(meth) acryloyloxyaryl] fluorene skeleton or 9,9-bis [(meth) acryloyloxy (poly) alkoxyaryl] fluorene skeleton, Two benzene rings constituting the fluorene skeleton and / or a compound having a non-reactive substituent in the rings Z 1 and Z 2 (in the formula (2a), k1 and k2 and / or m1 and m2 are 1 or more. It is used in the meaning including a certain compound.
 9,9-ビス[(メタ)アクリロイルオキシフェニル]フルオレン類としては、前記式(2a)において、環Z及びZがベンゼン環、n1及びn2が0、p1及びp2が1である化合物、例えば、9,9-ビス[(メタ)アクリロイルオキシフェニル]フルオレン(例えば、9,9-ビス[4-(メタ)アクリロイルオキシフェニル]フルオレン、9,9-ビス[3-(メタ)アクリロイルオキシフェニル]フルオレンなど);9,9-ビス[(メタ)アクリロイルオキシ-モノ又はジアルキルフェニル]フルオレン(例えば、9,9-ビス[4-(メタ)アクリロイルオキシ-3-メチルフェニル]フルオレン、9,9-ビス[4-(メタ)アクリロイルオキシ-3-t-ブチルフェニル]フルオレン、9,9-ビス[4-(メタ)アクリロイルオキシ-3,5-ジメチルフェニル]フルオレンなどの9,9-ビス[(メタ)アクリロイルオキシ-モノ又はジC1-4アルキルフェニル]フルオレンなど);9,9-ビス[(メタ)アクリロイルオキシ-アリールフェニル]フルオレン(例えば、9,9-ビス[4-(メタ)アクリロイルオキシ-3-フェニルフェニル]フルオレンなどの9,9-ビス[(メタ)アクリロイルオキシ-C6-10アリールフェニル]フルオレンなど)などが挙げられる。 As 9,9-bis [(meth) acryloyloxyphenyl] fluorenes, in the above formula (2a), the ring Z 1 and Z 2 are benzene rings, n1 and n2 are 0, p1 and p2 are 1, For example, 9,9-bis [(meth) acryloyloxyphenyl] fluorene (eg, 9,9-bis [4- (meth) acryloyloxyphenyl] fluorene, 9,9-bis [3- (meth) acryloyloxyphenyl) 9,9-bis [(meth) acryloyloxy-mono or dialkylphenyl] fluorene (eg, 9,9-bis [4- (meth) acryloyloxy-3-methylphenyl] fluorene, 9,9) -Bis [4- (meth) acryloyloxy-3-tert-butylphenyl] fluorene, 9,9-bis [4- (meth) Acryloyloxy-3,5-dimethylphenyl] fluorene such as 9,9-bis [(meth) acryloyloxy - such as mono- or di-C 1-4 alkyl phenyl] fluorene); 9,9-bis [(meth) acryloyl Oxy-arylphenyl] fluorene (eg, 9,9-bis [(meth) acryloyloxy-C 6-10 arylphenyl] such as 9,9-bis [4- (meth) acryloyloxy-3-phenylphenyl] fluorene) Fluorene, etc.).
 9,9-ビス[(メタ)アクリロイルオキシ(ポリ)アルコキシフェニル]フルオレン類としては、前記式(2a)において、環Z及びZがベンゼン環、n1及びn2が1~10(好ましくは1~6)、p1及びp2が1である化合物、例えば、9,9-ビス[(メタ)アクリロイルオキシ(ポリ)アルコキシフェニル]フルオレン(例えば、9,9-ビス[4-(2-(メタ)アクリロイルオキシエトキシ)フェニル]フルオレン、9,9-ビス[4-(2-(メタ)アクリロイルオキシプロポキシ)フェニル]フルオレン、9,9-ビス[4-(2-(2-(メタ)アクリロイルオキシエトキシ)エトキシ)フェニル]フルオレンなどの9,9-ビス[(メタ)アクリロイルオキシ(モノ乃至デカ)C2-4アルコキシフェニル]フルオレン);9,9-ビス[(メタ)アクリロイルオキシ(ポリ)アルコキシ-モノ又はジアルキルフェニル]フルオレン(例えば、9,9-ビス[4-(2-(メタ)アクリロイルオキシエトキシ)-3-メチルフェニル]フルオレン、9,9-ビス[4-(2-(メタ)アクリロイルオキシプロポキシ)-3-t-ブチルフェニル]フルオレン、9,9-ビス[4-(2-(2-(メタ)アクリロイルオキシエトキシ)エトキシ)-3,5-ジメチルフェニル]フルオレンなどの9,9-ビス[(メタ)アクリロイルオキシ(モノ乃至デカ)C2-4アルコキシ-モノ又はジC1-4アルキルフェニル]フルオレンなど);9,9-ビス[(メタ)アクリロイルオキシ(ポリ)アルコキシ-アリールフェニル]フルオレン(例えば、9,9-ビス[4-(2-(メタ)アクリロイルオキシエトキシ)-3-フェニルフェニル]フルオレン、9,9-ビス[4-(2-(メタ)アクリロイルオキシプロポキシ)-3-フェニルフェニル]フルオレン、9,9-ビス[4-(2-(2-(メタ)アクリロイルオキシエトキシ)エトキシ)-3-フェニルフェニル]フルオレンなどの9,9-ビス[(メタ)アクリロイルオキシ(モノ乃至デカ)C2-4アルコキシ-C6-10アリールフェニル]フルオレンなど)などが挙げられる。 As 9,9-bis [(meth) acryloyloxy (poly) alkoxyphenyl] fluorenes, in the formula (2a), rings Z 1 and Z 2 are benzene rings, and n1 and n2 are 1 to 10 (preferably 1 6), compounds wherein p1 and p2 are 1, for example, 9,9-bis [(meth) acryloyloxy (poly) alkoxyphenyl] fluorene (for example, 9,9-bis [4- (2- (meth)) Acryloyloxyethoxy) phenyl] fluorene, 9,9-bis [4- (2- (meth) acryloyloxypropoxy) phenyl] fluorene, 9,9-bis [4- (2- (2- (meth) acryloyloxyethoxy) ) ethoxy) phenyl] 9,9-bis fluorene [(meth) acryloyloxy (mono- to deca) C 2-4 alkoxyphenyl] 9,9-bis [(meth) acryloyloxy (poly) alkoxy-mono or dialkylphenyl] fluorene (eg, 9,9-bis [4- (2- (meth) acryloyloxyethoxy) -3-methyl Phenyl] fluorene, 9,9-bis [4- (2- (meth) acryloyloxypropoxy) -3-tert-butylphenyl] fluorene, 9,9-bis [4- (2- (2- (meth) acryloyl) 9,9-bis [(meth) acryloyloxy (mono-deca) C 2-4 alkoxy-mono or di-C 1-4 alkylphenyl] fluorene such as oxyethoxy) ethoxy) -3,5-dimethylphenyl] fluorene ); 9,9-bis [(meth) acryloyloxy (poly) alkoxy-arylphenyl] fluorene (eg 9 , 9-bis [4- (2- (meth) acryloyloxyethoxy) -3-phenylphenyl] fluorene, 9,9-bis [4- (2- (meth) acryloyloxypropoxy) -3-phenylphenyl] fluorene 9,9-bis [(meth) acryloyloxy (mono to deca) C such as 9,9-bis [4- (2- (2- (meth) acryloyloxyethoxy) ethoxy) -3-phenylphenyl] fluorene 2-4 alkoxy-C 6-10 arylphenyl] fluorene and the like.
 9,9-ビス[(メタ)アクリロイルオキシナフチル]フルオレン類としては、前記式(2a)において、環Z及びZがナフタレン環、n1及びn2が0、p1及びp2が1である化合物、例えば、9,9-ビス[(メタ)アクリロイルオキシナフチル]フルオレン(例えば、9,9-ビス[6-(メタ)アクリロイルオキシ-2-ナフチル]フルオレン、9,9-ビス[5-(メタ)アクリロイルオキシ-1-ナフチル]フルオレンなど)などが挙げられる。 As 9,9-bis [(meth) acryloyloxynaphthyl] fluorenes, in the above formula (2a), the ring Z 1 and Z 2 are naphthalene rings, n1 and n2 are 0, p1 and p2 are 1, For example, 9,9-bis [(meth) acryloyloxynaphthyl] fluorene (eg, 9,9-bis [6- (meth) acryloyloxy-2-naphthyl] fluorene, 9,9-bis [5- (meth)) Acryloyloxy-1-naphthyl] fluorene and the like.
 9,9-ビス[(メタ)アクリロイルオキシ(ポリ)アルコキシナフチル]フルオレン類としては、前記式(2a)において、環Z及びZがナフタレン環、n1及びn2が1~10(好ましくは1~6)、p1及びp2が1である化合物、例えば、9,9-ビス[(メタ)アクリロイルオキシ(ポリ)アルコキシナフチル]フルオレン(例えば、9,9-ビス[6-(2-(メタ)アクリロイルオキシエトキシ)-2-ナフチル]フルオレン、9,9-ビス[5-(2-(メタ)アクリロイルオキシプロポキシ)-1-ナフチル]フルオレン、9,9-ビス[6-(2-(2-(メタ)アクリロイルオキシエトキシ)エトキシ)-2-ナフチル]フルオレンなどの9,9-ビス[(メタ)アクリロイルオキシ(モノ乃至デカ)C2-4アルコキシナフチル]フルオレンなど)などが挙げられる。 As 9,9-bis [(meth) acryloyloxy (poly) alkoxynaphthyl] fluorenes, in the formula (2a), rings Z 1 and Z 2 are naphthalene rings, and n1 and n2 are 1 to 10 (preferably 1 6), compounds wherein p1 and p2 are 1, for example, 9,9-bis [(meth) acryloyloxy (poly) alkoxynaphthyl] fluorene (for example, 9,9-bis [6- (2- (meth)) [Acryloyloxyethoxy) -2-naphthyl] fluorene, 9,9-bis [5- (2- (meth) acryloyloxypropoxy) -1-naphthyl] fluorene, 9,9-bis [6- (2- (2- (meth) acryloyloxy) ethoxy) -2-naphthyl] fluorene such as 9,9-bis [(meth) acryloyloxy (mono- to deca) C 2-4 Rukokishinafuchiru] fluorene, etc.) and the like.
 これらのフルオレン骨格含有(メタ)アクリレートは、単独で又は2種以上組み合わせて使用することもできる。好ましいフルオレン骨格含有(メタ)アクリレートとしては、前記式(2a)において、環Z及びZがベンゼン環、n1及びn2が1~10(好ましくは1~6)、p1及びp2が1である化合物、例えば、9,9-ビス[(メタ)アクリロイルオキシ(ポリ)アルコキシフェニル]フルオレン類などが挙げられ、なかでも、9,9-ビス[(メタ)アクリロイルオキシ(ポリ)アルコキシフェニル]フルオレン(例えば、9,9-ビス[4-(2-(メタ)アクリロイルオキシエトキシ)フェニル]フルオレン、9,9-ビス[4-(2-(2-(メタ)アクリロイルオキシプロポキシ)プロポキシ)フェニル]フルオレンなどの9,9-ビス[(メタ)アクリロイルオキシ(モノ乃至デカ)C2-4アルコキシフェニル]フルオレン);9,9-ビス[(メタ)アクリロイルオキシ(ポリ)アルコキシ-モノ又はジアルキルフェニル]フルオレン(例えば、9,9-ビス[4-(2-(メタ)アクリロイルオキシエトキシ)-3-メチルフェニル]フルオレン、9,9-ビス[4-(2-(メタ)アクリロイルオキシプロポキシ)-3-t-ブチルフェニル]フルオレン、9,9-ビス[4-(2-(2-(メタ)アクリロイルオキシエトキシ)エトキシ)-3,5-ジメチルフェニル]フルオレンなどの9,9-ビス[(メタ)アクリロイルオキシ(モノ乃至デカ)C2-4アルコキシ-モノ又はジC1-4アルキルフェニル]フルオレンなど);9,9-ビス[(メタ)アクリロイルオキシ(ポリ)アルコキシ-アリールフェニル]フルオレン(例えば、9,9-ビス[4-(2-(メタ)アクリロイルオキシエトキシ)-3-フェニルフェニル]フルオレン、9,9-ビス[4-(2-(2-(メタ)アクリロイルオキシプロポキシ)プロポキシ)-3-フェニルフェニル]フルオレンなどの9,9-ビス[(メタ)アクリロイルオキシ(モノ乃至デカ)C2-4アルコキシ-C6-10アリールフェニル]フルオレンなど)などが好ましい。 These fluorene skeleton-containing (meth) acrylates can be used alone or in combination of two or more. As a preferred fluorene skeleton-containing (meth) acrylate, in the formula (2a), the rings Z 1 and Z 2 are benzene rings, n1 and n2 are 1 to 10 (preferably 1 to 6), and p1 and p2 are 1. Compounds such as 9,9-bis [(meth) acryloyloxy (poly) alkoxyphenyl] fluorenes, among which 9,9-bis [(meth) acryloyloxy (poly) alkoxyphenyl] fluorene ( For example, 9,9-bis [4- (2- (meth) acryloyloxyethoxy) phenyl] fluorene, 9,9-bis [4- (2- (2- (2- (meth) acryloyloxypropoxy) propoxy) phenyl) fluorene 9,9-bis such [(meth) acryloyloxy (mono- to deca) C 2-4 alkoxyphenyl] fluorene ); 9,9-bis [(meth) acryloyloxy (poly) alkoxy-mono or dialkylphenyl] fluorene (eg, 9,9-bis [4- (2- (meth) acryloyloxyethoxy) -3-methylphenyl) ] Fluorene, 9,9-bis [4- (2- (meth) acryloyloxypropoxy) -3-tert-butylphenyl] fluorene, 9,9-bis [4- (2- (2- (meth) acryloyloxy) 9,9-bis [(meth) acryloyloxy (mono-deca) C 2-4 alkoxy-mono or di-C 1-4 alkylphenyl] fluorene such as ethoxy) ethoxy) -3,5-dimethylphenyl] fluorene) 9,9-bis [(meth) acryloyloxy (poly) alkoxy-arylphenyl] fluorene (eg, 9,9-bi [4- (2- (meth) acryloyloxyethoxy) -3-phenylphenyl] fluorene, 9,9-bis [4- (2- (2- (meth) acryloyloxypropoxy) propoxy) -3-phenylphenyl 9,9-bis [(meth) acryloyloxy (mono to deca) C 2-4 alkoxy-C 6-10 arylphenyl] fluorene and the like) such as fluorene and the like are preferable.
 また、これらのフルオレン骨格含有(メタ)アクリレートは、市販品を使用してもよく、慣用の方法(例えば、特許文献1記載の方法など)により調製してもよい。 These fluorene skeleton-containing (meth) acrylates may be commercially available or may be prepared by a conventional method (for example, the method described in Patent Document 1).
 脂環族エポキシ(メタ)アクリレートは、少なくとも1つの脂環式炭化水素環(脂肪族性環)を有する多官能性エポキシ(メタ)アクリレートであればよく、脂肪族性環としては、例えば、C5-8シクロアルカン環(例えば、シクロペンタン環、シクロヘキサン環など)、C7-10ビ又はトリシクロアルカン環(例えば、ノルボルナン環、アダマンタン環など)などが挙げられる。代表的な脂環族エポキシ(メタ)アクリレートとしては、例えば、1,4-シクロヘキサンジメタノールジグリシジルエーテルのジ(メタ)アクリレートなどのC5-10脂肪族性環を有するエポキシ化合物のジ(メタ)アクリレートなどが挙げられる。これらの脂環族エポキシ(メタ)アクリレートは、単独で又は2種以上組み合わせて使用することもできる。 The alicyclic epoxy (meth) acrylate may be a polyfunctional epoxy (meth) acrylate having at least one alicyclic hydrocarbon ring (aliphatic ring), and examples of the aliphatic ring include C Examples thereof include 5-8 cycloalkane rings (eg, cyclopentane ring, cyclohexane ring), C 7-10 bi- or tricycloalkane rings (eg, norbornane ring, adamantane ring, etc.). As a typical alicyclic epoxy (meth) acrylate, for example, di (meth) acrylate of an epoxy compound having a C 5-10 aliphatic ring such as di (meth) acrylate of 1,4-cyclohexanedimethanol diglycidyl ether. ) Acrylate and the like. These alicyclic epoxy (meth) acrylates can be used alone or in combination of two or more.
 芳香族エポキシ(メタ)アクリレートは、少なくとも芳香族性環を有している多官能性エポキシ(メタ)アクリレートであればよく、芳香族性環としては、ベンゼン環、ナフタレン環などのC10-14縮合多環式アレーン環などが例示できる。芳香族エポキシ(メタ)アクリレートは、前記芳香族性環を有するため、高屈折率な硬化物を得るのに適している。代表的な芳香族エポキシ(メタ)アクリレートとしては、例えば、ビフェノール類若しくはビスフェノール類(又はそれらのアルキレンオキサイド付加体)のジグリシジルエーテルのジ(メタ)アクリレート、ノボラック型エポキシ樹脂のポリ(メタ)アクリレートなどが挙げられる。これらの芳香族エポキシ(メタ)アクリレートは、単独で又は2種以上組み合わせて使用することもできる。 The aromatic epoxy (meth) acrylate may be any polyfunctional epoxy (meth) acrylate having at least an aromatic ring, and examples of the aromatic ring include C 10-14 such as a benzene ring and a naphthalene ring. Examples thereof include a condensed polycyclic arene ring. Since the aromatic epoxy (meth) acrylate has the aromatic ring, it is suitable for obtaining a cured product having a high refractive index. Representative aromatic epoxy (meth) acrylates include, for example, di (meth) acrylates of diglycidyl ethers of biphenols or bisphenols (or their alkylene oxide adducts), poly (meth) acrylates of novolac type epoxy resins. Etc. These aromatic epoxy (meth) acrylates can be used alone or in combination of two or more.
 好ましい芳香族エポキシ(メタ)アクリレートとしては、ビフェノール類若しくはビスフェノール類(又はそれらのアルキレンオキサイド付加体)のジグリシジルエーテル(エポキシ化合物)のジ(メタ)アクリレートが挙げられる。前記ビフェノール類としては、例えば、p,p‘-ビフェノール、m,m’-ビフェノール、o,o’-ビフェノールなどが挙げられる。前記ビスフェノール類としては、例えば、ビスフェノールA、ビスフェノールF、ビスフェノールB、ビスフェノールAP、ビスフェノールAF、ビスフェノールSなどの汎用のビスフェノール類などが挙げられる。前記アルキレンオキサイドとしては、例えば、エチレンオキサイド、プロピレンオキサイドなどのC2-4アルキレンオキサイド、好ましくはC2-3アルキレンオキサイドなどが例示できる。なお、前記アルキレンオキサイド付加体は、例示したアルキレンオキサイドに対応するアルキレンカーボネートの付加体であってもよい。 Preferred aromatic epoxy (meth) acrylates include di (meth) acrylates of diglycidyl ethers (epoxy compounds) of biphenols or bisphenols (or their alkylene oxide adducts). Examples of the biphenols include p, p′-biphenol, m, m′-biphenol, o, o′-biphenol, and the like. Examples of the bisphenols include general-purpose bisphenols such as bisphenol A, bisphenol F, bisphenol B, bisphenol AP, bisphenol AF, and bisphenol S. Examples of the alkylene oxide include C 2-4 alkylene oxide such as ethylene oxide and propylene oxide, preferably C 2-3 alkylene oxide. The alkylene oxide adduct may be an alkylene carbonate adduct corresponding to the exemplified alkylene oxide.
 代表的なビフェノール類若しくはビスフェノール類(又はそれらのアルキレンオキサイド付加体)のジグリシジルエーテルのジ(メタ)アクリレートとしては、下記式(3)で表される芳香族エポキシ(メタ)アクリレートが例示できる。 Examples of di (meth) acrylates of diglycidyl ethers of typical biphenols or bisphenols (or their alkylene oxide adducts) include aromatic epoxy (meth) acrylates represented by the following formula (3).
Figure JPOXMLDOC01-appb-C000013
Figure JPOXMLDOC01-appb-C000013
(式中、Rはそれぞれ水素原子、アルキル基又はアリール基を示し、2つのRは互いに結合して、アルキル基を有してもよい炭化水素環を形成してもよく、R9a及びR9bはそれぞれアルキル基又はアリール基、R10a及びR10bは直鎖状又は分岐鎖状アルキレン基、R11a及びR11bは水素原子又はメチル基、q1及びq2は0~4の整数、r1及びr2は0又は1以上の整数、tは0又は1を示す。)
 前記式(3)において、Rのアルキル基としては、例えば、メチル基、エチル基、イソプロピル基、t-ブチル基などの直鎖状又は分岐鎖状C1-6アルキル基、好ましくは直鎖状又は分岐鎖状C1-4アルキル基(特にメチル基)などであってもよい。Rのアリール基としては、例えば、フェニル基、ナフチル基などのC6-10アリール基(特にフェニル基)などであってもよい。Rの種類は、同一又は異なっていてもよい。また、2つのRは互いに結合して形成してもよい炭化水素環としては、シクロペンタン環、シクロヘキサン環などのC5-8シクロアルカン環などであってもよい。炭化水素環に置換していてもよいアルキル基としては、例えば、上記Rのアルキル基の項に例示したアルキル基などが挙げられ、好ましい態様も含めて同様であってもよい。炭化水素環に置換するアルキル基の置換数及び置換位置は特に制限されない。前記置換数は、例えば、0~3の整数、好ましくは0~2の整数、さらに好ましくは0又は1、特に0であってもよい。前記置換位置は、炭化水素環がシクロヘキサン環である場合、例えば、3-位~5-位のいずれかの位置に置換していてもよい。
(Wherein R 8 represents a hydrogen atom, an alkyl group or an aryl group, respectively, and two R 8 may be bonded to each other to form a hydrocarbon ring which may have an alkyl group, R 9a and R 9b is an alkyl group or an aryl group, R 10a and R 10b are linear or branched alkylene groups, R 11a and R 11b are hydrogen atoms or methyl groups, q1 and q2 are integers of 0 to 4, r1 and r2 is 0 or an integer of 1 or more, and t is 0 or 1.)
In the formula (3), the alkyl group represented by R 8 is, for example, a linear or branched C 1-6 alkyl group such as a methyl group, an ethyl group, an isopropyl group, or a t-butyl group, preferably a linear group. Or a branched C 1-4 alkyl group (particularly a methyl group). The aryl group for R 8 may be, for example, a C 6-10 aryl group (particularly a phenyl group) such as a phenyl group or a naphthyl group. The type of R 8 may be the same or different. Further, the hydrocarbon ring that may be formed by bonding two R 8 to each other may be a C 5-8 cycloalkane ring such as a cyclopentane ring or a cyclohexane ring. Examples of the alkyl group which may be substituted on the hydrocarbon ring include the alkyl groups exemplified in the section of the alkyl group of R 8 above, and the same may be included including preferred embodiments. There are no particular restrictions on the number and position of substitution of the alkyl group substituted on the hydrocarbon ring. The number of substitutions may be, for example, an integer of 0 to 3, preferably an integer of 0 to 2, more preferably 0 or 1, particularly 0. When the hydrocarbon ring is a cyclohexane ring, the substitution position may be substituted, for example, at any position from the 3-position to the 5-position.
 R9a及びR9bは、Rの項において例示したアルキル基、アリール基などが挙げられ、好ましい態様を含めて同様であってもよい。R9a及びR9bの置換数q1及びq2は、0~4の整数であり、例えば、0~3の整数、好ましくは0~2の整数、さらに好ましくは0又は1、特に0であってもよい。また、R9a及びR9bの種類、同一又は異なっていてもよく、q1及びq2が2以上である場合、同一のベンゼン環に結合する2以上のR9a及びR9bの種類、同一又は異なっていてもよい。R9a及びR9bの置換位置は特に制限されず、ベンゼン環のいずれの位置(2-位、3-位など)に置換していてもよい。 Examples of R 9a and R 9b include the alkyl groups and aryl groups exemplified in R 8 , and may be the same including preferred embodiments. The number of substitutions q1 and q2 of R 9a and R 9b is an integer of 0 to 4, for example, an integer of 0 to 3, preferably an integer of 0 to 2, more preferably 0 or 1, particularly 0. Good. The types of R 9a and R 9b may be the same or different. When q1 and q2 are 2 or more, the types of two or more R 9a and R 9b bonded to the same benzene ring are the same or different. May be. The substitution position of R 9a and R 9b is not particularly limited, and may be substituted at any position (2-position, 3-position, etc.) of the benzene ring.
 R10a及びR10bで表される直鎖状又は分岐鎖状アルキレン基としては、前記式(1)のR(及び前記式(2)のR6a及びR6b)の項において例示した直鎖状又は分岐鎖状アルキレン基などが挙げられ、好ましい態様も含めて同様である。なお、R10a及びR10bの種類は、互いに同一又は異なっていてもよい。また、オキシアルキレン基(OR10a及びOR10b)の繰り返し数r1及びr2が2以上である場合、2以上のR10a及びR10bの種類は、異なっていてもよいが、同一であることが好ましい。 Examples of the linear or branched alkylene group represented by R 10a and R 10b include the straight chain exemplified in the section of R 2 of the formula (1) (and R 6a and R 6b of the formula (2)). Or a branched alkylene group, and the same applies to preferred embodiments. Note that the types of R 10a and R 10b may be the same or different from each other. In addition, when the number of repetitions r1 and r2 of the oxyalkylene group (OR 10a and OR 10b ) is 2 or more, the types of the two or more R 10a and R 10b may be different but are preferably the same. .
 前記r1及びr2、並びにr1及びr2の合計数[オキシアルキレン基の合計数(合計付加数)、単にr1+r2という場合がある。]は、前記式(2)のn1及びn2、並びにn1+n2の項において例示した値(整数又は平均値)と、好ましい態様も含めて同様である。r1+r2の値が小さすぎると、硬化性組成物の粘度が上昇し易く、ハンドリング性が低下するおそれがある。しかし、本発明では、前記式(1)で表される第1の単官能性(メタ)アクリレートを多量に混合しても屈折率を保持又は向上できるため、比較的r1+r2の値が小さくても、有効にハンドリング性を向上(粘度を低下)できる。r1+r2の値が大きすぎると、芳香族性環含有量(例えば、含有モル数)も低下するため、高屈折率などの優れた特性が低下するおそれがある。なお、r1+r2は、前記式(2)のn1+n2の項において例示した方法を参考に測定してもよい。 The total number of r1 and r2 and r1 and r2 [the total number of oxyalkylene groups (total number of additions), sometimes simply referred to as r1 + r2. ] Is the same as the values (integer or average value) exemplified in the terms of n1 and n2 and n1 + n2 in the formula (2), including preferred embodiments. If the value of r1 + r2 is too small, the viscosity of the curable composition tends to increase, and the handling properties may be reduced. However, in the present invention, the refractive index can be maintained or improved even if a large amount of the first monofunctional (meth) acrylate represented by the above formula (1) is mixed, so even if the value of r1 + r2 is relatively small. , Can effectively improve handling properties (decrease viscosity). If the value of r1 + r2 is too large, the aromatic ring content (for example, the number of moles contained) is also reduced, so that excellent properties such as a high refractive index may be reduced. Note that r1 + r2 may be measured with reference to the method exemplified in the section of n1 + n2 in the formula (2).
 R11a及びR11bは、互いに同一又は異なっていてもよく、通常、同一である。 R 11a and R 11b may be the same or different from each other, and are usually the same.
 tは0又は1であり、1であるのが好ましい。 T is 0 or 1, and is preferably 1.
 代表的な前記式(3)で表される芳香族エポキシ(メタ)アクリレートとしては、例えば、前記式(3)において、t=0である化合物(例えば、p,p’-ビフェノールジグリシジルエーテルのジ(メタ)アクリレートなど);前記式(3)において、q1=q2=0、r1=r2=0、t=1である化合物[例えば、2つのRがそれぞれ水素原子又はアルキル基である化合物(例えば、ビスフェノールA、ビスフェノールF、ビスフェノールE、ビスフェノールBなどのビスフェノール類のエポキシ化合物(ジグリシジルエーテル)のジ(メタ)アクリレートなど);2つのRのうち少なくとも一方がアリール基である化合物(例えば、ビスフェノールAP、ビスフェノールBPなどのビスフェノール類のエポキシ化合物のジ(メタ)アクリレートなど);2つのRが互いに結合してアルキル基を有してもよい炭化水素環を形成する化合物(例えば、ビスフェノールZ、ビスフェノールTMCなどのビスフェノール類のエポキシ化合物のジ(メタ)アクリレートなど)など]などが例示できる。 As the representative aromatic epoxy (meth) acrylate represented by the formula (3), for example, a compound in which t = 0 in the formula (3) (for example, p, p′-biphenol diglycidyl ether) Di (meth) acrylate, etc.]; a compound in which q1 = q2 = 0, r1 = r2 = 0, t = 1 in the above formula (3) [for example, two R 8 are each a hydrogen atom or an alkyl group, respectively] (For example, di (meth) acrylates of epoxy compounds (diglycidyl ether) of bisphenols such as bisphenol A, bisphenol F, bisphenol E, and bisphenol B); a compound in which at least one of two R 8 is an aryl group ( For example, di (meta) of epoxy compounds of bisphenols such as bisphenol AP and bisphenol BP Acrylate); two R 8 are compounds which form or hydrocarbon ring which may have an alkyl group bonded to each other (e.g., bisphenol Z, di (meth epoxy compounds of bisphenols, such as bisphenol TMC) acrylate, etc. Etc.] etc. can be illustrated.
 前記式(3)で表される芳香族エポキシ(メタ)アクリレートは、単独で又は2種以上組み合わせて使用することもできる。前記式(3)で表される芳香族エポキシ(メタ)アクリレートのうち、q1=q2=0、r1=r2=0である化合物、なかでもt=1である化合物が好ましく、特に、2つのRがそれぞれ水素原子又はアルキル基である化合物(例えば、ビスフェノールAジグリシジルエーテルのジ(メタ)アクリレートなど)が好ましい。 The aromatic epoxy (meth) acrylate represented by the formula (3) can be used alone or in combination of two or more. Of the aromatic epoxy (meth) acrylates represented by the formula (3), a compound in which q1 = q2 = 0 and r1 = r2 = 0 is preferable, and a compound in which t = 1 is particularly preferable. Compounds in which 8 is a hydrogen atom or an alkyl group (for example, di (meth) acrylate of bisphenol A diglycidyl ether) are preferable.
 ウレタン(メタ)アクリレートは、主鎖骨格(ウレタンオリゴマー又はウレタンポリマー部分の骨格)が、ポリオール成分とポリイソシアネート成分との反応物に由来する単位で形成されている。ポリオール成分は、低分子量ポリオール成分(例えば、エチレングリコールなどのアルキレングリコールなど)であってもよいが、硬化物における耐スクラッチ性を向上する観点から、高分子量ポリオール成分であるのが好ましい。なお、高分子量ポリオール成分は、ポリマーであってもよく、繰り返し単位数が比較的少ないオリゴマーであってもよい。高分子ポリオール成分の重量平均分子量(Mw)は、ゲル浸透クロマトグラフィー(GPC)などにより測定でき、標準ポリスチレン換算で、例えば、300以上(例えば、400~50000)程度の範囲から選択でき、例えば、500~10000(例えば、600~5000)、好ましくは700~3000(例えば、800~2000)程度であってもよい。ポリオール成分の分子量(重量平均分子量)が低すぎると、硬化物の耐スクラッチ性が低下するおそれがあり、高すぎると、高粘度になりハンドリング性が低下するおそれがある。本発明では、前記第1の単官能性(メタ)アクリレートと組み合わせることにより、比較的高粘度な多官能性(メタ)アクリレートであっても有効に低粘度化できる。 Urethane (meth) acrylate has a main chain skeleton (a skeleton of a urethane oligomer or urethane polymer portion) formed of units derived from a reaction product of a polyol component and a polyisocyanate component. The polyol component may be a low molecular weight polyol component (for example, alkylene glycol such as ethylene glycol), but is preferably a high molecular weight polyol component from the viewpoint of improving scratch resistance in a cured product. The high molecular weight polyol component may be a polymer or an oligomer having a relatively small number of repeating units. The weight average molecular weight (Mw) of the polymer polyol component can be measured by gel permeation chromatography (GPC) or the like, and can be selected from a range of, for example, about 300 or more (for example, 400 to 50000) in terms of standard polystyrene. It may be about 500 to 10000 (for example, 600 to 5000), preferably about 700 to 3000 (for example, 800 to 2000). If the molecular weight (weight average molecular weight) of the polyol component is too low, the scratch resistance of the cured product may be reduced, and if it is too high, the viscosity becomes high and the handling property may be reduced. In the present invention, by combining with the first monofunctional (meth) acrylate, even a relatively high-viscosity polyfunctional (meth) acrylate can be effectively reduced in viscosity.
 高分子量ポリオール成分としては、例えば、ポリエーテルポリオール、ポリエステルポリオール、ポリカーボネートポリオールなどが挙げられる。ポリエーテルポリオール(特に、ポリエーテルジオール)としては、例えば、ポリアルキレンオキサイド[又はポリアルキレングリコール、例えば、エチレンオキサイド、プロピレンオキサイド、1,2-ブチレンオキサイド、1,4-ブチレンオキサイド(テトラヒドロフラン)などのC2-6アルキレンオキサイドの単独又は共重合体(例えば、ポリエチレングリコール、ポリプロピレングリコール、ポリテトラメチレンエーテルグリコール、ポリエチレンオキサイド-ポリプロピレンオキサイドブロック共重合体などのポリオキシC2-6アルキレングリコールなど、特にポリテトラメチレンエーテルグリコール)など]、ビスフェノールA又は水添ビスフェノールAのアルキレンオキサイド付加体(例えば、ヒドロキシル基1モルに対してC2-4アルキレンオキサイド1~5モル程度が付加した付加体)などが例示できる。これらのポリエーテルポリオールは、単独で又は2種以上組み合わせて使用することもできる。 Examples of the high molecular weight polyol component include polyether polyol, polyester polyol, and polycarbonate polyol. Examples of the polyether polyol (particularly, polyether diol) include polyalkylene oxide [or polyalkylene glycols such as ethylene oxide, propylene oxide, 1,2-butylene oxide, 1,4-butylene oxide (tetrahydrofuran), etc. C 2-6 alkylene oxide homo- or copolymers (eg, polyoxy C 2-6 alkylene glycols such as polyethylene glycol, polypropylene glycol, polytetramethylene ether glycol, polyethylene oxide-polypropylene oxide block copolymers, etc., especially polytetra Methylene ether glycol), etc.], alkylene oxide adducts of bisphenol A or hydrogenated bisphenol A (for example, 1 mol of hydroxyl group) C 2-4 alkylene oxide 1-5 about moles are added adduct), and others against. These polyether polyols can be used alone or in combination of two or more.
 ポリエステルポリオール(特に、ポリエステルジオール)としては、ジオール成分とジカルボン酸成分[ジカルボン酸又はその誘導体(例えば、低級アルキルエステル(メチルエステルなどのC1-2アルキルエステルなど)、酸ハライド、酸無水物など]との反応物、ヒドロキシアルカンカルボン酸(3-ヒドロキシ酪酸など)及び/又はラクトン類(ε-カプロラクトン、δ-バレロラクトンなどのC3-10ラクトン)の単独又は共重合体(ポリ-ε-カプロラクトンなど)、前記ジオール成分とジカルボン酸成分とヒドロキシアルカンカルボン酸及び/又はラクトン類との共重合体などが含まれる。ジカルボン酸成分としては、芳香族ジカルボン酸(例えば、テレフタル酸、イソフタル酸、2,6-ナフタレンジカルボン酸など)、脂環族ジカルボン酸(例えば、シクロヘキサンジカルボン酸など)、脂肪族ジカルボン酸(例えば、アジピン酸、セバシン酸などの直鎖状C4-12ジカルボン酸など)、これらのジカルボン酸の誘導体などが挙げられる。また、ジオール成分としては、アルカンジオール(例えば、エチレングリコール、プロピレングリコール、トリメチレングリコール、1,3-ブタンジオール、1,4-ブタンジオール、1,6-ヘキサンジオール、ネオペンチルグリコールなどのC2-10アルカンジオールなど)、ポリオキシアルキレングリコール(例えば、ジエチレングリコールなどのポリアルカンジオール)などのポリエーテル系ジオール、脂環族ジオール(例えば、1,4-シクロヘキサンジオール、シクロヘキサンジメタノールなど)などが挙げられる。これらのジオール成分及びジカルボン酸成分は、それぞれ、単独で又は2種以上組み合わせてもよい。具体的なポリエステルポリオールには、末端ヒドロキシル基を有するポリエステルジオール、例えば、ポリエチレンアジペート、ポリジエチレングリコールアジペート、ポリプロピレンアジペート、ポリテトラメチレンアジペート、ポリヘキサメチレンアジペート、これらの共重合体などが含まれる。これらのポリエステルポリオールは、単独で又は2種以上組み合わせて使用することもできる。 Polyester polyols (particularly polyester diols) include diol components and dicarboxylic acid components [dicarboxylic acids or derivatives thereof (for example, lower alkyl esters (such as C 1-2 alkyl esters such as methyl esters), acid halides, acid anhydrides, etc.) ] Or a lactone (C 3-10 lactone such as ε-caprolactone, δ-valerolactone) or a copolymer (poly-ε-). Caprolactone, etc.), a copolymer of the diol component, dicarboxylic acid component, hydroxyalkanecarboxylic acid and / or lactone, etc. Examples of the dicarboxylic acid component include aromatic dicarboxylic acids (for example, terephthalic acid, isophthalic acid, 2,6-naphthalenedicarboxylic acid) Alicyclic dicarboxylic acids (e.g., cyclohexane dicarboxylic acid), aliphatic dicarboxylic acids (e.g., adipic acid, straight-chain C 4-12 dicarboxylic acid such as sebacic acid), and derivatives of these dicarboxylic acids. Examples of the diol component include alkanediols (for example, C 2 such as ethylene glycol, propylene glycol, trimethylene glycol, 1,3-butanediol, 1,4-butanediol, 1,6-hexanediol, neopentyl glycol). such as -10 alkanediol), polyoxyalkylene glycols (e.g., poly alkanediol) polyether diols, such as such as diethylene glycol, alicyclic diols (e.g., 1,4-cyclohexanediol, cyclohexanedimethanol, etc.), etc. These diol components and dicarboxylic acid components may be used alone or in combination of two or more, and specific polyester polyols include polyester diols having terminal hydroxyl groups such as polyethylene adipate and polydiethylene glycol adipate. , Polypropylene adipate, polytetramethylene adipate, polyhexamethylene adipate, copolymers thereof, etc. These polyester polyols can be used alone or in combination of two or more.
 ポリカーボネートポリオール(特に、ポリカーボネートジオール)としては、例えば、ポリオール(前記例示の低分子量ポリオール、ポリエーテルポリオール、ポリエステルポリオールなど)と、ジアルキルカーボネート(例えば、ジメチルカーボネートなど)又はアルキレンカーボネート(例えば、エチレンカーボネートなど)との反応により得られるポリカーボネートジオール(例えば、ポリヘキサメチレンカーボネートジオール)などが挙げられる。これらのポリオール成分は、単独で又は2種以上組み合わせて使用することもできる。 Examples of the polycarbonate polyol (particularly, polycarbonate diol) include a polyol (such as the low molecular weight polyol, polyether polyol, and polyester polyol exemplified above) and a dialkyl carbonate (such as dimethyl carbonate) or alkylene carbonate (such as ethylene carbonate). And polycarbonate diol (for example, polyhexamethylene carbonate diol) obtained by the reaction with). These polyol components can be used alone or in combination of two or more.
 ポリイソシアネート成分は、特に限定されず、例えば、脂肪族ポリイソシアネート(例えば、ヘキサメチレンジイソシアネート(HDI)、1,3,6-ヘキサメチレントリイソシアネートなど);脂環族ポリイソシアネート[例えば、イソホロンジイソシアネート(IPDI)、水添キシリレンジイソシアネート(水添XDI)、水添ジフェニルメタン-4,4’-ジイソシアネート(水添MDI)など];芳香脂肪族ポリイソシアネート[例えば、キシリレンジイソシアネート(XDI)、テトラメチルキシリレンジイソシアネート(TMXDI)など];芳香族ポリイソシアネート(例えば、トリレンジイソシアネート(TDI)、ジフェニルメタンジイソシアネート(MDI)、1,5-ナフタレンジイソシアネート(NDI)、トリジンジイソシアネート(TODI)、p-フェニレンジイソシアネートなど);末端イソシアネート基を有するプレポリマー[例えば、前記例示のポリオール成分(例えば、ジオール成分)と、ポリイソシアネート成分(例えば、ジイソシアネート成分)とが反応したウレタンプレポリマーなど]などが挙げられる。また、ポリイソシアネート成分は、変性体[又は誘導体、例えば、多量体(二量体、三量体(トリイソシアヌレート環など)など)、カルボジイミド体、ビウレット体、アロファネート体、ウレットジオン体、ポリアミン変性体など]であってもよい。これらのポリイソシアネート成分は、単独で又は2種以上組み合わせて使用することもできる。 The polyisocyanate component is not particularly limited, and examples thereof include aliphatic polyisocyanates (for example, hexamethylene diisocyanate (HDI), 1,3,6-hexamethylene triisocyanate); alicyclic polyisocyanates [for example, isophorone diisocyanate (for example, IPDI), hydrogenated xylylene diisocyanate (hydrogenated XDI), hydrogenated diphenylmethane-4,4′-diisocyanate (hydrogenated MDI), etc.]; araliphatic polyisocyanates [eg, xylylene diisocyanate (XDI), tetramethylxylylene Range isocyanate (TMXDI) and the like]; aromatic polyisocyanate (eg, tolylene diisocyanate (TDI), diphenylmethane diisocyanate (MDI), 1,5-naphthalene diisocyanate (NDI), Lysine diisocyanate (TODI), p-phenylene diisocyanate, etc.); prepolymer having a terminal isocyanate group [for example, urethane in which a polyol component (eg, diol component) exemplified above and a polyisocyanate component (eg, diisocyanate component) are reacted) Prepolymer etc.]. The polyisocyanate component is a modified product [or derivative such as a multimer (dimer, trimer (triisocyanurate ring, etc.)), carbodiimide body, biuret body, allophanate body, uretdione body, polyamine modified body. Etc.]. These polyisocyanate components can be used alone or in combination of two or more.
 代表的なウレタン(メタ)アクリレートとしてはポリエステル型ウレタン(メタ)アクリレート、ポリエーテル型ウレタン(メタ)アクリレート、ポリオール成分とするポリカーボネート型ウレタン(メタ)アクリレートなどが挙げられる。これらのウレタン(メタ)アクリレートは、単独で又は2種以上組み合わせて使用することもできる。これらのウレタン(メタ)アクリレートは、硬化物の耐スクラッチ性を有効に向上でき、なかでも、ポリエステル型ウレタン(メタ)アクリレート及び/又はポリエーテル型ウレタン(メタ)アクリレートを含むのが好ましい。 Typical urethane (meth) acrylates include polyester-type urethane (meth) acrylate, polyether-type urethane (meth) acrylate, and polycarbonate-type urethane (meth) acrylate having a polyol component. These urethane (meth) acrylates can be used alone or in combination of two or more. These urethane (meth) acrylates can effectively improve the scratch resistance of the cured product, and among them, it is preferable to include polyester type urethane (meth) acrylate and / or polyether type urethane (meth) acrylate.
 ポリエステル(メタ)アクリレートは、好ましい態様などを含めて、前記と同様のポリエステルポリオールと、(メタ)アクリル酸との反応により調製できる。硬化物における耐スクラッチ性を向上する観点から、ポリエステルポリオールは、脂肪族モノマー成分{例えば、脂肪族ジオール成分(ブチレングリコールなどのC2-12アルキレングリコールなど)及び脂肪族ジカルボン酸成分[アジピン酸、ドデカン二酸などのC4-20アルカンカルボン酸又はその誘導体(酸ハライド、酸無水物、低級アルキルエステル)など]、脂肪族ラクトン成分(ε-カプロラクトンなど)、脂肪族ヒドロキシカルボン酸成分(3-ヒドロキシ酪酸、5-ヒドロキシ吉草酸など)など}に由来する単位で形成されていてもよい。これらのポリエステルポリオールは、単独で又は2種以上組み合わせて使用することもできる。 The polyester (meth) acrylate can be prepared by a reaction of the same polyester polyol as described above and (meth) acrylic acid, including preferred embodiments. From the viewpoint of improving the scratch resistance in the cured product, the polyester polyol has an aliphatic monomer component (for example, an aliphatic diol component (such as C 2-12 alkylene glycol such as butylene glycol) and an aliphatic dicarboxylic acid component [adipic acid, C 4-20 alkanecarboxylic acid such as dodecanedioic acid or derivatives thereof (acid halide, acid anhydride, lower alkyl ester, etc.), aliphatic lactone component (ε-caprolactone, etc.), aliphatic hydroxycarboxylic acid component (3- Etc.) may be formed from units derived from such as hydroxybutyric acid, 5-hydroxyvaleric acid and the like. These polyester polyols can be used alone or in combination of two or more.
 なお、脂環族エポキシ(メタ)アクリレート、芳香族エポキシ(メタ)アクリレート、ウレタン(メタ)アクリレート、ポリエステル(メタ)アクリレートは、市販品を使用してもよい。 In addition, you may use a commercial item for alicyclic epoxy (meth) acrylate, aromatic epoxy (meth) acrylate, urethane (meth) acrylate, and polyester (meth) acrylate.
 高粘度多官能性(メタ)アクリレートの含有量は、多官能性(メタ)アクリレート全体に対して、例えば、10重量%以上の範囲から選択でき、例えば、30重量%以上、好ましくは50重量%以上、さらに好ましくは60重量%以上(例えば、80重量%以上)、特に、実質的に100重量%であってもよい。高粘度多官能性(メタ)アクリレートの割合が少なすぎると、有効に低粘度化できなくなるおそれがある。 The content of the high-viscosity polyfunctional (meth) acrylate can be selected from the range of, for example, 10% by weight or more, for example, 30% by weight or more, preferably 50% by weight, based on the entire multifunctional (meth) acrylate. More preferably, it may be 60% by weight or more (for example, 80% by weight or more), in particular, substantially 100% by weight. If the proportion of the high-viscosity polyfunctional (meth) acrylate is too small, the viscosity may not be effectively reduced.
 また、これらの高粘度多官能性(メタ)アクリレートは単独で使用してもよく、用途などに応じて、2種以上を組み合わせて使用し、各特性(例えば、屈折率、耐スクラッチ性、耐熱性、機械的特性など)のバランスを調整してもよい。一般に高屈折率の硬化物は剛性が大きく柔軟性に欠ける傾向があるが、本発明では、高屈折率と耐スクラッチ性(柔軟性)とを高いレベルで両立できる。例えば、多官能性(メタ)アクリレートは、高屈折率などの光学的特性に優れた9,9-ビスアリールフルオレン骨格を有する多官能性(メタ)アクリレート(例えば、前記式(2)で表されるフルオレン骨格含有(メタ)アクリレートなど)と、硬化物の耐スクラッチ性に優れたウレタン(メタ)アクリレートとを少なくとも含んでいてもよい。このような多官能性(メタ)アクリレートは、高い屈折率及び優れた耐スクラッチ性をバランスよく備えた硬化物を形成できる。9,9-ビスアリールフルオレン骨格を有する多官能性(メタ)アクリレート(例えば、式(2)で表されるフルオレン骨格含有(メタ)アクリレートなど)と、ウレタン(メタ)アクリレートとの割合は、例えば、前者/後者(重量比)=50/50~99/1程度の範囲から選択でき、例えば、53/47~90/10、好ましくは55/45~80/20、さらに好ましくは58/42~70/30(例えば、60/40~65/35)程度であってもよい。9,9-ビスアリールフルオレン骨格を有する多官能性(メタ)アクリレートが少なすぎると、硬化物の屈折率が低下するおそれがある。 In addition, these high-viscosity polyfunctional (meth) acrylates may be used alone or in combination of two or more depending on the application, etc., and each characteristic (for example, refractive index, scratch resistance, heat resistance) Property, mechanical properties, etc.) may be adjusted. Generally, a cured product having a high refractive index tends to have a large rigidity and lack flexibility, but in the present invention, both a high refractive index and scratch resistance (flexibility) can be achieved at a high level. For example, a polyfunctional (meth) acrylate is a polyfunctional (meth) acrylate having a 9,9-bisarylfluorene skeleton excellent in optical properties such as a high refractive index (for example, represented by the above formula (2)). Fluorene skeleton-containing (meth) acrylate and the like) and urethane (meth) acrylate excellent in scratch resistance of the cured product. Such a polyfunctional (meth) acrylate can form a cured product having a high refractive index and excellent scratch resistance in a balanced manner. The ratio of the polyfunctional (meth) acrylate having a 9,9-bisarylfluorene skeleton (for example, the fluorene skeleton-containing (meth) acrylate represented by the formula (2)) and the urethane (meth) acrylate is, for example, The former / the latter (weight ratio) can be selected from a range of about 50/50 to 99/1, for example, 53/47 to 90/10, preferably 55/45 to 80/20, and more preferably 58/42 to It may be about 70/30 (for example, 60/40 to 65/35). If the amount of the polyfunctional (meth) acrylate having a 9,9-bisarylfluorene skeleton is too small, the refractive index of the cured product may be lowered.
 多官能性(メタ)アクリレートは、高粘度多官能性(メタ)アクリレートに加えて、さらに、ビフェノール類又はビスフェノール類のアルキレンオキサイド付加体のジ(メタ)アクリレートを含んでいてもよい。このような多官能性(メタ)アクリレートは、硬化性組成物における低粘性と、硬化物における高屈折率及び耐スクラッチ性とをバランスよく向上しやすい。 The multifunctional (meth) acrylate may further contain di (meth) acrylate of an alkylene oxide adduct of biphenols or bisphenols in addition to the high-viscosity multifunctional (meth) acrylate. Such a polyfunctional (meth) acrylate is easy to improve the low viscosity in the curable composition and the high refractive index and scratch resistance in the cured product in a balanced manner.
 ビフェノール類又はビスフェノール類のアルキレンオキサイド付加体のジ(メタ)アクリレートに関して、ビフェノール類、ビスフェノール類、及びアルキレンオキサイドとしては、例えば、前記ビフェノール類若しくはビスフェノール類(又はそれらのアルキレンオキサイド付加体)のジグリシジルエーテルのジ(メタ)アクリレートの項において例示したビフェノール類、ビスフェノール類、及びアルキレンオキサイドなどが挙げられ、好ましい態様なども含めて同様である。アルキレンオキサイド(又はアルキレンカーボネート)の付加に由来するオキシアルキレン基の合計数(合計付加数)(整数又は平均付加モル数)は、例えば、1~30程度の範囲から選択でき、例えば、2~25、好ましくは3~20、さらに好ましくは5~15(例えば、8~12)程度であってもよい。オキシアルキレン基の合計数が低すぎると、耐スクラッチ性を向上できないおそれがある。 Regarding the di (meth) acrylate of an alkylene oxide adduct of biphenols or bisphenols, examples of the biphenols, bisphenols, and alkylene oxides include diglycidyl of the biphenols or bisphenols (or their alkylene oxide adducts). Biphenols, bisphenols, and alkylene oxides exemplified in the section of ether di (meth) acrylate are exemplified, and the same applies to preferred embodiments. The total number of oxyalkylene groups (total addition number) (integer or average addition mole number) derived from addition of alkylene oxide (or alkylene carbonate) can be selected from a range of about 1 to 30, for example, 2 to 25 Preferably, it may be about 3 to 20, more preferably about 5 to 15 (for example, 8 to 12). If the total number of oxyalkylene groups is too low, scratch resistance may not be improved.
 代表的なビフェノール類又はビスフェノール類のアルキレンオキサイド付加体のジ(メタ)アクリレートとしては、例えば、ビフェノール類のアルキレンオキサイド付加体のジ(メタ)アクリレート[例えば、1モルのp,p’-ビフェノールに対して、エチレンオキサイドが10モル程度付加した付加体のジ(メタ)アクリレートなどの1モルのビフェノール類に対してC2-4アルキレンオキサイドが2~25モル程度付加した付加体のジ(メタ)アクリレートなど];ビスフェノール類のアルキレンオキサイド付加体のジ(メタ)アクリレート[例えば、1モルのビスフェノールAに対して、エチレンオキサイドが10モル程度付加した付加体のジ(メタ)アクリレート、1モルのビスフェノールFに対して、プロピレンオキサイドが10モル程度付加した付加体のジ(メタ)アクリレートなどの1モルのビスフェノール類に対してC2-4アルキレンオキサイドが2~25モル程度付加した付加体のジ(メタ)アクリレートなど]などが挙げられる。 Examples of the di (meth) acrylate of an alkylene oxide adduct of biphenols or bisphenols include, for example, di (meth) acrylate of an alkylene oxide adduct of biphenol [for example, to 1 mol of p, p′-biphenol. On the other hand, adduct di (meth) in which about 2 to 25 mol of C 2-4 alkylene oxide is added to 1 mol biphenols such as di (meth) acrylate in adduct with about 10 mol of ethylene oxide added. Acrylates, etc.]; di (meth) acrylates of alkylene oxide adducts of bisphenols [for example, di (meth) acrylates of adducts in which about 10 mol of ethylene oxide is added to 1 mol of bisphenol A, 1 mol of bisphenol For F, propylene oxide is 0 one mole of C 2-4 di (meth) acrylate adducts of alkylene oxide are added about 2 to 25 mol relative to bisphenol such as di (meth) acrylate of moles added was adduct], and the like It is done.
 これらのビフェノール類又はビスフェノール類のアルキレンオキサイド付加体のジ(メタ)アクリレートは、単独で又は2種以上組み合わせて使用することもできる。これらのビフェノール類又はビスフェノール類のアルキレンオキサイド付加体のジ(メタ)アクリレートのうち、ビスフェノール類のアルキレンオキサイド付加体のジ(メタ)アクリレートが好ましく、1モルのビスフェノール類に対してC2-3アルキレンオキサイドが3~20モル程度付加した付加体のジ(メタ)アクリレート(例えば、1モルのビスフェノールAに対してエチレンオキサイドが10モル程度付加した付加体のジ(メタ)アクリレートなど)がさらに好ましい。なお、これらのビフェノール類又はビスフェノール類のアルキレンオキサイド付加体のジ(メタ)アクリレートは、市販品を使用してもよい。 These di (meth) acrylates of alkylene oxide adducts of biphenols or bisphenols may be used alone or in combination of two or more. Of these biphenols or di (meth) acrylates of alkylene oxide adducts of bisphenols, di (meth) acrylates of alkylene oxide adducts of bisphenols are preferred, and C 2-3 alkylene per mole of bisphenols An adduct di (meth) acrylate added with about 3 to 20 moles of oxide (for example, an adduct di (meth) acrylate with about 10 moles of ethylene oxide added to 1 mole of bisphenol A) is more preferable. Commercially available products may be used as the di (meth) acrylates of these biphenols or alkylene oxide adducts of bisphenols.
 高粘度多官能性(メタ)アクリレートと、ビフェノール類又はビスフェノール類のアルキレンオキサイド付加体のジ(メタ)アクリレートとの割合は、例えば、前者/後者(重量比)=50/50~99/1程度の範囲から選択でき、例えば、53/47~90/10、好ましくは55/45~80/20、さらに好ましくは58/42~70/30(例えば、60/40~65/35)程度であってもよい。ビスフェノール類のアルキレンオキサイド付加体のジ(メタ)アクリレートの割合が多すぎると、粘度低減の効果が得られなくなるおそれがある。 The ratio of the high-viscosity polyfunctional (meth) acrylate to the di (meth) acrylate of the alkylene oxide adduct of biphenols or bisphenols is, for example, the former / the latter (weight ratio) = about 50/50 to 99/1 For example, about 53/47 to 90/10, preferably about 55/45 to 80/20, more preferably about 58/42 to 70/30 (for example, 60/40 to 65/35). May be. If the proportion of di (meth) acrylate in the alkylene oxide adduct of bisphenol is too large, the effect of reducing viscosity may not be obtained.
 <他の単官能性の重合性成分>
 本発明の硬化性組成物は、多官能性(メタ)アクリレート及び前記式(1)で表される第1の単官能性(メタ)アクリレートに加え、さらに、他の単官能性の重合性成分(又はモノマー)を含んでいてもよい。硬化性組成物は、他の単官能性の重合性成分を含むことにより、用途に応じて、ハンドリング性(低粘性)や屈折率、耐スクラッチ性(柔軟性)などの特性を、調整又は向上することもできる。他の単官能性の重合性成分としては、重合性基(又は重合性不飽和結合)(例えば、アルケニル基(例えば、ビニル基、アリル基など)、(メタ)アクリロイル基など)を1つ有する化合物であればよく、例えば、単官能性ビニル系モノマー[例えば、α-オレフィン系モノマー(例えば、エチレン、プロピレンなど);スチレン系モノマー(例えば、スチレン、α-メチルスチレン、ビニルトルエンなど);ビニルエステル系モノマー(例えば、酢酸ビニルなど);N-ビニルピロリドンなど]、単官能性(メタ)アクリル系モノマーなどが挙げられる。これらの単官能性の重合性成分は、単独で又は2種以上組み合わせて使用することもできる。これらの単官能性の重合性成分のうち、単官能性(メタ)アクリル系モノマーが好ましい。
<Other monofunctional polymerizable components>
In addition to the polyfunctional (meth) acrylate and the first monofunctional (meth) acrylate represented by the formula (1), the curable composition of the present invention further includes other monofunctional polymerizable components. (Or monomer) may be included. The curable composition contains other monofunctional polymerizable components to adjust or improve properties such as handling properties (low viscosity), refractive index, and scratch resistance (flexibility) according to the application. You can also As another monofunctional polymerizable component, it has one polymerizable group (or polymerizable unsaturated bond) (for example, alkenyl group (for example, vinyl group, allyl group), (meth) acryloyl group). Any compound may be used, for example, a monofunctional vinyl monomer [eg, α-olefin monomer (eg, ethylene, propylene, etc.); styrene monomer (eg, styrene, α-methylstyrene, vinyl toluene, etc.); vinyl Examples thereof include ester monomers (for example, vinyl acetate); N-vinylpyrrolidone, etc.], monofunctional (meth) acrylic monomers, and the like. These monofunctional polymerizable components can be used alone or in combination of two or more. Of these monofunctional polymerizable components, monofunctional (meth) acrylic monomers are preferred.
 単官能性(メタ)アクリル系モノマーとしては、例えば、(メタ)アクリル酸、(メタ)アクリルアミド、N-置換(メタ)アクリルアミド(例えば、N-メチロール(メタ)アクリルアミド、N,N-ジメチル(メタ)アクリルアミドなど)、(メタ)アクリロニトリルなどであってもよいが、単官能性(メタ)アクリレートが利用されることが多い。 Examples of the monofunctional (meth) acrylic monomer include (meth) acrylic acid, (meth) acrylamide, N-substituted (meth) acrylamide (for example, N-methylol (meth) acrylamide, N, N-dimethyl (meth) ) Acrylamide), (meth) acrylonitrile, etc., but monofunctional (meth) acrylates are often used.
 単官能性(メタ)アクリレートとしては、例えば、脂肪族単官能性(メタ)アクリレート[例えば、メチル(メタ)アクリレート、ブチル(メタ)アクリレート、2-エチルヘキシル(メタ)アクリレートなどのC1-20アルキル(メタ)アクリレートなど];脂環族単官能性(メタ)アクリレート[例えば、シクロヘキシル(メタ)アクリレートなどのC5-10シクロアルキル(メタ)アクリレート、ジシクロペンテニル(メタ)アクリレート、イソボルニル(メタ)アクリレートなどの橋架け環式(メタ)アクリレートなど];芳香族単官能性(メタ)アクリレート(ただし、前記式(1)で表される単官能性(メタ)アクリレートを含まない。);硫黄原子を含有する単官能性(メタ)アクリレートなどが挙げられる。これらの単官能性(メタ)アクリレートは、単独で又は2種以上組み合わせて使用することもできる。これらの単官能性(メタ)アクリレートのうち、硬化性組成物のハンドリング性と、硬化物の高い屈折率及び耐スクラッチ性とをバランスよく向上できる点から、硬化性組成物は、硫黄原子を含有する単官能性(メタ)アクリレート(単に、第2の単官能性(メタ)アクリレートという場合がある。)を含むのが好ましく、第2の単官能性(メタ)アクリレートは、芳香族性環を有していてもよい。また、硬化性組成物のハンドリング性を向上しつつ、硬化物の屈折率をさらに向上できる点から、硬化性組成物は、芳香族単官能性(メタ)アクリレート(単に、第3の単官能性(メタ)アクリレートという場合がある。)を含むのが好ましく、第3の単官能性(メタ)アクリレートは、硫黄原子を有していてもよい。好ましい単官能性(メタ)アクリレートは、芳香族性環を有し、硫黄原子を有する単官能性(メタ)アクリレートであってもよい。 Examples of monofunctional (meth) acrylates include aliphatic monofunctional (meth) acrylates [for example, C 1-20 alkyl such as methyl (meth) acrylate, butyl (meth) acrylate, 2-ethylhexyl (meth) acrylate, etc. (meth) acrylate, etc.]; alicyclic monofunctional (meth) acrylates [e.g., cyclohexyl (meth) C 5-10 cycloalkyl (meth) acrylates such as acrylate, dicyclopentenyl (meth) acrylate, isobornyl (meth) Bridged cyclic (meth) acrylates such as acrylates, etc.]; aromatic monofunctional (meth) acrylates (however, the monofunctional (meth) acrylates represented by the above formula (1) are not included); sulfur atoms And monofunctional (meth) acrylates containing These monofunctional (meth) acrylates can be used alone or in combination of two or more. Among these monofunctional (meth) acrylates, the curable composition contains a sulfur atom because it can improve the handleability of the curable composition and the high refractive index and scratch resistance of the cured product in a well-balanced manner. It is preferable to include a monofunctional (meth) acrylate (sometimes simply referred to as a second monofunctional (meth) acrylate), and the second monofunctional (meth) acrylate has an aromatic ring. You may have. Moreover, from the point which can improve the refractive index of hardened | cured material, improving the handleability of a hardenable composition, a hardenable composition is aromatic monofunctional (meth) acrylate (only 3rd monofunctionality). (Sometimes referred to as (meth) acrylate)), and the third monofunctional (meth) acrylate may have a sulfur atom. A preferred monofunctional (meth) acrylate may be a monofunctional (meth) acrylate having an aromatic ring and having a sulfur atom.
 硫黄原子を含有する第2の単官能性(メタ)アクリレートとしては、例えば、アルキルチオ(メタ)アクリレート(例えば、メチルチオ(メタ)アクリレートなどのC1-6アルキルチオ(メタ)アクリレートなど)、アリールチオ(メタ)アクリレート(例えば、フェニルチオ(メタ)アクリレートなどのC6-10アリールチオ(メタ)アクリレートなど)、アラルキルチオ(メタ)アクリレート(例えば、ベンジルチオ(メタ)アクリレートなどのC6-10アリールC1-6アルキルチオ(メタ)アクリレートなど)、アリールチオアルキル(メタ)アクリレート(例えば、フェニルチオエチル(メタ)アクリレートなどのC6-10アリールチオC2-6アルキル(メタ)アクリレートなど)などが例示できる。これらの硫黄原子を含有する第2の単官能性(メタ)アクリレートは、単独で又は2種以上組み合わせて使用することもできる。これらの硫黄原子を含有する第2の単官能性(メタ)アクリレートのうち、硬化性組成物のハンドリング性と、硬化物における屈折率及び耐スクラッチ性とを特にバランスよく向上できる観点から、アリールチオアルキル(メタ)アクリレートを含むのが好ましく、特に、フェニルチオエチル(メタ)アクリレートなどのC6-10アリールチオC2-4アルキル(メタ)アクリレートが好ましい。このような硫黄原子を含有する第2の単官能性(メタ)アクリレートは、市販品などを使用してもよい。 Examples of the second monofunctional (meth) acrylate containing a sulfur atom include alkylthio (meth) acrylate (for example, C 1-6 alkylthio (meth) acrylate such as methylthio (meth) acrylate), arylthio (meta) ) Acrylates (eg C 6-10 arylthio (meth) acrylates such as phenylthio (meth) acrylate), aralkylthio (meth) acrylates (eg C 6-10 aryl C 1-6 alkylthio such as benzylthio (meth) acrylate) (Meth) acrylates), arylthioalkyl (meth) acrylates (eg, C 6-10 arylthio C 2-6 alkyl (meth) acrylates such as phenylthioethyl (meth) acrylate), and the like. These 2nd monofunctional (meth) acrylate containing a sulfur atom can also be used individually or in combination of 2 or more types. Among the second monofunctional (meth) acrylates containing these sulfur atoms, arylthio can be particularly improved from the viewpoint of improving the handleability of the curable composition and the refractive index and scratch resistance of the cured product. preferably includes an alkyl (meth) acrylates, in particular, C 6-10 arylthio C 2-4 alkyl, such as phenyl thio (meth) acrylate (meth) acrylate. A commercial item etc. may be used for the 2nd monofunctional (meth) acrylate containing such a sulfur atom.
 また、第1の単官能性(メタ)アクリレートと、第2の単官能性(メタ)アクリレートとの割合は、例えば、前者/後者(重量比)=100/0~20/80(例えば、80/20~20/80)程度の範囲から選択でき、例えば、70/30~25/75、好ましくは65/35~30/70(例えば、60/40~35/65)、さらに好ましくは55/45~40/60(例えば、50/50~40/60)程度であってもよい。第1の単官能性(メタ)アクリレートの割合が少なすぎると、ハンドリング性や、硬化物の屈折率が低下するおそれがある。 The ratio of the first monofunctional (meth) acrylate and the second monofunctional (meth) acrylate is, for example, the former / the latter (weight ratio) = 100/0 to 20/80 (for example, 80 / 20 to 20/80), for example, 70/30 to 25/75, preferably 65/35 to 30/70 (eg 60/40 to 35/65), more preferably 55 / It may be about 45 to 40/60 (for example, 50/50 to 40/60). When the ratio of the first monofunctional (meth) acrylate is too small, the handling property and the refractive index of the cured product may be reduced.
 前記芳香族単官能性(メタ)アクリレート(第3の単官能性(メタ)アクリレート)としては、例えば、アリール(メタ)アクリレート(例えば、(メタ)アクリル酸フェニルなど)、アラルキル(メタ)アクリレート(例えば、ベンジル(メタ)アクリレートなど)、ビスフェノール類(又はそのアルキレンオキサイド付加体)のモノ(メタ)アクリレート(例えば、ビスフェノールAのエチレンオキサイド付加体のモノ(メタ)アクリレートなど)、フルオレン骨格を有する(メタ)アクリレート(例えば、9-(メタ)アクリロイルオキシメチルフルオレンなど)、下記式(4) Examples of the aromatic monofunctional (meth) acrylate (third monofunctional (meth) acrylate) include aryl (meth) acrylate (for example, phenyl (meth) acrylate), aralkyl (meth) acrylate ( For example, benzyl (meth) acrylate, etc.), mono (meth) acrylate of bisphenols (or alkylene oxide adducts thereof) (for example, mono (meth) acrylate of ethylene oxide adducts of bisphenol A), fluorene skeleton ( (Meth) acrylate (for example, 9- (meth) acryloyloxymethylfluorene), the following formula (4)
Figure JPOXMLDOC01-appb-C000014
Figure JPOXMLDOC01-appb-C000014
(式中、R12は水素原子又はメチル基、R13はアルキレン基、R14はアルキル基、Arはベンゼン環又は環集合アレーン環、cは1~4の整数、dは0又は1以上の整数を示す。)
で表される単官能性(メタ)アクリレートなどが挙げられる。これらの第3の単官能性(メタ)アクリレートは、単独で又は2種以上組み合わせて使用することもできる。これらの第3の単官能性(メタ)アクリレートのうち、硬化性組成物のハンドリング性を向上しつつ、硬化物の屈折率を特に向上できる点から、前記式(4)で表される第3の単官能性(メタ)アクリレートを含むのが好ましい。
(Wherein R 12 is a hydrogen atom or a methyl group, R 13 is an alkylene group, R 14 is an alkyl group, Ar 2 is a benzene ring or a ring-arene ring, c is an integer of 1 to 4, and d is 0 or 1 or more. Indicates an integer.)
And monofunctional (meth) acrylates represented by These third monofunctional (meth) acrylates can be used alone or in combination of two or more. Among these third monofunctional (meth) acrylates, the third represented by the above formula (4) is able to improve the refractive index of the cured product while improving the handleability of the curable composition. The monofunctional (meth) acrylate is preferably included.
 前記式(4)において、基R12は水素原子又はメチル基である。また、基R13は直鎖状又は分岐鎖状アルキレン基であり、例えば、前記基R(並びに基R6a及びR6b)に例示したアルキレン基などが例示でき、好ましい態様も前記基R(並びに基R6a及びR6b)と同様である。基(R13O)の繰り返し数cは、1~4程度の整数から選択でき、例えば、1~3程度の整数、好ましくは1又は2、さらに好ましくは1であってもよい。繰り返し数cが大きすぎると、硬化物の屈折率が低下するおそれがある。なお、cが2以上である場合、2以上の基R13は、同一又は異なっていてもよい。 In the formula (4), the group R 12 is a hydrogen atom or a methyl group. The base R 13 is a linear or branched alkylene group, for example, the group R 2 can be exemplified include (as well as radicals R 6a and R 6b) alkylene group exemplified in the preferred embodiment also the radical R 2 (And groups R 6a and R 6b ). The repeating number c of the group (R 13 O) can be selected from an integer of about 1 to 4, for example, an integer of about 1 to 3, preferably 1 or 2, and more preferably 1. If the number of repetitions c is too large, the refractive index of the cured product may be reduced. In addition, when c is 2 or more, two or more groups R 13 may be the same or different.
 前記式(4)において、環Arはベンゼン環又は環集合アレーン環であり、環集合アレーン環としては、例えば、前記環Z及びZに例示した環集合アレーン環などが例示でき、好ましい態様も前記環Z及びZの環集合アレーン環と同様である。これらの環Arのうち、ベンゼン環又はビフェニル環(特にビフェニル環)が好ましい。前記式(4)において、環Arに対する基[-O-(R13O)-CO-CR12=CH]の結合位置は特に制限されず、例えば、環Arがビフェニル環である場合には、ビフェニル環の2~6-位のいずれかの位置に結合していてもよいが、2-位に結合しているのが好ましい。 In the formula (4), the ring Ar 2 is a benzene ring or a ring assembly arene ring, and examples of the ring assembly arene ring include the ring assembly arene rings exemplified in the rings Z 1 and Z 2. The embodiment is also the same as the ring assembly arene ring of the rings Z 1 and Z 2 . Of these rings Ar 2 , a benzene ring or a biphenyl ring (particularly a biphenyl ring) is preferable. In the formula (4), the bonding position of the group [-O- (R 13 O) c -CO-CR 12 = CH 2] for the ring Ar 2 is not particularly limited, for example, the ring Ar 2 is a biphenyl ring In some cases, it may be bonded to any position of the 2-6-position of the biphenyl ring, but is preferably bonded to the 2-position.
 前記式(4)において、基R14はアルキル基であり、例えば、前記式(1)において、基Rに例示したアルキル基などが挙げられ、好ましい態様も基Rと同様である。基R14の置換数dは0又は1以上の整数であればよく、例えば0~4程度の整数、好ましくは0~2程度の整数、さらに好ましくは0又は1、特に0であってもよい。なお、dが2以上である場合、2以上の基R14の種類はそれぞれ同一又は異なっていてもよい。また、基R14の置換位置は特に制限されず、例えば、環Arがベンゼン環であり、基[-O-(R13O)-CO-CR12=CH]の結合位置を1-位として、1-フェニル基の2~6-位のうちのいずれかの位置に置換していてもよく、例えば、3~5-位のうちのいずれかの位置(例えば、4-位)に置換していてもよい。また、環Arがビフェニル環であり、基[-O-(R13O)-CO-CR12=CH]が2-位に結合している場合、2-ビフェニリル基の3~6-位及び2’~6’-位のうちのいずれかの位置に置換していてもよい。 In the formula (4), the group R 14 is an alkyl group, and examples thereof include the alkyl group exemplified in the group R 3 in the formula (1), and the preferred embodiment is the same as the group R 3 . The substitution number d of the group R 14 may be 0 or an integer of 1 or more, for example, an integer of about 0 to 4, preferably an integer of about 0 to 2, more preferably 0 or 1, particularly 0. . When d is 2 or more, the types of the two or more groups R 14 may be the same or different. Further, the substitution position of the group R 14 is not particularly limited. For example, the ring Ar 2 is a benzene ring, and the bonding position of the group [—O— (R 13 O) c —CO—CR 12 ═CH 2 ] is 1 As the -position, the 1-phenyl group may be substituted at any position from 2 to 6-position, for example, any position from 3 to 5-position (for example, 4-position) May be substituted. When the ring Ar 2 is a biphenyl ring and the group [—O— (R 13 O) c —CO—CR 12 ═CH 2 ] is bonded to the 2-position, 3 to 6 of the 2-biphenylyl group It may be substituted at any position of the -position and the 2 'to 6'-position.
 前記式(4)で表される第3の単官能性(メタ)アクリレートの代表例としては、例えば、前記式(4)において、c=1及びd=1、かつArがベンゼン環である化合物、すなわち、アルキルフェノキシアルキル(メタ)アクリレート[例えば、2-(ノニルフェノキシ)エチル(メタ)アクリレートなどのC1-12アルキルフェノキシC2-4アルキル(メタ)アクリレートなど];前記式(4)において、c=1及びd=1、かつArが環集合アレーン環である化合物、すなわち、アルキル-環集合多環式アリールオキシアルキル(メタ)アクリレート[例えば、2-(ノニルビフェニリルオキシ)エチル(メタ)アクリレートなどのC1-12アルキルC6-10アリールC6-10アリールオキシC2-4アルキル(メタ)アクリレートなど];前記式(4)において、c≧2及びd=1、かつArがベンゼン環である化合物、すなわち、アルキルフェノキシ(モノ乃至トリ)アルコキシアルキル(メタ)アクリレート[例えば、2-(2-(ノニルフェノキシ)エトキシ)エチル(メタ)アクリレートなどのC1-12アルキルフェノキシ(モノ乃至トリ)C2-4アルコキシC2-4アルキル(メタ)アクリレートなど];前記式(4)において、c≧2及びd=1、かつArが環集合アレーン環である化合物、すなわち、アルキル-環集合多環式アリールオキシ(モノ乃至トリ)アルコキシアルキル(メタ)アクリレート[例えば、2-(2-(ノニルビフェニリルオキシ)エトキシ)エチル(メタ)アクリレートなどのC1-12アルキルC6-10アリールC6-10アリールオキシ(モノ乃至トリ)C2-4アルコキシC2-4アルキル(メタ)アクリレートなど];前記式(4)において、c=1及びd=0、かつArがベンゼン環である化合物、すなわち、フェノキシアルキル(メタ)アクリレート[例えば、2-フェノキシエチル(メタ)アクリレート、2-フェノキシプロピル(メタ)アクリレートなどのフェノキシC2-4アルキル(メタ)アクリレートなど];前記式(4)において、c=1及びd=0、かつArが環集合アレーン環である化合物、すなわち、環集合多環式アリールオキシアルキル(メタ)アクリレート[例えば、2-(o-フェニルフェノキシ)エチル(メタ)アクリレート、2-(m-フェニルフェノキシ)エチル(メタ)アクリレート、2-(p-フェニルフェノキシ)プロピル(メタ)アクリレートなどのC6-10アリールC6-10アリールオキシC2-4アルキル(メタ)アクリレートなど];前記式(4)において、c≧2及びd=0、かつArがベンゼン環である化合物、すなわち、フェノキシ(モノ乃至トリ)アルコキシアルキル(メタ)アクリレート[例えば、2-(2-フェノキシエトキシ)エチル(メタ)アクリレート、2-(2-フェノキシプロポキシ)プロピル(メタ)アクリレートなどのフェノキシ(モノ乃至トリ)C2-4アルコキシC2-4アルキル(メタ)アクリレートなど];前記式(4)において、c≧2及びd=0、かつArが環集合アレーン環である化合物、すなわち、環集合多環式アリールオキシ(モノ乃至トリ)アルコキシアルキル(メタ)アクリレート[例えば、2-(2-(o-フェニルフェノキシ)エトキシ)エチル(メタ)アクリレート、2-(2-(m-フェニルフェノキシ)プロポキシ)プロピル(メタ)アクリレートなどのC6-10アリールC6-10アリールオキシ(モノ乃至トリ)C2-4アルコキシC2-4アルキル(メタ)アクリレートなど]などが挙げられる。 As a representative example of the third monofunctional (meth) acrylate represented by the formula (4), for example, in the formula (4), c = 1 and d = 1, and Ar 2 is a benzene ring. Compound, ie, alkylphenoxyalkyl (meth) acrylate [eg, C 1-12 alkylphenoxy C 2-4 alkyl (meth) acrylate such as 2- (nonylphenoxy) ethyl (meth) acrylate, etc.]; In which c = 1 and d = 1 and Ar 2 is a ring-assembled arene ring, ie alkyl-ring-assembled polycyclic aryloxyalkyl (meth) acrylate [eg 2- (nonylbiphenylyloxy) ethyl (meth) C 1-12 alkyl C 6-10 aryl C 6-10 aryloxy C 2-4 alkyl, such as acrylates ( Data) acrylate, etc.]; and the formula (4), compound c ≧ 2 and d = 1, and Ar 2 is a benzene ring, i.e., alkylphenoxy (mono- to tri) alkoxyalkyl (meth) acrylates [e.g., 2 -C 1-12 alkylphenoxy (mono to tri) C 2-4 alkoxy C 2-4 alkyl (meth) acrylate such as (2- (nonylphenoxy) ethoxy) ethyl (meth) acrylate]; In which c ≧ 2 and d = 1, and Ar 2 is a ring-assembled arene ring, that is, an alkyl-ring-assembled polycyclic aryloxy (mono to tri) alkoxyalkyl (meth) acrylate [eg, 2- ( C 1-12 alkyl C such as 2- (nonylbiphenylyloxy) ethoxy) ethyl (meth) acrylate 6-10 aryl C 6-10 aryloxy (mono to tri) C 2-4 alkoxy C 2-4 alkyl (meth) acrylate, etc.]; in formula (4), c = 1 and d = 0, and Ar 2 Is a benzene ring, ie, phenoxyalkyl (meth) acrylate [for example, phenoxy C 2-4 alkyl (meth) acrylate such as 2-phenoxyethyl (meth) acrylate, 2-phenoxypropyl (meth) acrylate, etc.]; In the formula (4), a compound in which c = 1 and d = 0 and Ar 2 is a ring-assembled arene ring, that is, a ring-assembled polycyclic aryloxyalkyl (meth) acrylate [for example, 2- (o-phenyl) Phenoxy) ethyl (meth) acrylate, 2- (m-phenylphenoxy) ethyl (meth) acrylate And C 6-10 aryl C 6-10 aryloxy C 2-4 alkyl (meth) acrylate such as 2- (p-phenylphenoxy) propyl (meth) acrylate]; in the above formula (4), c ≧ 2 and d = 0, and a compound in which Ar 2 is a benzene ring, that is, phenoxy (mono to tri) alkoxyalkyl (meth) acrylate [for example, 2- (2-phenoxyethoxy) ethyl (meth) acrylate, 2- ( 2-phenoxypropoxy) propyl (meth) acrylate and other phenoxy (mono to tri) C 2-4 alkoxy C 2-4 alkyl (meth) acrylate and the like]; in the above formula (4), c ≧ 2 and d = 0, And Ar 2 is a ring-assembled arene ring, that is, a ring-assembled polycyclic aryloxy (mono to tri) C 6 such as alkoxyalkyl (meth) acrylate [eg, 2- (2- (o-phenylphenoxy) ethoxy) ethyl (meth) acrylate, 2- (2- (m-phenylphenoxy) propoxy) propyl (meth) acrylate, etc. -10 aryl C 6-10 aryloxy (mono to tri) C 2-4 alkoxy C 2-4 alkyl (meth) acrylate, etc.].
 これらの前記式(4)で表される第3の単官能性(メタ)アクリレートは単独で又は二種以上組み合わせて使用できる。好ましい第3の単官能性(メタ)アクリレートとしては、前記式(4)において、c=1及びd=0、かつArが環集合アレーン環である化合物、すなわち、環集合多環式アリールオキシアルキル(メタ)アクリレートなどが挙げられ、さらに好ましくは、C6-10アリールC6-10アリールオキシC2-4アルキル(メタ)アクリレート(例えば、2-(o-フェニルフェノキシ)エチル(メタ)アクリレートなどのフェニルフェノキシC2-4アルキル(メタ)アクリレートなど)などが挙げられる。 These third monofunctional (meth) acrylates represented by the formula (4) can be used alone or in combination of two or more. As a preferred third monofunctional (meth) acrylate, a compound in which c = 1 and d = 0 and Ar 2 is a ring-assembled arene ring in the above formula (4), that is, a ring-assembled polycyclic aryloxy Alkyl (meth) acrylates and the like, and more preferably, C 6-10 aryl C 6-10 aryloxy C 2-4 alkyl (meth) acrylate (eg, 2- (o-phenylphenoxy) ethyl (meth) acrylate) Phenylphenoxy C 2-4 alkyl (meth) acrylate and the like.
 なお、式(4)で表される化合物は、市販品を使用してもよく、公知の方法、例えば、フェノール又はヒドロキシ環集合多環式アレーンのアルキレンオキサイド又はアルキレンカーボネート付加体を、硫酸などのエステル化触媒、ハイドロキノンなどの重合禁止剤、及び必要に応じて溶媒の存在下、(メタ)アクリル酸と反応させる方法などにより調製できる。 In addition, the compound represented by Formula (4) may use a commercial item, for example, an alkylene oxide or alkylene carbonate adduct of phenol or a hydroxy ring assembly polycyclic arene, such as sulfuric acid, may be used. It can be prepared by a method of reacting with (meth) acrylic acid in the presence of an esterification catalyst, a polymerization inhibitor such as hydroquinone and, if necessary, a solvent.
 また、式(1)で表される第1の単官能性(メタ)アクリレートと、式(4)で表される第3の単官能性(メタ)アクリレートとの割合は、前者/後者(重量比)=100/0~20/80(例えば、80/20~20/80)程度の範囲から選択でき、例えば、70/30~25/75、好ましくは65/35~30/70(例えば、60/40~35/65)、さらに好ましくは55/45~40/60(例えば、50/50~43/57)程度であってもよい。式(1)で表される第1の単官能性(メタ)アクリレートの割合が少なすぎると、ハンドリング性や、硬化物の屈折率が低下するおそれがある。 The ratio of the first monofunctional (meth) acrylate represented by the formula (1) and the third monofunctional (meth) acrylate represented by the formula (4) is the former / the latter (weight). Ratio) = 100/0 to 20/80 (for example, 80/20 to 20/80) or so, for example, 70/30 to 25/75, preferably 65/35 to 30/70 (for example, 60/40 to 35/65), more preferably about 55/45 to 40/60 (for example, 50/50 to 43/57). If the ratio of the first monofunctional (meth) acrylate represented by the formula (1) is too small, the handling property and the refractive index of the cured product may be lowered.
 なお、本発明の低粘度化剤においても、第1の単官能性(メタ)アクリレートに加え、さらに、前記他の単官能性の重合性成分[例えば、第2の単官能性(メタ)アクリレート、第3の単官能性(メタ)アクリレート(特に第2の単官能性(メタ)アクリレート)など]を含んでいてもよい。また、他の単官能性の重合性成分は、好ましい態様(代表的な化合物、第1の単官能性(メタ)アクリレートとの割合など)などを含めて前記と同様であってもよい。 In the low viscosity agent of the present invention, in addition to the first monofunctional (meth) acrylate, the other monofunctional polymerizable component [for example, the second monofunctional (meth) acrylate 3rd monofunctional (meth) acrylate (especially 2nd monofunctional (meth) acrylate) etc.] may be included. Further, other monofunctional polymerizable components may be the same as described above, including preferred embodiments (representative compounds, ratios with the first monofunctional (meth) acrylate, etc.) and the like.
 <重合性成分以外の成分>
 (重合開始剤)
 硬化性組成物は、重合性成分(又はモノマー成分)の他に、重合開始剤を含んでいてもよい。重合開始剤は熱重合開始剤(熱ラジカル発生剤)であってもよく、光重合開始剤(光ラジカル発生剤)であってもよい。
<Ingredients other than polymerizable components>
(Polymerization initiator)
The curable composition may contain a polymerization initiator in addition to the polymerizable component (or monomer component). The polymerization initiator may be a thermal polymerization initiator (thermal radical generator) or a photopolymerization initiator (photo radical generator).
 熱重合開始剤としては、例えば、有機過酸化物[例えば、ジアルキルパーオキサイド類(例えば、ジ-tert-ブチルパーオキサイドなど)、ジアシルパーオキサイド類(例えば、ラウロイルパーオキサイド、ベンゾイルパーオキサイドなど)、過酸(又は過酸エステル)類(例えば、tert-ブチルハイドロパーオキサイド、クメンハイドロパーオキサイド、過酢酸tert-ブチルなど)、ケトンパーオキサイド類、パーオキシカーボネート類、パーオキシケタール類など]、アゾ化合物[例えば、2,2’-アゾビス(イソブチロニトリル)などのアゾニトリル化合物、アゾアミド化合物、アゾアミジン化合物など]などが例示できる。これらの熱重合開始剤は、単独で又は2種以上組み合わせて使用できる。 Examples of the thermal polymerization initiator include organic peroxides [eg, dialkyl peroxides (eg, di-tert-butyl peroxide), diacyl peroxides (eg, lauroyl peroxide, benzoyl peroxide, etc.), Peracids (or peracid esters) (for example, tert-butyl hydroperoxide, cumene hydroperoxide, tert-butyl peracetate, etc.), ketone peroxides, peroxycarbonates, peroxyketals, etc.], azo Examples include compounds [for example, azonitrile compounds such as 2,2′-azobis (isobutyronitrile), azoamide compounds, azoamidine compounds, etc.]. These thermal polymerization initiators can be used alone or in combination of two or more.
 光重合開始剤としては、例えば、ベンゾイン類(例えば、ベンゾイン、ベンゾインエチルエーテルなどのベンゾインアルキルエーテル類など)、アセトフェノン類(例えば、アセトフェノン、2-ヒドロキシ-2-メチル-1-フェニルプロパン-1-オンなど)、アミノアセトフェノン類{例えば、2-メチル-1-[4-(メチルチオ)フェニル]-2-モルホリノアミノプロパノン-1など}、アントラキノン類(例えば、アントラキノン、2-メチルアントラキノンなど)、チオキサントン類(例えば、2,4-ジメチルチオキサントン、2,4-ジエチルチオキサントン、2-クロロチオキサントンなど)、ケタール類(例えば、アセトフェノンジメチルケタール、ベンジルジメチルケタールなど)、ベンゾフェノン類(例えば、ベンゾフェノンなど)、キサントン類などが例示できる。これらの光重合開始剤は、単独で又は2種以上を組み合わせて使用してもよい。 Examples of the photopolymerization initiator include benzoins (for example, benzoin alkyl ethers such as benzoin and benzoin ethyl ether) and acetophenones (for example, acetophenone, 2-hydroxy-2-methyl-1-phenylpropane-1- ), Aminoacetophenones {eg 2-methyl-1- [4- (methylthio) phenyl] -2-morpholinoaminopropanone-1}, anthraquinones (eg anthraquinone, 2-methylanthraquinone etc.), Thioxanthones (eg, 2,4-dimethylthioxanthone, 2,4-diethylthioxanthone, 2-chlorothioxanthone, etc.), ketals (eg, acetophenone dimethyl ketal, benzyldimethyl ketal, etc.), benzophenones (eg, Benzophenone), such as xanthones can be exemplified. These photopolymerization initiators may be used alone or in combination of two or more.
 重合開始剤(熱及び/又は光重合開始剤)の割合は、重合性成分の総量100重量部に対して0.1~15重量部、好ましくは0.5~10重量部(例えば、1~8重量部)、さらに好ましくは2~5重量部程度であってもよい。 The ratio of the polymerization initiator (heat and / or photopolymerization initiator) is 0.1 to 15 parts by weight, preferably 0.5 to 10 parts by weight (for example, 1 to 1 part by weight based on 100 parts by weight of the total amount of the polymerizable components). 8 parts by weight), more preferably about 2 to 5 parts by weight.
 光重合開始剤は、光増感剤と組み合わせてもよい。光増感剤としては、例えば、第3級アミン類{例えば、トリアルキルアミン、トリアルカノールアミン(例えば、トリエタノールアミンなど)、N,N-ジメチルアミノ安息香酸エチル[例えば、p-(ジメチルアミノ)安息香酸エチルなど]、N,N-ジメチルアミノ安息香酸アミル[例えば、p-(ジメチルアミノ)安息香酸アミルなど]などのジアルキルアミノ安息香酸アルキルエステル、4,4-ビス(ジエチルアミノ)ベンゾフェノンなどのビス(ジアルキルアミノ)ベンゾフェノン、4-(ジメチルアミノ)ベンゾフェノンなどのジアルキルアミノベンゾフェノンなど}などの慣用の光増感剤などが挙げられる。これらの光増感剤は、単独で又は2種以上組み合わせてもよい。 The photopolymerization initiator may be combined with a photosensitizer. Examples of the photosensitizer include tertiary amines {eg, trialkylamine, trialkanolamine (eg, triethanolamine), ethyl N, N-dimethylaminobenzoate [eg, p- (dimethylamino). ) Ethyl benzoate, etc.], N, N-dimethylaminobenzoic acid amyl [eg, p- (dimethylamino) benzoic acid amyl etc.], etc., dialkylaminobenzoic acid alkyl esters, 4,4-bis (diethylamino) benzophenone, etc. Conventional photosensitizers such as bis (dialkylamino) benzophenone, dialkylaminobenzophenone such as 4- (dimethylamino) benzophenone} and the like. These photosensitizers may be used alone or in combination of two or more.
 光増感剤の割合は、前記重合開始剤100重量部に対して、1~200重量部、好ましくは5~150重量部、さらに好ましくは10~100重量部程度であってもよい。 The ratio of the photosensitizer may be 1 to 200 parts by weight, preferably 5 to 150 parts by weight, and more preferably about 10 to 100 parts by weight with respect to 100 parts by weight of the polymerization initiator.
 (溶媒)
 また、硬化性組成物は、必用に応じて、溶媒を含んでいてもよい。溶媒としては、特に限定されず、例えば、炭化水素類(例えば、ヘキサン、ヘプタンなどの脂肪族炭化水素類、シクロヘキサンなどの脂環族炭化水素類、トルエン、キシレンなどの芳香族炭化水素類など);ハロゲン化炭化水素類(例えば、塩化メチレン、クロロホルム、1,2-ジクロロエタンなど);エーテル類(例えば、ジエチルエーテルなどのジアルキルエーテル類、テトラヒドロフラン、ジオキサンなどの環状エーテル類など);ケトン類(例えば、アセトン、メチルエチルケトンなどのジアルキルケトン類、シクロヘキサノンなどの環状ケトン類など);エステル類(例えば、酢酸メチル、酢酸エチル、酢酸ブチルなどの酢酸エステル類など);グリコールエーテルアセテート類(例えば、プロピレングリコールモノメチルエーテルアセテート、ジエチレングリコールモノブチルエーテルアセテートなどの(ポリ)アルキレングリコールモノアルキルエーテルアセテート類など);スルホキシド類(例えば、ジメチルスルホキシドなど);アミド類(例えば、ジメチルホルムアミド、ジメチルアセトアミド、N-メチルピロリドンなど);ニトリル類(例えば、アセトニトリルなど)などが例示できる。これらの溶媒は、単独で又は2種以上組み合わせた混合溶媒として使用することもできる。
(solvent)
Moreover, the curable composition may contain the solvent as needed. The solvent is not particularly limited. For example, hydrocarbons (for example, aliphatic hydrocarbons such as hexane and heptane, alicyclic hydrocarbons such as cyclohexane, aromatic hydrocarbons such as toluene and xylene, etc.) Halogenated hydrocarbons (eg, methylene chloride, chloroform, 1,2-dichloroethane, etc.); ethers (eg, dialkyl ethers such as diethyl ether, cyclic ethers such as tetrahydrofuran, dioxane, etc.); ketones (eg, , Dialkyl ketones such as acetone and methyl ethyl ketone, cyclic ketones such as cyclohexanone, etc .; esters (eg, acetate esters such as methyl acetate, ethyl acetate, butyl acetate, etc.); glycol ether acetates (eg, propylene glycol monomethyl) A (Poly) alkylene glycol monoalkyl ether acetates such as diacetate and diethylene glycol monobutyl ether acetate); sulfoxides (eg dimethyl sulfoxide); amides (eg dimethylformamide, dimethylacetamide, N-methylpyrrolidone, etc.); Nitriles (for example, acetonitrile etc.) etc. can be illustrated. These solvents can be used alone or as a mixed solvent in which two or more kinds are combined.
 (他の添加剤)
 さらに、硬化性組成物は、慣用の添加剤、例えば、着色剤、安定剤(熱安定剤、酸化防止剤、紫外線吸収剤など)、充填剤、帯電防止剤、難燃剤、界面活性剤、可塑剤、硬化剤、重合禁止剤などを含んでいてもよい。これらの添加剤は単独で又は2種以上組み合わせて使用できる。
(Other additives)
Further, the curable composition can be prepared by using conventional additives such as colorants, stabilizers (thermal stabilizers, antioxidants, ultraviolet absorbers, etc.), fillers, antistatic agents, flame retardants, surfactants, plasticizers. An agent, a curing agent, a polymerization inhibitor and the like may be included. These additives can be used alone or in combination of two or more.
 <硬化物>
 本発明の硬化性組成物は、活性エネルギー(又は活性エネルギー線)を付与することで容易に硬化し、硬化物を生成する。前記活性エネルギーは、熱エネルギー及び/又は光エネルギー(例えば、紫外線、X線など)が有用である。
<Hardened product>
The curable composition of this invention hardens | cures easily by providing active energy (or active energy ray), and produces | generates hardened | cured material. As the active energy, thermal energy and / or light energy (for example, ultraviolet rays, X-rays, etc.) are useful.
 熱エネルギーを利用して加熱処理する場合、加熱温度としては、例えば、50~200℃、好ましくは60~150℃、さらに好ましくは70~120℃程度であってもよい。 When heat treatment is performed using thermal energy, the heating temperature may be, for example, 50 to 200 ° C., preferably 60 to 150 ° C., more preferably about 70 to 120 ° C.
 また、光エネルギー(例えば、紫外線など)を利用して光照射する場合、光照射エネルギー量は、用途に応じて適宜選択でき、例えば、50~10000mJ/cm、好ましくは70~8000mJ/cm、さらに好ましくは100~5000mJ/cm(例えば、500~3000mJ/cm)程度であってもよい。 Further, when light irradiation is performed using light energy (for example, ultraviolet light), the amount of light irradiation energy can be appropriately selected according to the application, for example, 50 to 10000 mJ / cm 2 , preferably 70 to 8000 mJ / cm 2. More preferably, it may be about 100 to 5000 mJ / cm 2 (for example, 500 to 3000 mJ / cm 2 ).
 硬化物の形状は、特に制限されず、三次元構造の硬化物(例えば、レンズなど)であってもよく、二次元構造の硬化物(又は硬化膜)(例えば、フィルム、シートなど)、一次元構造の硬化物(例えば、線状、棒状、管状など)であってもよい。 The shape of the cured product is not particularly limited, and may be a cured product having a three-dimensional structure (for example, a lens), a cured product having a two-dimensional structure (or a cured film) (for example, a film or a sheet), a primary The cured product may have a base structure (for example, linear, rod-like, tubular, etc.).
 硬化物の製造方法は、特に限定されず、例えば、三次元構造又は一次元構造の硬化物の製造方法としては、硬化物の形状に応じて、前記硬化性組成物を成形又は所定の型内に注型(注入)した後、硬化処理(加熱及び/又は光照射)して製造してもよい。また、二次元構造の硬化物の製造方法としては、例えば、前記硬化性組成物を基材又は基板[例えば、金属(例えば、アルミニウムなど)、セラミックス(例えば、酸化チタン、ガラス、石英など)などの無機材料、プラスチック(例えば、環状オレフィン系樹脂、ポリカーボネート系樹脂など)などの有機材料、木材などの多孔質体など]に塗布してフィルム状の塗膜(又は薄膜)を形成させた後、硬化処理を施すことで製造してもよい。 The method for producing a cured product is not particularly limited. For example, as a method for producing a cured product having a three-dimensional structure or a one-dimensional structure, the curable composition is molded according to the shape of the cured product or in a predetermined mold. After being cast (injected), it may be produced by curing (heating and / or light irradiation). As a method for producing a cured product having a two-dimensional structure, for example, the curable composition is used as a base material or a substrate [for example, metal (for example, aluminum), ceramics (for example, titanium oxide, glass, quartz, etc.), etc. Inorganic materials, organic materials such as plastics (for example, cyclic olefin-based resins, polycarbonate-based resins, etc., porous materials such as wood, etc.) to form a film-like coating film (or thin film), You may manufacture by giving a hardening process.
 <硬化性組成物及び硬化物の特性>
 本発明の硬化性組成物は、多官能性(メタ)アクリレートと、前記式(1)で表される第1の単官能性(メタ)アクリレートとを含むため、比較的低い粘度を有し、ハンドリング性に優れており、さらに、高屈折率な硬化物を形成できる。
<Characteristics of curable composition and cured product>
Since the curable composition of the present invention contains a polyfunctional (meth) acrylate and the first monofunctional (meth) acrylate represented by the formula (1), it has a relatively low viscosity, It has excellent handling properties and can form a cured product having a high refractive index.
 硬化性組成物の粘度(温度25℃)は、多官能性(メタ)アクリレートの種類などに応じて、例えば、1~500000mPa・s(例えば、50~100000mPa・s)程度であってもよく、例えば、1~50000mPa・s(例えば、5~25000mPa・s)程度の範囲から選択でき、例えば、10~20000mPa・s(例えば、20~10000mPa・s)、好ましくは30~6000mPa・s(例えば、50~2000mPa・s)、さらに好ましくは70~1000mPa・s(例えば、90~300mPa・s)程度であってもよい。また、本発明では、極めて粘度が高い多官能性(メタ)アクリレートであっても、第1の単官能性(メタ)アクリレートと組み合わせることで、粘度を有効に低減できる。そのため、硬化性組成物の粘度(温度60℃)は、例えば、100Pa・s以下(例えば、0.1~50Pa・s)程度の範囲から選択でき、例えば、30Pa・s以下(例えば、1~27Pa・s)、好ましくは25Pa・s以下(例えば、10~23Pa・s)程度であってもよい。なお、粘度は、後述する実施例に記載の方法などにより測定できる。 The viscosity (temperature 25 ° C.) of the curable composition may be, for example, about 1 to 500,000 mPa · s (for example, 50 to 100,000 mPa · s), depending on the type of polyfunctional (meth) acrylate, etc. For example, it can be selected from a range of about 1 to 50000 mPa · s (for example, 5 to 25000 mPa · s), for example, 10 to 20000 mPa · s (for example, 20 to 10000 mPa · s), preferably 30 to 6000 mPa · s (for example, 50 to 2000 mPa · s), more preferably about 70 to 1000 mPa · s (for example, 90 to 300 mPa · s). Moreover, in this invention, even if it is polyfunctional (meth) acrylate with very high viscosity, a viscosity can be effectively reduced by combining with 1st monofunctional (meth) acrylate. Therefore, the viscosity (temperature 60 ° C.) of the curable composition can be selected from a range of about 100 Pa · s or less (eg, 0.1 to 50 Pa · s), for example, 30 Pa · s or less (eg, 1 to 1). 27 Pa · s), preferably about 25 Pa · s or less (eg, 10 to 23 Pa · s). The viscosity can be measured by the method described in Examples described later.
 硬化前の硬化性組成物の屈折率(硬化前屈折率)(温度25℃、波長589nm)は、例えば、1.5~1.7程度の範囲から選択でき、例えば、1.52~1.65(例えば、1.53~1.62)、好ましくは1.54~1.61、さらに好ましくは1.55~1.60程度であってもよい。 The refractive index (refractive index before curing) (temperature 25 ° C., wavelength 589 nm) of the curable composition before curing can be selected from the range of about 1.5 to 1.7, for example, 1.52 to 1. It may be 65 (for example, 1.53 to 1.62), preferably 1.54 to 1.61, and more preferably about 1.55 to 1.60.
 また、硬化性組成物は、通常、硬化により屈折率が向上する傾向があり、重合性成分100重量部に対して、光重合開始剤3重量部を加熱混合した硬化性組成物を調製し、UV照射(500mJ/cm)により硬化した硬化物(例えば、後述する実施例の項に記載の方法で硬化した硬化物など)の屈折率(温度25℃、波長589nm)は、例えば、1.5~1.7程度の範囲から選択でき、例えば、1.52~1.66、好ましくは1.54~1.63、さらに好ましくは1.56~1.6程度であってもよい。なお、屈折率は、後述する実施例に記載の方法などにより測定できる。 Further, the curable composition usually has a tendency to improve the refractive index by curing, and a curable composition prepared by heating and mixing 3 parts by weight of a photopolymerization initiator with respect to 100 parts by weight of the polymerizable component is prepared. The refractive index (temperature 25 ° C., wavelength 589 nm) of a cured product cured by UV irradiation (500 mJ / cm 2 ) (for example, a cured product cured by the method described in the Examples section below) is, for example, 1. It can be selected from a range of about 5 to 1.7, and may be, for example, about 1.52 to 1.66, preferably 1.54 to 1.63, and more preferably about 1.56 to 1.6. In addition, a refractive index can be measured by the method as described in the Example mentioned later.
 以下に、実施例に基づいて本発明をより詳細に説明するが、本発明はこれらの実施例によって限定されるものではない。以下に、評価方法及び原料を示す。 Hereinafter, the present invention will be described in more detail based on examples, but the present invention is not limited to these examples. The evaluation methods and raw materials are shown below.
 (粘度)
 25℃における粘度を、TV-22形粘度計(コーンプレートタイプ、東機産業(株)製「TVE-22L」)を用い、測定粘度に応じたオプションロータ(01:1゜34’×R24、07:3゜×R7.7)を選択し、回転数0.5~20rpmで測定した。
(viscosity)
Using a TV-22 type viscometer (cone plate type, “TVE-22L” manufactured by Toki Sangyo Co., Ltd.), the viscosity at 25 ° C. was measured using an optional rotor (01: 1 ° 34 ′ × R24, 07: 3 ° × R7.7) was selected, and the measurement was performed at a rotational speed of 0.5 to 20 rpm.
 また、60℃における粘度は、E型溶融粘度計(BROOK FIELD社製「CAP2000+」)を使用して測定した。 Further, the viscosity at 60 ° C. was measured using an E-type melt viscometer (“CAP2000 +” manufactured by BROOK FIELD).
 (屈折率)
 多波長アッベ屈折計((株)アタゴ製、DR-M2<循環式恒温水槽60-C3>)を用いて、温度25℃、589nmでの屈折率を測定した。
(Refractive index)
Using a multiwavelength Abbe refractometer (manufactured by Atago Co., Ltd., DR-M2 <circulating constant temperature water bath 60-C3>), the refractive index at a temperature of 25 ° C. and 589 nm was measured.
 (耐スクラッチ性)
 表面性測定器HEIDON-14DR(新東科学(株)製)を用いて、スチールウール♯0000を鉛筆硬度計の先端に装着し、硬化物(50mm×15mm×2mm)に荷重250gを垂直負荷させ、速度1mm/sで硬化物上を移動させ、傷の有無を目視にて確認した。この操作を5本の硬化物について行い、以下の基準で耐スクラッチ性を評価した。
(Scratch resistance)
Using a surface property measuring instrument HEIDON-14DR (manufactured by Shinto Kagaku Co., Ltd.), steel wool # 0000 was attached to the tip of a pencil hardness meter, and a load of 250 g was vertically applied to the cured product (50 mm × 15 mm × 2 mm). The cured product was moved at a speed of 1 mm / s, and the presence or absence of scratches was confirmed visually. This operation was performed on five cured products, and scratch resistance was evaluated according to the following criteria.
 ○:すべての硬化物に傷が付かない
 △:1本でも傷付く硬化物があるが、回復性が確認できる。
○: All cured products are not scratched. Δ: Even one cured product is scratched, but recovery can be confirmed.
 ×:傷が付き、回復を確認できない。 ×: Scratched and cannot be confirmed.
 (原料)
 BPEFA:大阪ガスケミカル(株)製、9,9-ビス[4-(2-アクリロイルオキシエトキシ)フェニル]フルオレン
 BPEF-9EOA:大阪ガスケミカル(株)製、9,9-ビス[4-(2-ヒドロキシエトキシ)フェニル]フルオレン1モルに対して、エチレンオキサイドが平均値で9モル付加した付加体のジアクリレート
 UV-3200B:日本合成化学工業(株)製、二官能性ウレタンアクリレート
 FA-321A:日立化成工業(株)製、ビスフェノールA 1モルに対して、エチレンオキサイドが平均値で10モル付加した付加体のジアクリレート
 エポキシエステル3000A:共栄社化学(株)製、ビスフェノールAのジグリシジルエーテルのアクリル酸付加物
 KAYARAD UX-5000:日本化薬(株)製、6官能エステル系ウレタンアクリレート
 POA:2-フェノキシエチルアクリレート
 NEOA:2-(2-ナフトキシ)エチルアクリレート(後述する合成例1により調製)
 PTEA:Miwon Specialty Chemical Co., Ltd.製、フェニルチオエチルアクリレート
 OPPEOA:日本化薬(株)製、o-フェニルフェノキシエチルアクリレート
 イルガキュア184:BASFジャパン(株)製、光重合開始剤。
(material)
BPEFA: 9,9-bis [4- (2-acryloyloxyethoxy) phenyl] fluorene manufactured by Osaka Gas Chemical Co., Ltd. BPEF-9EOA: 9,9-bis [4- (2 manufactured by Osaka Gas Chemical Co., Ltd.) -Hydroxyethoxy) phenyl] diacrylate adduct obtained by adding 9 moles of ethylene oxide on average to 1 mole of fluorene UV-3200B: manufactured by Nippon Synthetic Chemical Industry Co., Ltd., bifunctional urethane acrylate FA-321A: Adhesive diacrylate epoxy ester 3000A with an average of 10 moles of ethylene oxide added to 1 mole of bisphenol A manufactured by Hitachi Chemical Co., Ltd .: Kyoeisha Chemical Co., Ltd., acrylic bisphenol A diglycidyl ether Acid adduct KAYARAD UX-5000: Nippon Kayaku Co., Ltd., 6 Functional ester urethane acrylate POA: 2-phenoxyethyl acrylate NEOA: 2- (2-naphthoxy) ethyl acrylate (prepared according to Synthesis Example 1 described later)
PTEA: manufactured by Miwon Specialty Chemical Co., Ltd., phenylthioethyl acrylate OPPEOA: manufactured by Nippon Kayaku Co., Ltd., o-phenylphenoxyethyl acrylate Irgacure 184: manufactured by BASF Japan, photopolymerization initiator.
 (合成例1)
 ディーンスタークを付けた500mL三口フラスコに、2-(2-ナフチルオキシ)エタノール(NEO)49.4g(0.26mol)、アクリル酸24.6g(0.34mol)、4-メトキシフェノール0.56g(0.0046mol)及びトルエン256gを加えた。系内を窒素置換し、60℃まで昇温して、前記成分を溶解させた後、p-トルエンスルホン酸一水和物6.24g(0.033mol)を添加した。再度窒素置換後、115℃まで昇温して、3時間還流脱水した。
(Synthesis Example 1)
To a 500 mL three-necked flask equipped with Dean Stark, 49.4 g (0.26 mol) of 2- (2-naphthyloxy) ethanol (NEO), 24.6 g (0.34 mol) of acrylic acid, and 0.56 g of 4-methoxyphenol ( 0.0046 mol) and 256 g of toluene were added. The system was purged with nitrogen, heated to 60 ° C. to dissolve the above components, and then 6.24 g (0.033 mol) of p-toluenesulfonic acid monohydrate was added. After substituting with nitrogen again, the temperature was raised to 115 ° C. and refluxed and dehydrated for 3 hours.
 得られた溶液を20重量%食塩水で洗浄後、10重量%水酸化ナトリウム水溶液と20重量%食塩水で中和し、水層がpH10以上であることを確認した。その後、有機層に500ppmの4-メトキシフェノールを添加し、溶液を均一化した。この溶液を20重量%食塩水で2回、蒸留水で3回洗浄し、水層がpH7であることを確認した後、有機層を濃縮し、セライト濾過を行った。濾過後、濾液を濃縮乾燥し、粉末状の白色固体であるNEOAを得た。 The obtained solution was washed with 20% by weight saline solution, neutralized with 10% by weight sodium hydroxide aqueous solution and 20% by weight saline solution, and it was confirmed that the aqueous layer had a pH of 10 or more. Thereafter, 500 ppm of 4-methoxyphenol was added to the organic layer to homogenize the solution. This solution was washed twice with 20% by weight saline and three times with distilled water. After confirming that the aqueous layer had a pH of 7, the organic layer was concentrated and filtered through Celite. After filtration, the filtrate was concentrated and dried to obtain NEOA as a powdery white solid.
 NEOAの屈折率(25℃、589nm)は1.59、融点は62℃であった。なお、融点は示差走査熱量計(DSC)(エスアイアイ・ナノテクノロジー(株)製「EXSTAR DSC6220」)により測定した。 NEOA had a refractive index (25 ° C., 589 nm) of 1.59 and a melting point of 62 ° C. The melting point was measured with a differential scanning calorimeter (DSC) (“EXSTAR DSC 6220” manufactured by SII Nanotechnology Inc.).
 (比較例1~5及び実施例1~5)
 下記表1に示す割合で、各重合性成分(多官能性(メタ)アクリレートとしてのBPEFA、及び反応性希釈剤としてのPOA又はNEOA)を混合して、硬化性組成物を調製し、硬化前屈折率及び粘度を測定した。測定結果を表1及び図1~2に示す。
(Comparative Examples 1 to 5 and Examples 1 to 5)
Each polymerizable component (BPEFA as a polyfunctional (meth) acrylate and POA or NEOA as a reactive diluent) is mixed at a ratio shown in Table 1 below to prepare a curable composition, before curing. Refractive index and viscosity were measured. The measurement results are shown in Table 1 and FIGS.
Figure JPOXMLDOC01-appb-T000015
Figure JPOXMLDOC01-appb-T000015
 表1及び図1~2から明らかなように、比較例に比べて、実施例では、希釈剤を多量に含むにもかかわらず、比較的高い屈折率を維持し、かつ、粘度も同程度まで低減できる。なお、常温(例えば、25℃程度)において、POAは、一般的な反応性希釈剤と同様に、透明な液体であるが、NEOAは全く流動性を示さない粉末状の白色固体であり、粘稠体であるBPEFAと混合して始めて液状となり、低粘性を示すため、極めて意外な結果であった。 As is apparent from Table 1 and FIGS. 1 and 2, in the Examples, the comparative example maintains a relatively high refractive index and has a viscosity of the same level even though it contains a large amount of diluent, as compared with the Comparative Examples. Can be reduced. At normal temperature (for example, about 25 ° C.), POA is a transparent liquid like a general reactive diluent, but NEOA is a powdery white solid that does not exhibit fluidity at all, and has a viscosity. Only when mixed with BPEFA, which was a solid, became liquid and showed low viscosity, which was a very surprising result.
 また、図1及び図2には、各反応性希釈剤の配合割合をx、屈折率又は粘度をyとして、比較例1~5及び実施例1~5の測定値に基づく近似線を示す式を表記した。なお、近似線は、マイクロソフト社製「Microsoft Excel (Microsoft Office Standard 2010)」を使用して算出し、屈折率については、線形近似を、粘度については、累乗近似を採用した。比較例及び実施例から得られた結果をより分かりやすく比較するため、これらの近似線(又は近似線を示す式)に基づき、BPEFAと各反応性希釈剤との配合系において、下記表2に記載の目標屈折率(硬化前)を達成する配合割合、及びその配合割合における硬化性組成物の粘度を、それぞれの反応性希釈剤について算出した。計算結果を表2及び図3に示す。 1 and FIG. 2 are equations showing approximate lines based on the measured values of Comparative Examples 1 to 5 and Examples 1 to 5, where x is the mixing ratio of each reactive diluent and y is the refractive index or viscosity. Was written. The approximate line was calculated using “Microsoft Excel (Microsoft Office Standard 2010)” manufactured by Microsoft Corporation, linear approximation was used for the refractive index, and power approximation was used for the viscosity. In order to compare the results obtained from the comparative examples and examples more easily, in the blending system of BPEFA and each reactive diluent based on these approximate lines (or formulas indicating the approximate lines), the following Table 2 The blending ratio to achieve the stated target refractive index (before curing) and the viscosity of the curable composition at the blending ratio were calculated for each reactive diluent. The calculation results are shown in Table 2 and FIG.
Figure JPOXMLDOC01-appb-T000016
Figure JPOXMLDOC01-appb-T000016
 表2及び図3から明らかなように、BPEFA/POA配合系に比べて、BPEFA/NEOA配合系では、各目標屈折率を達成する硬化性組成物の粘度が低く、特に、目標屈折率が大きくなるほど、粘度の差が極めて大きくなることが分かった。また、BPEFA/NEOA配合系では、目標屈折率を達成するための配合比において、反応性希釈剤の割合が多く、BPEFAの使用割合を低減できることが分かる。 As is apparent from Table 2 and FIG. 3, in the BPEFA / NEOA blending system, the viscosity of the curable composition that achieves each target refractive index is lower than that in the BPEFA / POA blending system, and in particular, the target refractive index is large. It turns out that the difference in viscosity becomes very large. Moreover, in the BPEFA / NEOA blending system, it can be seen that the proportion of the reactive diluent is large in the blending ratio for achieving the target refractive index, and the use proportion of BPEFA can be reduced.
 (比較例6及び実施例6~12)
 下記表3に示す割合で、各重合性成分を混合して、硬化性組成物を調製し、粘度及び屈折率(硬化前)を測定した。
(Comparative Example 6 and Examples 6 to 12)
Each polymerizable component was mixed at a ratio shown in Table 3 to prepare a curable composition, and the viscosity and refractive index (before curing) were measured.
 調製した各硬化性組成物(重合性成分)100重量部に対して、光重合開始剤3重量部を添加し、加熱溶融して混合した。得られたそれぞれの硬化性組成物を、TAC(酢酸セルロース)フィルム上に、アプリケーターを使用して膜厚200μmに塗布し、UV照射(500mJ/cm)を1回行って硬化物を作製した。得られたそれぞれの硬化物は、いずれも膜厚100μmのフィルム状であり、この硬化物を使用して、屈折率(硬化後)を測定した。 3 parts by weight of a photopolymerization initiator was added to 100 parts by weight of each prepared curable composition (polymerizable component), and the mixture was heated and melted and mixed. Each obtained curable composition was applied on a TAC (cellulose acetate) film to a film thickness of 200 μm using an applicator, and UV irradiation (500 mJ / cm 2 ) was performed once to prepare a cured product. . Each of the obtained cured products was a film having a film thickness of 100 μm, and the refractive index (after curing) was measured using this cured product.
 また、離型剤をスプレーにより付着させたガラスに金型を載せ、この金型に前記光重合開始剤を混合した各硬化性組成物を流し込み、同じ処理を施したガラスで金型を挟み、UV照射(500mJ/cm)を4回繰り返し、50mm×15mm×2mmのサイズを有する硬化物を作製した。得られた硬化物を用いて、耐スクラッチ性を測定した。 Also, a mold is placed on the glass to which the release agent is attached by spraying, and each curable composition mixed with the photopolymerization initiator is poured into this mold, and the mold is sandwiched between the glass subjected to the same treatment, UV irradiation (500 mJ / cm 2 ) was repeated four times to produce a cured product having a size of 50 mm × 15 mm × 2 mm. Scratch resistance was measured using the obtained cured product.
 配合割合及び評価結果を表3に示す。なお、表3中の( )内の数字は、硬化性組成物における各構成成分の重量部を意味する(以下、表4も同じ)。 Table 3 shows the blending ratio and evaluation results. In addition, the number in () of Table 3 means the weight part of each structural component in a curable composition (hereinafter, Table 4 is also the same).
Figure JPOXMLDOC01-appb-T000017
Figure JPOXMLDOC01-appb-T000017
 表3から明らかなように、比較例6は、屈折率は高いものの、粘度が高いためハンドリング性が十分ではなく、ハンドリング性と高屈折率とを両立できない。一方、実施例6では、耐スクラッチ性を維持しつつ、優れたハンドリング性及び高屈折率を有している。 As is clear from Table 3, Comparative Example 6 has a high refractive index, but has a high viscosity, so that the handling property is not sufficient, and the handling property and the high refractive index cannot be achieved at the same time. On the other hand, Example 6 has excellent handling properties and high refractive index while maintaining scratch resistance.
 また、実施例7~8では、軟質二官能性(メタ)アクリレートを含むためか、比較的良好なハンドリング性を維持しつつ、かつ高屈折率と耐スクラッチ性とを両立できるため、各特性のバランスにも優れている。特に実施例7で混合したUV-3200Bは、60℃における粘度が40000~60000mPa・sとかなり高粘度であるにもかかわらず、比較的良好なハンドリング性を示している。 Further, in Examples 7 to 8, each of the properties is different because it contains a soft bifunctional (meth) acrylate or maintains a relatively good handling property and achieves both a high refractive index and scratch resistance. Excellent balance. In particular, the UV-3200B mixed in Example 7 shows relatively good handling properties even though the viscosity at 60 ° C. is as high as 40,000 to 60,000 mPa · s.
 さらに、実施例9~12では、他の単官能性アクリレート(硫黄原子を含有する第2の単官能性(メタ)アクリレート又は前記式(3)で表される第3の単官能性(メタ)アクリレート)を組み合わせることで、より優れたハンドリング性と高屈折率との両立を達成している。特に、実施例10では、高いレベルでハンドリング性と高屈折率とを両立するだけでなく、耐スクラッチ性も向上している。 Further, in Examples 9 to 12, other monofunctional acrylates (second monofunctional (meth) acrylate containing a sulfur atom or third monofunctional (meth) represented by the above formula (3)) are used. (Acrylate) in combination achieves both excellent handling properties and a high refractive index. In particular, in Example 10, not only the handling property and the high refractive index are compatible at a high level, but also the scratch resistance is improved.
 (比較例7~9及び実施例13~15)
 下記表4に示す割合で、各重合性成分を混合して、硬化性組成物を調製し、粘度(温度25℃)及び屈折率(硬化前)を測定した。さらに、比較例7~8及び実施例13~14では、60℃における硬化性組成物の粘度も併せて測定した。
(Comparative Examples 7 to 9 and Examples 13 to 15)
Each polymerizable component was mixed at the ratio shown in Table 4 to prepare a curable composition, and the viscosity (temperature 25 ° C.) and the refractive index (before curing) were measured. Further, in Comparative Examples 7 to 8 and Examples 13 to 14, the viscosity of the curable composition at 60 ° C. was also measured.
 また、比較例6及び実施例6~12と同様の方法により、調製した各硬化性組成物の硬化物(膜厚100μmのフィルム状の硬化物及び50mm×15mm×2mmのサイズを有する硬化物)を作製し、これらの硬化物を使用して、屈折率(硬化後)及び耐スクラッチ性を測定した。配合割合及び評価結果を表4に示す。 Further, cured products of the respective curable compositions prepared by the same method as in Comparative Example 6 and Examples 6 to 12 (a cured film having a film thickness of 100 μm and a cured product having a size of 50 mm × 15 mm × 2 mm) Were used, and the refractive index (after curing) and scratch resistance were measured using these cured products. Table 4 shows the blending ratio and the evaluation results.
Figure JPOXMLDOC01-appb-T000018
Figure JPOXMLDOC01-appb-T000018
 表4の結果から明らかなように、実施例13~15のいずれにおいても、10重量%のNEOAの添加により、ハンドリング性が大幅に向上し、かつ屈折率も向上した。また、ウレタン(メタ)アクリレートを用いた実施例13及び15は、耐スクラッチ性も良好であった。 As is clear from the results in Table 4, in any of Examples 13 to 15, the addition of 10% by weight of NEOA significantly improved handling properties and also improved the refractive index. In addition, Examples 13 and 15 using urethane (meth) acrylate also had good scratch resistance.
 本発明の硬化性組成物は、低粘度、高屈折率、耐スクラッチ性などの特性に優れているため、種々の用途に利用できる。例えば、インク材料、発光材料(例えば、有機EL用発光材料など)、有機半導体、黒鉛化前駆体、ガス分離膜(例えば、COガス分離膜など)、コート剤(例えば、LED(発光ダイオード)用素子のコート剤などの光学用オーバーコート剤又はハードコート剤など)、レンズ[例えば、ピックアップレンズ(例えば、DVD(デジタル・バーサタイル・ディスク)用ピックアップレンズなど)、マイクロレンズ(例えば、液晶プロジェクター用マイクロレンズなど)、眼鏡レンズなど]、偏光膜(例えば、液晶ディスプレイ用偏光膜など)、反射防止フィルム(又は反射防止膜、例えば、表示デバイス用反射防止フィルムなど)、タッチパネル用フィルム、フレキシブル基板用フィルム、ディスプレイ用フィルム[例えば、PDP(プラズマディスプレイ)、LCD(液晶ディスプレイ)、VFD(真空蛍光ディスプレイ)、SED(表面伝導型電子放出素子ディスプレイ)、FED(電界放出ディスプレイ)、NED(ナノ・エミッシブ・ディスプレイ)、ブラウン管、電子ペーパーなどのディスプレイ(特に薄型ディスプレイ)用フィルム(フィルタ、保護フィルムなど)など]、燃料電池用膜、光ファイバー、光導波路、ホログラムなどに好適に使用できる。特に、本発明の硬化性組成物は、光学材料用途に好適に利用でき、このような光学材料の形状としては、例えば、フィルム状(又はシート状)、板状、レンズ状、管状などが挙げられる。 Since the curable composition of the present invention is excellent in properties such as low viscosity, high refractive index, and scratch resistance, it can be used in various applications. For example, ink materials, light emitting materials (for example, organic EL light emitting materials), organic semiconductors, graphitized precursors, gas separation membranes (for example, CO 2 gas separation membranes), coating agents (for example, LEDs (light emitting diodes)) Optical overcoat agent or hard coat agent such as a coating agent for an optical element), lens [eg, pickup lens (eg, pickup lens for DVD (digital versatile disk)), micro lens (eg, for liquid crystal projector) Micro lenses, etc.), spectacle lenses, etc.], polarizing films (eg, polarizing films for liquid crystal displays), antireflection films (or antireflection films, eg, antireflection films for display devices), touch panel films, flexible substrates Film, display film [for example, PDP ( Laser display), LCD (liquid crystal display), VFD (vacuum fluorescent display), SED (surface conduction electron-emitting device display), FED (field emission display), NED (nano-emissive display), cathode ray tube, electronic paper, etc. It can be suitably used for films for displays (particularly thin displays) (filters, protective films, etc.), fuel cell membranes, optical fibers, optical waveguides, holograms, and the like. In particular, the curable composition of the present invention can be suitably used for optical material applications. Examples of the shape of such an optical material include a film shape (or sheet shape), a plate shape, a lens shape, and a tubular shape. It is done.
 また、本発明の第1の単官能性(メタ)アクリレートは、多官能性(メタ)アクリレートの粘度を低減するための低粘度化剤としても利用できる。 Further, the first monofunctional (meth) acrylate of the present invention can also be used as a viscosity reducing agent for reducing the viscosity of the polyfunctional (meth) acrylate.

Claims (19)

  1.  多官能性(メタ)アクリレートと、下記式(1)
    Figure JPOXMLDOC01-appb-C000001
    (式中、Rは水素原子又はメチル基、Rは直鎖状又は分岐鎖状アルキレン基、Rはアルキル基、Arは縮合多環式アレーン環、aは1~4の整数、bは0又は1以上の整数を示す。)
    で表される第1の単官能性(メタ)アクリレートとを含む硬化性組成物。
    Multifunctional (meth) acrylate and the following formula (1)
    Figure JPOXMLDOC01-appb-C000001
    (Wherein R 1 is a hydrogen atom or a methyl group, R 2 is a linear or branched alkylene group, R 3 is an alkyl group, Ar 1 is a condensed polycyclic arene ring, a is an integer of 1 to 4, b represents 0 or an integer of 1 or more.)
    The curable composition containing 1st monofunctional (meth) acrylate represented by these.
  2.  第1の単官能性(メタ)アクリレートが、縮合多環式C10-14アリールオキシC2-4アルキル(メタ)アクリレートである請求項1記載の硬化性組成物。 The curable composition according to claim 1, wherein the first monofunctional (meth) acrylate is a condensed polycyclic C 10-14 aryloxy C 2-4 alkyl (meth) acrylate.
  3.  多官能性(メタ)アクリレートが、下記式(2)
    Figure JPOXMLDOC01-appb-C000002
    (式中、環Z及びZ並びに環Z及びZはアレーン環、R4a及びR4b並びにR5a及びR5bはそれぞれ同一又は異なる非反応性置換基、R6a及びR6bは直鎖状又は分岐鎖状アルキレン基、R7a及びR7bは水素原子又はメチル基、k1及びk2は0又は1以上の整数、m1及びm2は0又は1以上の整数、n1及びn2は0又は1以上の整数、p1及びp2は1以上の整数を示す。)
    で表されるフルオレン骨格含有(メタ)アクリレート、脂環族又は芳香族エポキシ(メタ)アクリレート、ウレタン(メタ)アクリレート及びポリエステル(メタ)アクリレートからなる群より選択された少なくとも1種の高粘度多官能性(メタ)アクリレートを含む請求項1又は2記載の硬化性組成物。
    The polyfunctional (meth) acrylate is represented by the following formula (2)
    Figure JPOXMLDOC01-appb-C000002
    (Wherein rings Z 1 and Z 2 and rings Z 3 and Z 4 are arene rings, R 4a and R 4b and R 5a and R 5b are the same or different non-reactive substituents, and R 6a and R 6b are direct A linear or branched alkylene group, R 7a and R 7b are hydrogen atoms or methyl groups, k1 and k2 are 0 or an integer of 1 or more, m1 and m2 are 0 or an integer of 1 or more, and n1 and n2 are 0 or 1 (The above integers, p1 and p2 represent integers of 1 or more.)
    At least one high-viscosity multifunctional selected from the group consisting of fluorene skeleton-containing (meth) acrylates, alicyclic or aromatic epoxy (meth) acrylates, urethane (meth) acrylates and polyester (meth) acrylates The curable composition of Claim 1 or 2 containing a property (meth) acrylate.
  4.  多官能性(メタ)アクリレートが、式(2)で表されるフルオレン骨格含有(メタ)アクリレートと、ウレタン(メタ)アクリレートとを少なくとも含む請求項3記載の硬化性組成物。 The curable composition according to claim 3, wherein the polyfunctional (meth) acrylate includes at least a fluorene skeleton-containing (meth) acrylate represented by the formula (2) and a urethane (meth) acrylate.
  5.  さらに、ビフェノール類又はビスフェノール類のアルキレンオキサイド付加体のジ(メタ)アクリレートを含む請求項3又は4記載の硬化性組成物。 The curable composition according to claim 3 or 4, further comprising a di (meth) acrylate of an alkylene oxide adduct of biphenols or bisphenols.
  6.  式(2)において、環Z及びZ並びに環Z及びZがそれぞれベンゼン環又はナフタレン環、k1及びk2が0、R5a及びR5bがC1-6アルキル基又はC6-10アリール基、m1及びm2が0又は1~2の整数、R6a及びR6bが直鎖状C2-6アルキレン基、n1及びn2が1~10の整数、p1及びp2が1であり、
     芳香族エポキシ(メタ)アクリレートが、下記式(3)
    Figure JPOXMLDOC01-appb-C000003
    (式中、Rはそれぞれ水素原子、アルキル基又はアリール基を示し、2つのRは互いに結合して、アルキル基を有してもよい炭化水素環を形成してもよく、R9a及びR9bはそれぞれアルキル基又はアリール基、R10a及びR10bは直鎖状又は分岐鎖状アルキレン基、R11a及びR11bは水素原子又はメチル基、q1及びq2は0~4の整数、r1及びr2は0又は1以上の整数、tは0又は1を示す。)
    で表される芳香族エポキシ(メタ)アクリレートであり、
     ウレタン(メタ)アクリレートが、ポリエステル型ウレタン(メタ)アクリレート、ポリエーテル型ウレタン(メタ)アクリレート又はポリカーボネート型ウレタン(メタ)アクリレートである請求項3~5のいずれかに記載の硬化性組成物。
    In the formula (2), rings Z 1 and Z 2 and rings Z 3 and Z 4 are respectively a benzene ring or a naphthalene ring, k1 and k2 are 0, R 5a and R 5b are C 1-6 alkyl groups or C 6-10 An aryl group, m1 and m2 are 0 or an integer of 1 to 2, R 6a and R 6b are linear C 2-6 alkylene groups, n1 and n2 are integers of 1 to 10, p1 and p2 are 1,
    Aromatic epoxy (meth) acrylate is represented by the following formula (3)
    Figure JPOXMLDOC01-appb-C000003
    (Wherein R 8 represents a hydrogen atom, an alkyl group or an aryl group, respectively, and two R 8 may be bonded to each other to form a hydrocarbon ring which may have an alkyl group, R 9a and R 9b is an alkyl group or an aryl group, R 10a and R 10b are linear or branched alkylene groups, R 11a and R 11b are hydrogen atoms or methyl groups, q1 and q2 are integers of 0 to 4, r1 and r2 is 0 or an integer of 1 or more, and t is 0 or 1.)
    Is an aromatic epoxy (meth) acrylate represented by
    6. The curable composition according to claim 3, wherein the urethane (meth) acrylate is a polyester type urethane (meth) acrylate, a polyether type urethane (meth) acrylate, or a polycarbonate type urethane (meth) acrylate.
  7.  多官能性(メタ)アクリレートの粘度(25℃)が、3000mPa・s以上である請求項1~6のいずれかに記載の硬化性組成物。 The curable composition according to any one of claims 1 to 6, wherein the polyfunctional (meth) acrylate has a viscosity (25 ° C) of 3000 mPa · s or more.
  8.  多官能性(メタ)アクリレートと、第1の単官能性(メタ)アクリレートとの割合が、前者/後者(重量比)=80/20~5/95である請求項1~7のいずれかに記載の硬化性組成物。 The ratio of the polyfunctional (meth) acrylate and the first monofunctional (meth) acrylate is the former / the latter (weight ratio) = 80/20 to 5/95. The curable composition as described.
  9.  式(2)で表されるフルオレン骨格含有(メタ)アクリレートと、ウレタン(メタ)アクリレートとの割合が、前者/後者(重量比)=50/50~99/1である請求項4~8のいずれかに記載の硬化性組成物。 The ratio of the fluorene skeleton-containing (meth) acrylate represented by the formula (2) and the urethane (meth) acrylate is the former / the latter (weight ratio) = 50/50 to 99/1. The curable composition in any one.
  10.  高粘度多官能性(メタ)アクリレートと、ビフェノール類又はビスフェノール類のアルキレンオキサイド付加体のジ(メタ)アクリレートとの割合が、前者/後者(重量比)=50/50~99/1である請求項5~9のいずれかに記載の硬化性組成物。 The ratio of the high-viscosity polyfunctional (meth) acrylate to the di (meth) acrylate of the alkylene oxide adduct of biphenols or bisphenols is the former / the latter (weight ratio) = 50/50 to 99/1 Item 10. The curable composition according to any one of Items 5 to 9.
  11.  さらに、アルキルチオ(メタ)アクリレート、アリールチオ(メタ)アクリレート、アラルキルチオ(メタ)アクリレート及びアリールチオアルキル(メタ)アクリレートからなる群より選択される少なくとも1種の硫黄原子を含有する第2の単官能性(メタ)アクリレートを含み、かつ第1の単官能性(メタ)アクリレートと、第2の単官能性(メタ)アクリレートとの割合が、前者/後者(重量比)=80/20~20/80である請求項1~10のいずれかに記載の硬化性組成物。 Furthermore, the second monofunctional containing at least one sulfur atom selected from the group consisting of alkylthio (meth) acrylate, arylthio (meth) acrylate, aralkylthio (meth) acrylate and arylthioalkyl (meth) acrylate The ratio of the first monofunctional (meth) acrylate and the second monofunctional (meth) acrylate containing (meth) acrylate is the former / the latter (weight ratio) = 80/20 to 20/80 The curable composition according to any one of claims 1 to 10.
  12.  さらに、下記式(4)
    Figure JPOXMLDOC01-appb-C000004
    (式中、R12は水素原子又はメチル基、R13はアルキレン基、R14はアルキル基、Arはベンゼン環又は環集合アレーン環、cは1~4の整数、dは0又は1以上の整数を示す。)
    で表される第3の単官能性(メタ)アクリレートを含み、かつ第1の単官能性(メタ)アクリレートと、第3の単官能性(メタ)アクリレートとの割合が、前者/後者(重量比)=80/20~20/80である請求項1~11のいずれかに記載の硬化性組成物。
    Further, the following formula (4)
    Figure JPOXMLDOC01-appb-C000004
    (Wherein R 12 is a hydrogen atom or a methyl group, R 13 is an alkylene group, R 14 is an alkyl group, Ar 2 is a benzene ring or a ring-arene ring, c is an integer of 1 to 4, and d is 0 or 1 or more. Indicates an integer.)
    The ratio of the first monofunctional (meth) acrylate and the third monofunctional (meth) acrylate is the former / the latter (weight). The curable composition according to claim 1, wherein the ratio is 80/20 to 20/80.
  13.  さらに、重合開始剤を含む請求項1~12のいずれかに記載の硬化性組成物。 The curable composition according to any one of claims 1 to 12, further comprising a polymerization initiator.
  14.  請求項1~13のいずれかに記載の硬化性組成物が硬化した硬化物。 A cured product obtained by curing the curable composition according to any one of claims 1 to 13.
  15.  請求項1~13のいずれかに記載の硬化性組成物に、活性エネルギーを与えて硬化させ、請求項14記載の硬化物を製造する方法。 A method for producing a cured product according to claim 14, wherein the curable composition according to any one of claims 1 to 13 is cured by applying active energy.
  16.  多官能性(メタ)アクリレートを低粘度化するための低粘度化剤であって、請求項1又は2記載の第1の単官能性(メタ)アクリレートを含む低粘度化剤。 A viscosity reducing agent for reducing the viscosity of a polyfunctional (meth) acrylate, comprising the first monofunctional (meth) acrylate according to claim 1 or 2.
  17.  さらに、請求項11記載の第2の単官能性(メタ)アクリレートを含む請求項16記載の低粘度化剤。 Furthermore, the low viscosity agent of Claim 16 containing the 2nd monofunctional (meth) acrylate of Claim 11.
  18.  多官能性(メタ)アクリレートに、請求項1又は2記載の第1の単官能性(メタ)アクリレートを添加して、多官能性(メタ)アクリレートの粘度を低減する方法。 A method for reducing the viscosity of a polyfunctional (meth) acrylate by adding the first monofunctional (meth) acrylate according to claim 1 or 2 to the polyfunctional (meth) acrylate.
  19.  請求項1又は2記載の第1の単官能性(メタ)アクリレート。 The first monofunctional (meth) acrylate according to claim 1 or 2.
PCT/JP2016/076818 2015-09-16 2016-09-12 Curable composition and cured product of same WO2017047547A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017539891A JP7138437B2 (en) 2015-09-16 2016-09-12 Curable composition and cured product thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2015183324 2015-09-16
JP2015-183324 2015-09-16
JP2015-217759 2015-11-05
JP2015217759 2015-11-05

Publications (1)

Publication Number Publication Date
WO2017047547A1 true WO2017047547A1 (en) 2017-03-23

Family

ID=58288736

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2016/076818 WO2017047547A1 (en) 2015-09-16 2016-09-12 Curable composition and cured product of same

Country Status (3)

Country Link
JP (1) JP7138437B2 (en)
TW (1) TW201714948A (en)
WO (1) WO2017047547A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017209004A1 (en) * 2016-05-30 2017-12-07 日産化学工業株式会社 Low-viscosity agent for polymerizable compound having high refractive index and polymerizable composition containing same
EP4043502A1 (en) * 2021-02-11 2022-08-17 Xetos AG Photopolymerizable hoe composition

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216848A (en) * 1983-05-20 1984-12-06 Showa Denko Kk Naphthalene derivative
JPS60144701A (en) * 1984-01-05 1985-07-31 Showa Denko Kk High refractive index plastic lens
JP2007517929A (en) * 2003-12-11 2007-07-05 スリーエム イノベイティブ プロパティズ カンパニー Composition for fine screen
JP2008088132A (en) * 2006-10-04 2008-04-17 Kawasaki Kasei Chem Ltd Novel anthracene compound, its production method, and its use
WO2013022065A1 (en) * 2011-08-11 2013-02-14 大阪ガスケミカル株式会社 Multifunctional (meth)acrylate having fluorene skeleton and curable composition containing same
WO2014196381A1 (en) * 2013-06-06 2014-12-11 Dic株式会社 Curable composition for imprinting
JP2015199952A (en) * 2014-04-01 2015-11-12 大阪ガスケミカル株式会社 (meth) acrylate compound having fluorene skeleton and production method thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216848A (en) * 1983-05-20 1984-12-06 Showa Denko Kk Naphthalene derivative
JPS60144701A (en) * 1984-01-05 1985-07-31 Showa Denko Kk High refractive index plastic lens
JP2007517929A (en) * 2003-12-11 2007-07-05 スリーエム イノベイティブ プロパティズ カンパニー Composition for fine screen
JP2008088132A (en) * 2006-10-04 2008-04-17 Kawasaki Kasei Chem Ltd Novel anthracene compound, its production method, and its use
WO2013022065A1 (en) * 2011-08-11 2013-02-14 大阪ガスケミカル株式会社 Multifunctional (meth)acrylate having fluorene skeleton and curable composition containing same
WO2014196381A1 (en) * 2013-06-06 2014-12-11 Dic株式会社 Curable composition for imprinting
JP2015199952A (en) * 2014-04-01 2015-11-12 大阪ガスケミカル株式会社 (meth) acrylate compound having fluorene skeleton and production method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017209004A1 (en) * 2016-05-30 2017-12-07 日産化学工業株式会社 Low-viscosity agent for polymerizable compound having high refractive index and polymerizable composition containing same
EP4043502A1 (en) * 2021-02-11 2022-08-17 Xetos AG Photopolymerizable hoe composition
WO2022171821A1 (en) * 2021-02-11 2022-08-18 Xetos Ag Photopolymerizable hoe composition

Also Published As

Publication number Publication date
JP7138437B2 (en) 2022-09-16
TW201714948A (en) 2017-05-01
JPWO2017047547A1 (en) 2018-07-05

Similar Documents

Publication Publication Date Title
JP6487308B2 (en) Polyester poly (meth) acrylate having fluorene skeleton, curable composition and cured product thereof, and production method thereof
TWI439522B (en) Radical-polymerizable composition, cured article and plastic lens
TWI551645B (en) Radical-polymerizable composition, cured article and plastic lens
JP5411370B2 (en) Urethane (meth) acrylate having fluorene skeleton and cured product thereof
JP6470620B2 (en) (Meth) acrylate compound having fluorene skeleton and method for producing the same
JP5513640B2 (en) Urethane (meth) acrylate having fluorene skeleton and cured product thereof
JP6871667B2 (en) Curable composition and its cured product
JP7245778B2 (en) Monofunctional (meth)acrylates and curable compositions
JP2016126141A (en) Resin composition for light diffusion film, and light diffusion film
WO2017047547A1 (en) Curable composition and cured product of same
JP5297030B2 (en) Urethane (meth) acrylate with fluorene skeleton
JP2018059063A (en) Curable composition and cured product thereof
KR20170077175A (en) Light control panel and optical imaging device
JP2013028662A (en) Energy ray-curable resin composition for optical lens sheet and cured product using the same
JP2010122633A (en) Energy-ray curable resin composition for optical lens sheet, and optical lens sheet
JP6923314B2 (en) Epoxy (meth) acrylate and its curable composition
JP2004323643A (en) Active energy ray-curable composition
JP2004323557A (en) Curable composition and cured product thereof
JPH0940730A (en) Ultraviolet-curing resin composition for fresnel lens and transmission screen
JP3617699B2 (en) UV curable resin composition for Fresnel lens and transmissive screen
JP2013227393A (en) Energy ray-curable resin composition for optical lens sheet and cured product of the same
JP6487239B2 (en) Phenoxy (meth) acrylate and production method and use thereof
JPH01152114A (en) Resin composition and coating material
WO2019031310A1 (en) Patterned film and photocurable composition
JPS6278131A (en) Coating material for optical glass fiber

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16846418

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2017539891

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16846418

Country of ref document: EP

Kind code of ref document: A1